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Abstract 
Metabolic engineering—the process of altering an organism’s metabolism to achieve a desired goal—
presents an alternative to established chemical processes. By tapping into the enormous range of 
metabolic transformations carried out by microbes, we can create microbial cell factories that improve 
upon chemical processes efficiencies while eliminating potential waste products. One of the greatest 
obstacles to realizing this potential is our incomplete picture of the possibilities of metabolism, a 
challenge we address by developing automated tools and databases to guide our inquiries. Though 
these high throughput studies have greatly accelerated the timeline to go from sequencing a genome to 
piecing together overall metabolic functions, these accelerated results generally come at the price of 
higher error rates. In my thesis work, I investigated ways to mitigate this loss of precision by more 
deeply integrating manually curated information into automated approaches.  
In the first part of my thesis, I focused on defined microbial growth media, the essential substances that 
comprise the raw materials of biochemical processes. The vast majority of microbes cannot currently be 
cultured in a laboratory, a formidable obstacle to characterizing these organisms and their metabolisms. 
Methods that predict new defined media could expedite culturing experiments; however, such efforts 
require a repository of known defined media that collects successful growth conditions. To address this 
need, I created MediaDB, an open access database of chemically defined microbial media from 
published biochemical literature. MediaDB enables studies across different media that can reveal 
emergent trends in known media formulations across organisms. By examining media in the database, I 
found that they often contain similar trace mineral and vitamin solutions, suggesting a measure of 
uniformity in the way that biologists have traditionally created growth media. Clustering organisms 
based on their media compounds, I found no connection between media similarity and organism 
phylogeny, though several cases demonstrated a link connecting media to specific metabolic functions. 
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For the second part of my thesis, I built a genome scale metabolic reconstruction for Methanococcus 
maripaludis, an archaeon that produces methane from CO2 and H2. M. maripaludis provided an excellent 
engineering target, both for modifying forward methanogenesis as well as for working to oxidize 
methane to methanol, a first step towards building a pathway to liquid fuel that is of interest to the 
Department of Energy. I reconstructed my metabolic network model by relying chiefly on manual, 
resulting in the first network to correctly depict hydrogenotrophic methanogenesis. My reconstruction 
demonstrates the importance of electron bifurcation in central metabolism, providing both a window 
into hydrogenotrophic methanogenesis and platform to generate metabolic engineering hypotheses. I 
validated my model on growth yield and gene knockout data, showing its strong ability to reproduce 
experimentally measured results. Using the completed network, I predicted the previously unknown 
gene for glycine biosynthesis, a hypothesis I am now verifying with auxotrophic growth experiments. 
Moreover, I generated strain designs to achieve energetically feasible conversion of methane to 
methanol and in doing so, further demonstrated the vital role of manual curation for these predicted 
engineering strategies.  
For the final piece of my thesis, I explored how to leverage manual curation to improve automated 
metabolic reconstruction. To this end, I created a method that “morphs” a manually curated metabolic 
model to a draft model of a closely related organism. My method combines genes from the original 
manually curated model with genes from an annotation database to create a final structure that 
contains gene-associated reactions from both sources. I used this method to create morphed models of 
three methanogens from iMR540 and showed that phylogenetic similarity between the source and 
target organisms correlated with the similarity of their models. I also found that gene annotations from 
iMR540 showed very low intersection with those from the annotation database, demonstrating the 
volume of information added by my manual curation. The morphing method could provide a viable 
 iv 
 
alternative to other automated reconstruction methods for organisms that are dissimilar from those 
that form the foundation of annotation databases.   
Together, my work exemplifies the advantages conferred by integrating manual methods with 
automated tools. My studies demonstrate the importance of maximizing the information we glean from 
manually curated data and blending that data with automated tools that accelerate large scale studies 
of metabolism. Such approaches mitigate the pitfalls associated with relying solely on automated 
methods, ensuring the high quality and depth of data as we work to characterize the space of microbial 
metabolism.  
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Chapter 1: Introduction 
DNA Sequencing and Metabolism 
Biology is well entrenched in its information age, with more tools available than ever before to help us 
understand the complexity of living systems. Perhaps the most ubiquitous example of this age is the 
evolution of DNA sequencing technology. A useful beginning reference is the advent of Sanger chain 
elongation sequencing in 1977 [1], the first technology to enable manual DNA sequencing in a non-
destructive way. This initial technology became the backbone of the myriad of technologies that 
followed, innovations that massively increased the speed at which we can sequence full organisms and 
survey metagenomes, enabling many more technologies that leverage sequencing data. Since the first 
fully-sequenced genome for bacteriophage φX174 was published 38 years ago [2], our collection of 
complete genome sequences has grown to encompass over 58,000 species per the NCBI RefSeq 
database [3]. Such an abundance of genomic information presents a plethora of opportunities to use the 
available information for performing both isolate and interspecies studies. 
GEnome scale metabolic Network REconstructions (GENREs) present a promising avenue for using 
sequencing information to elucidate mechanisms that drive organisms’ metabolism. A GENRE is built on 
top of gene-protein-reaction (GPR) relationships that link the genome to metabolism[4]. In these 
constructs, a complete organism’s genome is converted into proteins and annotated by mapping each 
protein or protein complex to the reaction(s) it catalyzes. The stoichiometry of these reactions is 
represented in a stoichiometric matrix (S-matrix) that ties each reaction to its metabolites using 
stoichiometric coefficients. The resulting reaction network depicts, to the fullest extent of our 
knowledge, the scope of metabolic reactions occurring within the sequenced organism, essentially 
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ascribing functional roles to all metabolic genes. A reconstruction provides a powerful way to look 
holistically at metabolism and to analyze the various mechanisms at play. As such, it can also serve as a 
platform for generating strain design hypotheses, making a reconstruction a valuable tool for metabolic 
engineering efforts as well [5].  
Genome scale metabolic reconstructions form the basis for much of the work performed for this 
dissertation, thus many introductory concepts regarding their nature are explained in the following 
chapters. However, given the volume written regarding metabolic reconstructions in following sections, 
a brief word on some nomenclature is in order, specifically regarding the distinction between a 
metabolic reconstruction and a GEnome scale Model (GEM). An excellent overview of the differences 
between these two constructs is described by Heavner et al [6]; for the purposes of this work, they can 
all be distilled to the ability to simulate growth. A GENRE is a network for organizing known metabolic 
information for an organism, thus it can be manually examined but cannot simulate growth. By contrast, 
a metabolic model is a mathematical construct and thus must be able to simulate growth. For 
mathematical completeness, a GEM must necessarily contain complete synthesis pathways for all 
components of cell mass; hence it must fill any network “gaps” that would otherwise prevent growth. 
Accordingly, a GEM supplements the established information in a GENRE with potentially hypothetical 
additional reactions to achieve mathematical completeness, a process known as gap filling. This major 
inherent difference manifests in other diverging features between GENREs and GEMs, as shown in 
Figure 1.1.  
Among these differences, the critical elements of GEMs all relate to subjecting the mathematical model 
to constraints that reduce the size of the model’s solution space. For example, within the map of a 
reconstructed network, metabolic reactions can be assumed to carry any magnitude of reaction fluxes; 
reactions in a GEM are much more restricted and are often constrained to carry only a certain level of 
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flux. Thus, in the chapters that follow I often use the terms “constraint based modeling” and “metabolic 
modeling” interchangeably. This is distinct from my use of the terms “reconstruction” and “model”, 
which are inherently different. All that being said, it is nearly impossible to discuss one construct 
without at least acknowledging the other. Reconstructions and models are intrinsically linked, with the 
former providing a scaffold that directly leads to the latter and the latter providing predictive 
functionality that utilizes the information in the former. Thus, any sort of tool or innovation that affects 
a GENRE must also impact a GEM and vice versa. Having digressed sufficiently at this point, let us return 
to the matter at hand, which is that of metabolic networks and how they are analogous to DNA 
sequencing.  
An Analogy Between DNA Sequencing and Metabolic Reconstructions 
Strikingly, the evolution of genome-scale metabolic reconstructions strongly parallels that of DNA 
sequencing itself (reviewed by Mardis [7]), albeit over two decades later (see Figure 1.2). Much like 
modern DNA sequencing technologies can logically be traced back to Sanger’s sequencing in of phage 
ϕX174 in 1977, genome scale metabolic network reconstruction can be traced to the genome-scale 
network of H. influenzae published in 1999 [8]. This first GENRE laid the groundwork for all 
reconstructions that followed it, sketching out the necessary steps and demonstrating the utility of the 
final product. Both technologies were completely manual in their inceptions, requiring months of 
dedicated effort to produce a final structure. Unsurprisingly, both of these examples contained multiple 
manual bottlenecks that presented opportunities for improvement through standardization and 
automation. In the case of DNA sequencing, running fragments in a gel, exposing them to X-rays, and 
reading the results by eye were all labor-intensive manual steps with much room for improvement [7]. 
As for reconstructions, much effort in the manual protocol was dedicated to tracing each individual gene 
to its proposed metabolic function through arduous literature searches [4]. Recognizing the abundance 
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of manual bottlenecks in both processes, the scientific community responded by developing numerous 
improvements for these first efforts, revolving around introducing tools to automate much of each 
procedure.   
DNA sequencing received perhaps its most important upgrade in 1986, with the commercialization of 
fluorescently-labeled automatic sequencing [9]. This automated sequencing platform removed many 
manual steps required to process and read the resulting sequences, reducing some previous sources of 
human error and enabling much more ambitious sequencing efforts. It essentially paved the way for 
realistically sequencing whole genomes in multicellular organisms, including the beginning of the Human 
Genome Project. A parallel development for metabolic reconstructions was the birth of annotation 
databases, arguably the most crucial element for quickening the pace of metabolic reconstruction. An 
annotation database is simply a collection of manually-annotated genes and provides a repository of 
proposed gene functions (genes and their GPRs) based upon previous biochemical characterizations. The 
first major annotation database was the Kyoto Encyclopedia of Genes and Genomes (KEGG), published 
in 2000 [10] and followed by MetaCyc in 2004[11]. Such resources were hugely important because they 
centralized much of the information needed for a high quality reconstruction, eliminating a large 
amount of literature search time. Furthermore, databases established standard identifiers for 
metabolites and reactions, essentially introducing languages with which to build and share 
reconstructions. Such resources represented an important step forward in speed akin to the advent of 
the automatic DNA sequencer for DNA sequencing, making it much more realistic to reconstruct 
networks, even an ambitious reconstruction of human metabolism [12]. In both cases, the underlying 
procedure remained largely the same, but the existence of a central tool—either a machine sequencer 
or central database—significantly sped up the process. As a result, automated Sanger sequencing with 
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fluorescent labeling dominated the DNA sequencing landscape up until about a decade ago [13] and 
nearly every GEM and GENRE published in the last decade stems from an annotation database.  
In the case of DNA sequencing, the next major process improvement was that of the capillary 
sequencing instrument 1997 [14]. By employing fixed capillaries, this method eliminated slab gels in the 
sequencing process, alleviating both the time and effort needed to prepare, dry, and read a gel. The 
subsequent gains in speed from this method enabled major undertakings, giving rise to many of the 
reference genomes we now possess [7]. Somewhat analogously, metabolic reconstructions got a 
technological boost in 2007 with the publication of the GapFind and GapFill algorithms, automated 
methods that accelerated the gap filling process needed to convert a GENRE to a GEM [15]. These 
methods, which filled network gaps using a maximum parsimony (i.e. “shortest path”) approach, 
removed virtually all of the manual work necessary for taking a metabolic network and finding ways to 
make it predict growth. Much as capillary sequencing enabled full genome sequencing for many model 
organisms, automated gap filling greatly enhanced our ability to create fully functional GEMs with little 
effort. Though both innovations still contained the same basic set of steps, they eliminated more 
manual bottlenecks, greatly speeding the overall processes of DNA sequencing and metabolic modeling, 
respectively.  
As reviewed by Shendure and Ji [16], DNA sequencing progressed into a “second generation” or “next-
generation” of techniques beginning in 2005. That year the 454 pyrosequencing platform became 
commercially available [17] and was followed in the next few years by a variety of other techniques, 
such as the Solexa platform based upon bridge PCR and reversible terminators [18,19] and the HeliScope 
platform based on single molecule techniques[20,21]. The broad group of second generation techniques 
is linked by their parallelization of sequencing and detection steps; hence they enabled what is 
commonly referred to as “massively parallel sequencing” [7,16]. This parallelization has made possible a 
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complete paradigm shift in the way that we regard DNA sequencing, with sequencing reads shrinking in 
individual size but multiplying many times in number [16]. In short, next generation sequencing has 
completely changed the way we sequence and as a result, the last decade has witnessed easily the most 
rapid technological growth for DNA sequencing in terms of sheer number of advancements. A similar 
change took place for metabolic reconstructions and models in 2010 with the publication of the Model 
SEED automated reconstruction algorithm [22]. In using the SEED database of genomes and annotations 
to build a metabolic network directly from a genome, this algorithm mostly eliminated the manual steps 
of pulling reactions from a database. Analogously to DNA sequencing, the Model SEED method 
performed multiple steps, annotating a supplied genome to create a reconstruction and using 
automated gap filling to create a model capable of simulating growth. Like next generation sequencing 
methods, this new innovation changed the landscape of metabolic reconstructions, enabling high 
throughput generation of a functioning GEM for any organism with a completely sequenced genome. 
Moreover, by creating a more user-friendly set of tools for building reconstructions or simulating models 
through a web interface, the Model SEED made metabolic reconstruction and modeling more widely 
accessible to the biological community, just as decreased costs and processing time associated with next 
generation sequencing have made DNA sequencing accessible for most research groups.  
These parallel paradigm shifts have not come without consequence; for their prodigious gains in speed, 
both DNA sequencing and metabolic modeling have sacrificed a measure of depth to achieve wider 
breadth. In next generation sequencing, relying on many short reads has increased speed dramatically, 
resulting in a larger total pool of information for the sequenced organism but less sense of how the 
reads fit together (i.e. lower raw accuracy when practiced in de novo fashion) [16]. For this reason, large 
sequencing efforts typically eschew less accurate de novo sequencing in favor of mapping reads onto a 
reference genome assembled using more accurate but slower Sanger techniques [7]. Similarly, although 
 
 
7 
 
automated reconstruction has enabled us to create models for many more organisms, these models lack 
organism-specific richness and run the risk of resembling the models of more common organisms. This is 
illustrated by the fact despite increasing publishing rates for reconstructions, recent GENREs tend to 
overwhelmingly contain the same reactions as previously published models rather than adding their 
own unique reactions [23]. To mitigate the effects of incorporating the same generic reactions into each 
model, these automatically-generated models must be treated as first drafts; expanding and enriching 
these models relies on literature searches and biochemical characterizations. 
Of course, despite their similarities, DNA sequencing and metabolic reconstructions differ considerably 
in terms of their current capabilities. Likely due to the fact that sequencing predates genome-scale 
reconstructions by over 2 decades, existing technologies for metabolic reconstructions lag behind those 
for DNA sequencing. DNA sequencing has arguably progressed on to a third generation of techniques 
that leverage single molecule sequencing to achieve even greater gains in speed and cost efficiency [24]. 
As a result, although the number of metabolic reconstructions has grown substantially in recent years, 
the several hundred networks in existence pale in comparison to the 58,000+ sequenced genomes in the 
RefSeq database. Though closing this gap is improbable based on the ever-increasing speed of 
sequencing and impossible due to a GENRE’s inherent dependence on an existing DNA sequence, there 
appears to be ample opportunity to increase the speed of reconstruction with more advances akin to 
those already realized in sequencing. However, working toward this end will require that the metabolic 
reconstruction community begin to address a number of challenges that face GENREs.  
Challenges for metabolic reconstructions 
Arguably the greatest obstacle to creating high-quality reconstructions is the relative dearth of available 
biochemistry information. Considering the incredible breadth of microbial species, the bulk of known 
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biochemical phenomena have been characterized in a miniscule number of organisms. For example, 
compared to the 58,000+ complete genomes in RefSeq, the MetaCyc database has pathway databases 
for 7,668 organisms, or about 13% of fully sequenced organisms [25]. The remaining majority of 
organisms occupying the rest of the sequenced microbial biosphere represent a huge space of unknown 
function, greatly limiting our ability to construct reaction networks for these organisms. Even within the 
well-characterized organisms, we still annotate many genes as “hypothetical proteins”, enzymes with no 
known function that may presumably participate in metabolism. With respect to the overwhelming 
volume of unknown information, these unknown portions of metabolism ultimately limit the predictive 
power of GENREs and GEMs, decreasing the degree with which we can use such constructs to discover 
emergent network properties. However, this same limitation presents an opportunity to use metabolic 
reconstructions to propose functions for unknown portions of metabolism, particularly by simulation as 
GEMs. 
Another obstacle to metabolic reconstructions is the generic nature of annotation databases. Like next 
generation sequencing, which trades increased speed and volume of reads for decreased overall read 
precision, annotation databases speed up the reconstruction process but are also fairly error prone. 
Although in both cases this tradeoff results in a much larger overall breadth of data than could be 
achieved with fewer, more precise pieces of information, this advantage is greatly reduced for GENREs 
because it generally ends up requiring many additional manual corrections [26]. Annotations derived 
from such databases come from gene homology and are not necessarily even consistent across 
databases. An illustrative example of this problem is found in the reconstruction of C. beijerinckii, which 
was derived using annotations from three separate annotation databases [27]. As demonstrated by the 
authors, very few reactions in the final reconstruction appeared in all 3 databases and many appeared in 
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only one database. Thus, any GENRE built using an annotation database may contain numerous mis-
annotations and will necessarily be biased toward the annotations in that database. 
Annotation errors and differences between databases are further complicated by the lack of 
standardized reconstruction format and nomenclature. A strength of DNA sequencing is its integration 
into standard file formats—FASTA [28], GenBank [29]—and a standard alphabet—A, G, T, C—such that 
any publically available sequence can easily be used by any researcher in the world. Although several 
groups have attempted to impose or suggest standards for biochemical networks, both generally for all 
systems [30] and specifically for metabolic networks [31], the current scope of available GENREs exist in 
a variety of formats and identifiers. This lack of extensibility presents a major problem, as many 
published GENRE and GEMs reportedly cannot be used to reproduce results in from their reference 
materials [31,32]. Furthermore, disparate nomenclature greatly complicates efforts to update and 
consolidate multiple GENREs of the same organism into consensus networks, as in e.g. the first 
consensus yeast network [33]. This particular complication is exacerbated by the large number of 
GENREs that lack any standard identifiers [31]. The issue of a standardized format has been addressed to 
some extent by the adoption of the systems biology markup language (SBML) [34], a format for 
representing all biochemical networks that has recently been updated specifically for constraint-based 
networks [35]. However, the metabolic reconstruction community as a whole has yet to unite itself 
behind any particular standard and thus, GENREs still exist in a variety of different formats [31].  
Standardization problems are further magnified when considering the lack of a central repository 
specific to constraint-based network reconstructions. To once again borrow from DNA sequencing, 
genome sequences can be deposited straightforwardly in the RefSeq database by any group in the 
world, provided that they adhere to the standards upheld by NCBI [36]. Thus, RefSeq exists not only to 
centralize all complete genome sequences in one hub, but also to enforce formatting and nomenclature 
 
 
10 
 
standards on its content. Furthermore, the NCBI interface intrinsically houses genome sequences in a 
framework that permits usage of common analysis tools, such as BLAST+ [37]. At this time, no 
comparable database exists for constraint based networks; rather, the modeling community maintains 
several disparate resources aimed at serving different functions.  
Table 1.1 displays a set of desired database functions, with  performance of current databases as 
compared to these guidelines; as demonstrated, no one database contains all of these functions. The 
BioModels database [38] is designed as general biochemical model repository that adheres to 
established MIRIAM standards [30] and contains many manually-created models and networks. Thus it 
lacks any additional tools and is not specific to constraint-based models or networks. The BiGG database 
2.0 [39] is specifically for constraint-based reconstructions and allows users to download GENREs or 
examine reaction pathways through its web interface. However, it is primarily an outward-facing 
resource, designed to facilitate use of the GENREs from one particular lab group rather than all known 
reconstructions.  Kbase, built on top of the Model SEED [22], fulfills the largest number of the guidelines 
specified in Table 1.1 because it allows upload of new networks and provides tools for building and 
downloading new networks and models. Yet Kbase also falls short of meeting these standards as it does 
not contain an outward-facing database of manual reconstructions and does not rigorously enforce 
formatting or nomenclature standards. Examining these resources, it is evident that the metabolic 
modeling community currently lacks a unified standard of how reconstructions are created, stored, and 
distributed, a hurdle that must be cleared if GENREs are to ever achieve the current usability of DNA 
sequences.  
Manual and automated: a combined approach 
In examining these four primary challenges, it is useful to segregate them into two separate groups: 
those that affect individual reconstructions and those that affect the entire reconstruction community. 
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The latter two obstacles—need for nomenclature/format standardization and lack of a centralized 
repository—present significant difficulties for reconstruction and model usability, particularly in 
reconciling and comparing networks constructed by different groups. Resolving these problems will 
likely take a widespread commitment to adopt universal standards and designate a standardized central 
database for storing and using GENREs. Until such steps are taken,  it is vital that any published 
reconstruction be explicit in explaining all of its facets and subjective annotation decisions to enable 
better sharing and usability [40]. 
However, the former two obstacles—lack of sufficient data and abundance of mis-annotations in 
existing resources—present obstacles to producing a high-quality reconstructions. Remarkably, these 
obstacles bear a resemblance to current challenges inherent in DNA sequencing. Despite the speed 
gains in both processes resulting from increased automation and technological advancement, both DNA 
sequencing and metabolic reconstruction are still somewhat constrained by error. Much as decreased 
sequencing read lengths have magnified the influence of sequencing noise and error, metabolic 
reconstruction’s increased reliance on centralized databases and high throughput algorithms has 
exacerbated the problem of missing or incorrect gene annotations. The solution to both of these 
problems lies in the ability to compare to high quality reference information; in the case of DNA 
sequencing, this involves comparing a new sequence to a reference genome like those produced using 
capillary sequencing. For metabolic reconstructions, this means returning to high confidence 
information from biochemical literature sources; in short, it necessitates employing meticulous manual 
methods. 
On its surface, relying on the manual-based curation is somewhat counterintuitive as it seemingly 
represents a step backward in the evolution of reconstruction techniques. However, manual curation is 
vital for producing a high-quality reconstruction. Any automatically-curated reconstruction can only be 
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considered a first draft and is generally followed by 6-12 months of manual effort [4]. This consists of 
sifting through virtually all available biochemical literature and sometimes multiple annotation 
databases to uncover the maximum amount of biochemical phenomena occurring within an organism. 
In putting forth this effort, a metabolic modeler can alleviate the detrimental effects of mis-annotations 
by replacing incorrect GPRs with correct annotations from literature sources. Furthermore, even though 
overall data limitations are still difficult to overcome, a high-quality manual reconstruction can shed 
light on many areas of metabolism and point directly at portions of pathways that still require 
biochemical characterization. Thus, although automated methods enabled by annotation databases and 
algorithm development have shortened the timetable needed to produce a high-quality reconstruction, 
the current state-of-the-art process is a combination of these automated resources and careful manual 
curation. 
Manually curated GENREs are but one example of the current duality present in biology, where 
pervasive manual techniques are employed in concert with automated methods. Routine tasks within 
the field are being increasingly automated to cut down on processing time by leveraging technological 
advances and growing computational power. With the rise of computational biology, an increasing 
amount of data analyses are performed in silico on large datasets, creating a pipeline for quickly 
extracting meaningful information from experimental datasets. But ultimately, these tools often 
produce a starting point for using manual techniques, the gold standard for achieving maximum 
accuracy. Even with the huge speed gains we have experienced in recent years, current computational 
models are often inadequate for solving complex biological problems without substantial manual effort. 
Thus, procedures that blend automated and manual methods hold considerable promise for addressing 
a variety of problems.  
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A hybrid approach to developing growth media 
As I will describe in Chapter 2, integrating manually-curated data into computational methods could 
greatly aid the field of microbial growth media design. Traditionally, new defined growth media are 
developed by manually adapting existing media to fit the needs of a new organism. The lengthy, arduous 
nature of this manual approach is well illustrated by the SAR11 clan, perhaps the most ubiquitous group 
of organisms in the world [41]. After discovering these organisms in 1990, researchers required another 
12 years of work to first isolate a culture in complex media [42,43]; developing a working chemically 
defined medium took another 11 years [44]. With the growing wealth of available sequencing data for 
uncultured organisms, it is possible linking organisms’ genomes to their growth media might hold some 
sort of key for speeding up this process [45].  
This concept laid the groundwork for MediaDB [46], the first publically-available repository of defined 
microbial growth media from literature sources. MediaDB, discussed further in Chapter 2, was followed 
by the KOMODO database [47], a larger repository that included an algorithm for predicting organism 
growth media based upon phylogeny. Both of these resources created centralized spaces for studying 
existing media and trends across organisms, plus the addition of a media prediction algorithm presented 
an automated process to supplement manual work. Furthermore, topological network analysis methods, 
such as computing organisms’ seed sets to determine compounds that must come from the 
environment [48], have also shown promise for relating genomic information to nutritional 
requirements. These tools could potentially speed up media development by informing the choice of a 
starting set of media compounds. However, a multitude of other factors influence organism growth, 
such as the need for dilute metabolite concentrations or siderophores from other organisms [49,50].  
Thus, advances in media formulations are still dependent on manual methods that incorporate these 
variables, which are not currently considered by an automated media prediction algorithm. 
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Leveraging manual efforts to improve automated methods 
As demonstrated by the cases of metabolic reconstructions and media formulations, advances in 
computational techniques have improved our capabilities on multiple biological fronts, in large part by 
greatly increasing the speed of repetitive tasks. Yet ultimately, these technologies still cannot achieve 
the same results as slower, more meticulous manual methods. Much as media formulations ultimately 
rely on experimental methods, high quality metabolic reconstructions depend on careful manual 
curation, even when beginning from automatically-generated starting points. Though there may be a 
time in the near future when advanced computational models eliminate the need for more of these 
manual procedures, current technologies cannot approach the accuracy achieved through manual 
means, creating a potential choice between quick results and accurate ones. Furthermore, it is not 
necessarily reasonable to expect that future technologies will completely eliminate the need for 
rigorous manual methods.  
It is therefore crucial to improve the hybridization of manual and automated methods to better inform 
the high-throughput results of automated tools with meticulously gathered experimental data. Despite 
the fact that much of biology is information-limited, whether by inability to culture the vast majority of 
organisms or ignorance of uncharacterized biochemical pathways, there is a tremendous amount of 
manually-generated data available through biochemical literature. Current methods, such as those 
emerging in the space of developing microbial growth media, are beginning to integrate existing 
experimental data with more automated methods, but more work is needed to create effective 
workflows that maximally leverage manually-curated data. Through my dissertation work, I have strived 
to establish tools and methods that encourage increased usage of published biochemical knowledge, 
centered around the aforementioned issues of formulating growth media and building metabolic 
reconstructions. Specifically, my dissertation is structured as follows: 
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 Chapter 2 describes MediaDB, a manually-curated database of chemically defined microbial 
growth media. As the first resource of its kind, MediaDB provided a resource for using and 
studying known media formulations by bringing together growth data from many published 
journal articles into one central repository.  
 Chapter 3 describes the creation of iMR540, a manually-curated metabolic reconstruction of 
Methanococcus maripaludis S2 built on top of automated reconstruction methods. In addition 
to providing a valuable tool for studying microbial methane production, this network aptly 
demonstrates the efficacy of manual reconstruction methods to leverage biochemical literature 
data for improving automated draft reconstructions.  
 Chapter 4 describes multiple applications of the completed iMR540 reconstruction as a tool for 
studying methanogenesis, elucidating uncharacterized biosynthetic pathways, and generating 
metabolic engineering strategies.  
 Chapter 5 describes a novel method designed to morph a manually-curated metabolic network 
into a functioning reconstruction of a novel organism. Unlike existing automated reconstruction, 
this method incorporates both automated gene annotations and manually-curated information 
from the original network, effectively using gene homology to create an automated draft 
reconstruction that incorporates much manual curation.  
 Chapter 6 reflects upon the previous chapters and discusses the implications of this work as a 
whole, focusing on summarizing their contents and describing future directions of this work. 
Together, these chapters will describe my efforts to integrate more manually gathered data into 
automated methods, creating processes that utilize the best qualities of both approaches.  
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Tables and Figures 
Desired Database Feature BioModels BiGG 2.0 
ModelSEED/ 
Kbase 
Can upload a manually created GENRE/GEM X 
 
X 
Checks for standards adherence and reproducibility X 
  
Has tools for GENRE/GEM creation 
  
X 
Has tools for GENRE/GEM analysis 
 
X X 
Allows GENRE/GEM downloads in standard format X X 
 
Specific to constraint based networks/models 
 
X X 
Table 1.1: An evaluation of the 3 major metabolic reconstruction databases according to desired features 
 
 
Figure 1.1: A comparison of unique and shared features between a GENRE and a GEM.  
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Figure 1.2: A side-by-side look at major advances in DNA sequencing (red) and metabolic reconstruction (blue). 
Text in gray boxes indicates the relationship that connects adjacent boxes; for instance, “Capillary Sequencing” and 
“Automated Gapfilling” represent the “Second Major Automation” in their respective fields.  
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Chapter 2: MediaDB: a database of microbial growth conditions 
in defined media1 
Introduction 
Genomic and high-throughput sequencing technologies enable the generation of large amounts 
of genetic information on microorganisms without the need to grow cultures in the lab. Armed 
with these technologies, we can automatically generate draft metabolic network reconstructions 
for organisms directly from genome annotations [51] and derive metabolic network models to 
simulate microbial growth in silico. These models can be improved through an iterative curation 
process between experimental and computational investigations [52]. To date, this iterative 
process has been most successfully advanced by partnering in silico reconstruction with in vitro 
characterization of isolates grown in defined laboratory media—an experimental approach that 
remains the most comprehensive method for characterizing microbial physiology [53–59]. 
Techniques for building metabolic network reconstructions from genomic data have progressed 
sufficiently to enable the application of in silico models for characterizing microbes that have not 
been cultivated in vitro. 
Only 0.1-1% of the estimated number of microbial species have been isolated and successfully 
cultivated in a laboratory environment [55,56,58]. The collection of species we can currently 
culture spans only 30 of over 100 established phyla and mostly contains fast-growing 
organisms—organisms that are not the most prevalent species in the environment[57,59]. A 
                                                          
1
 This chapter is a reprint of a published article. The citation is as follows: Richards MA, Cassen V, Heavner BD, 
Ajami NE, Herrmann A, Simeonidis E, and Price ND. “MediaDB: a database of microbial growth conditions in 
defined media.” PLoS ONE (2014) 9(8): e103458. doi: 10.1371/journal.pone.0103548   
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range of novel techniques have been applied in efforts to culture less characterized microbes, 
such as using diffusion chambers to mimic environmental conditions [60–63], adding growth 
factors or signaling compounds secreted from other organisms [64–67], diluting media nutrients 
to lower concentrations [43,49,68–72], increasing incubation time [69,70,72–76] and running 
high-throughput cultures [71,77–79]. These innovations have increased the diversity and number 
of culturable organisms, but the large number of factors that can affect in vitro growth still 
presents a challenge for isolating and culturing microbes from environmental samples.  
Recently, computational modeling has been successfully applied to support culturing efforts. 
Several groups have used metabolic reconstructions, which are based on organism-specific 
genome sequence and biochemical knowledge, to assist in media design. Applications of these 
networks to media design have included both direct querying of the metabolic network to 
identify key metabolites for growth media design [44] and simulating growth on different 
substrates with a genome-scale metabolic model to predict media formulation [80]. Efforts that 
use a metabolic network model must define an in silico medium to enable calculations such as 
Flux Balance Analysis (FBA) [81–83]. The model and simulated medium then are iteratively 
refined until the network successfully predicts biomass production. 
Thus, simulating growth of an uncultured organism with a metabolic model requires the 
definition of an in silico growth medium or a set of candidate media, which may then be 
validated in vitro. The definition of a growth medium in silico often begins in the same fashion 
as in vitro attempts: by starting with a medium that has supported simulated growth in models of 
organisms related to the desired isolate. However, this approach is complicated by the 
fragmentation of information in the literature. To overcome this obstacle, we have created 
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MediaDB: a database of experimentally determined, chemically defined growth media 
conditions that aims to support efforts to leverage -omics data and modeling techniques for 
characterizing previously uncultured isolates. MediaDB is a manually curated database of 
defined media formulations for organisms with fully sequenced genomes, emphasizes organisms 
that have existing metabolic network models, and is the first publically available electronic 
resource that specifically brings together organisms with genomic data and their associated 
growth media. MediaDB will facilitate investigation of the relationship between microbial 
genomes and media composition, serving as both a central repository of data linking genome 
sequence to media compositions, and as a resource that facilitates model-supported design of 
cultivation media. 
Database construction and content 
All data in MediaDB were manually curated from existing primary literature sources. We 
conducted organism-by-organism literature searches using standard search engines—Google 
Scholar, PubMed, Web of Science—on the list of in silico organisms maintained by the Systems 
Biology Research Group at UCSD [84]. Our searches were aimed at finding experimentally-
verified growth data on defined media for as many organisms with curated metabolic models as 
possible. The search results were curated manually and the media related information was 
extracted and formatted in the MediaDB schema, a MySQL database consisting of 12 tables and 
constructed around 6 main data tables: Organisms, Compounds, Media_Names, Biomass, 
Sources, and Growth_Data (Figure 2.1). The full schema is included as supporting information 
(Figure A.1). 
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Organisms 
The Organisms table includes fields for genus, species, and strain, a “type” designation that 
specifies the organism’s kingdom classification, a Boolean value denoting whether the organism 
has been modeled in silico, and, if applicable, a link to the biomass composition for that 
organism. As shown in Table 2.1, MediaDB currently contains 208 unique Organisms objects 
spanning 57 species and 46 genera.  
Bacteria make up the majority of organisms in the database, reflecting the distribution of species 
that have been cultured in the laboratory and the MediaDB’s emphasis on organisms with 
existing in silico metabolic reconstructions. Such reconstructions exist for 39 of the 43 bacterial 
species and 51 of the 57 total species in the database. The database also includes many strains for 
model organisms; Escherichia coli and Bacillus subtilis contribute 54 and 16 bacterial strains, 
respectively, to the database.  
Compounds 
The Compounds table includes fields to describe a chemically-defined compound in terms of its 
common names, chemical formula, and identifiers that can be used to cross-reference with other 
databases (KEGG, BiGG, Seed, ChEBI and PubChem)[85–90]. We included identifiers from 
these databases to enable easier exchange of information between researchers, enhance 
compatibility with commonly-used resources, and ease development of automated computational 
analyses that use data in MediaDB. Of the 14,795 compounds contained in the database, 14,785 
(99.9%) have identifiers from at least one other database.  
Unlike the other tables in the MediaDB schema, the Compounds table was initially curated based 
on the KEGG database rather than from specific literature sources and was supplemented with 
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manual entries from other databases as necessary. Its primary purpose is to describe the 
composition of other data types (Media_Names, Biomass).  
Media_Names 
The Media_Names table consists of fields specifying a media formulation with a descriptive 
name, a Boolean value indicating whether or not the particular media formulation was described 
as minimal in its source material, and a list of names and amounts of each compound that makes 
up that medium in units of millimolar (mM). Due to the many-to-many nature of relating 
compounds to different media compositions, the relationship between media formulations and 
compounds are contained within the Media_Compounds table, but can be queried to find the 
compounds that make up a particular media formulation. MediaDB only contains chemically 
defined media formulations and does not include complex formulations, such as media that use 
yeast extract. The focus on chemically defined media was selected to facilitate computational 
simulation of growth conditions and to support efforts to cultivate uncultured organisms in the 
laboratory. MediaDB currently contains 461 different media formulations. 
Biomass 
The Biomass table consists of fields describing the compounds included in the biomass objective 
function used in FBA of metabolic network models to simulate exponential cell growth and 
contains organism genus and species, the list of compounds present in the biomass composition, 
and the stoichiometric coefficient of each compound in relation to one “unit” of biomass. Like 
the MediaDB description of media, biomass is also specified by the compounds that make up its 
composition, resulting in a many-to-many relationship. The Biomass_Compounds table contains 
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the links between biomass compositions and compounds and can be queried to find the 
compounds that make up a particular biomass composition.  
As detailed in Thiele et al. [52], the biomass composition is an important objective function for 
FBA of metabolic network models; however, it can also be difficult to experimentally determine 
detailed biomass composition for an organism. Thus, the biomass composition is a salient factor 
to consider in model construction and refinement, but we found few unique examples of this data 
type in existing literature sources. Instead, many models have defined the organism biomass 
composition by using or slightly modifying the biomass objective function from another model. 
We have included 4 different biomass compositions in MediaDB to provide a basis for users to 
construct biomass compositions for their own organisms by refining established ones. 
Sources 
The Sources table consists of fields describing a primary literature source (usually a book or a 
journal article) and is specified using the first author’s last name, the title of the work, the 
journal, the year of publication and, if applicable, the PubMed identifier and URL to the article. 
Sources are added to MediaDB if they report experimental laboratory growth of an organism in 
MediaDB in a medium in MediaDB. MediaDB currently contains 147 unique sources that 
directly link to any experimental growth media information they provided.  
Growth Data 
The Growth_Data table describes the combination of physical parameters reported by a literature 
source for in vitro growth of a specific organism. The Growth_Data table links the tables 
describing an organism, medium, and literature source, and adds information about temperature, 
 
 
24 
 
pH, growth rate, product secretion rates, and nutrient uptake rates (whenever reported in the 
literature source). MediaDB currently contains 765 growth conditions.  
In many instances, we found rate data associated with a particular growth condition in the form 
of an experimentally-measured growth rate (μ) measured in h-1. We stored growth rates in the 
Growth_Data data field, thereby providing quantitative measures to assist in future metabolic 
model development. Some growth conditions were also reported with other growth-associated 
measurements: product secretion rates, medium compound uptake rates and product yields. 
Unlike growth rates, a growth condition could be associated with multiple measurements of 
secretion/uptake/yield; hence, we created the Secretion_Uptake table to house these rates and 
link them to their growth conditions. MediaDB currently contains 557 measured growth rates, 49 
metabolite uptake rates, 22 product secretion rates, and 58 product yield coefficients.  
Website construction and navigation 
The MediaDB website (https://mediadb.systemsbiology.net/) provides a user-friendly interface 
for performing the two main functions of our database: data browsing and exporting.  
Data browsing  
Browsing allows the user to query MediaDB with provided data type categories, to manually 
search through information by navigating through the different data tables or to use keywords to 
search through the parameters that specify the growth condition entries (see Figure 2.2). The 
search function matches the given keyword to data entries in all tables and returns the results 
sorted by the table that contains the matched record.  
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Tables in the database are linked together on the webpage by cross-referencing to better display 
all pertinent information for each entry. For example, an entry in the Organisms table shows all 
of the related growth condition entries collected for that organism, including links to the 
literature source entries. Similarly, each media formulation entry links to entries for all the 
compounds present in that media formulation, all of the organisms reported to grow in that media 
formulation, and the literature source entries where the media formulation was reported. A 
Compounds entry displays links to all the media formulations in which the compound appears. A 
Source entry displays links to all the growth conditions reported in that source, as well as links to 
the online version of that source, when applicable.  
Data export 
Data can be exported from MediaDB in two different ways, allowing the user flexibility in 
deciding what information is important for their particular project. The most basic export, found 
under “Downloads” on the webpage, allows the user to download a copy of the entire MediaDB 
schema and all database entries to use independently of the website. This option allows the most 
flexibility in dealing with the data, but requires that the user be familiar enough with relational 
database management in MySQL to use the SQL file generated by this export.  
The second export option is individual media formulation or biomass composition download, 
available on each media formulation or biomass composition entry page under “Tab-delimited 
version”. This option generates a tab-delimited text file with a list of compounds and their 
concentrations in the chosen media formulation or biomass composition. The file also includes 
identifiers for the compounds in other databases. These identifiers facilitate cross-referencing of 
the various metabolite identifiers used in different in silico metabolic network models.  
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Database utility 
Statistics for compounds 
Because the MediaDB schema provides links between organisms and the compounds in their 
growth media, it enables investigation of media components across organisms. For example, we 
compiled a list of every chemical compound that appears at least once in a growth medium for 
all 57 species in the database (see Table A.1 for full results). Out of 260 unique compounds, the 
most commonly occurring compound across all species was calcium chloride (CaCl2), a salt that 
appears in the growth media of 49 species (86% of all species in MediaDB), because it is often 
included in stock trace element/mineral solutions. Salts accounted for nine of the top ten most 
frequent compounds with the only exception being biotin, a vitamin that often appears in stock 
vitamin solutions and was present for 29 species (51%). Other components of media, such as the 
carbon source and amino acids, were less uniform across species; the most common carbon 
source and amino acid were glucose (47%) and cysteine (37%), respectively (a list of the most 
frequent compounds is shown in Table 2.2). 
Our analysis also identified the least common compounds in media; 97 of the 260 compounds 
(37%) appeared in media for only one species and 139 (53%) appeared in media for one or two 
species only. These uncommon compounds generally fell into one of the following categories: 1) 
Trace metals included in stock solutions (e.g., nickel sulfate for Shewanella oneidensis); 2) 
Buffers for pH maintenance (e.g., ACES for Mycobacterium tuberculosis); 3) Antibiotics used to 
select for mutant strains (e.g., kanamycin for Synechocystis PCC6803); 4) Uncommon carbon 
sources (e.g., galactose for Streptomyces coelicolor); 5) Alternate vitamin forms (e.g., sodium 
pantothenate rather than calcium pantothenate for Haemophilus influenzae); 6) Compounds that 
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fit niche organism metabolisms (e.g., 2-mercaptoethanesulfonate for Methanococcus 
maripaludis). Compounds in the final category were of particular interest, because they could be 
tied to unique portions of the known metabolism of the organism. For example, 2-
mercaptoethanesulfonate (coenzyme M) only appears in media for the methanogen M. 
maripaludis, because it is a vital cofactor involved in methane production for that organism. As 
MediaDB grows, we expect that identifying such unusual compounds will play an increasingly 
useful role in media design.  
Linking growth media to metabolism 
MediaDB provides a framework for comparing the nutritional requirements of different 
organisms and currently includes information on a range of microbes, with a focus on organisms 
that have been modeled in silico. In order to demonstrate how MediaDB supports such 
comparative analysis, we compared media formulations for two organisms that have metabolic 
network models:  E. coli, a model bacterium that has been grown with a wide range of 
compounds (81 different compounds), and Methanosarcina acetivorans, a model archaeon that 
has been grown using a smaller range of compounds (12 different compounds).  
Seven compounds appeared in media formulations for both organisms: one carbon source 
(acetate) and six simple salts (NH4Cl, CaCl2, MgCl2, KCl, KH2PO4, NaCl). The compounds 
unique to E. coli included multiple 5- or 6-carbon sugars (e.g., glucose, lactose, fructose, and 
succinate) and 19 of the 20 standard L-form amino acids (all except cysteine). The 5 compounds 
unique to M. acetivorans included methanol, a simple carbon source for methanogens that rarely 
appears in media for other organisms (fellow methanogen Methanosarcina barkeri and pathogen 
Candida glabrata are the only other species in MediaDB with media that include methanol). We 
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also observed that, in contrast to the E. coli media data, cysteine was the only amino acid that 
appeared in growth media for M. acetivorans. 
We expanded our comparison by using manually curated metabolic models for both E. coli [91] 
and M. acetivorans [92] to examine the differences found in media compounds. By examining 
reactions in the models, we observed that the model for E. coli included uptake pathways for 
many carbon sources that are absent in the M. acetivorans model, including all of the carbon 
sources reported in MediaDB. The E. coli model predicted that methanol could be produced 
during growth, but not consumed, whereas the M. acetivorans model predicted the ability to 
consume methanol for growth and methane production. The models also provided mechanistic 
justification for our media analysis that suggested differences in cysteine metabolism; the M. 
acetivorans model had the ability to both consume and secrete cysteine and the E. coli model 
predicted cysteine secretion, but not consumption. We extended this analysis by testing the 
models for growth on a range of experimental media from the database. We selected 11 media 
for E. coli—one for each carbon source—and the one medium for M. acetivorans in MediaDB, 
then simulated each model for growth on all 12 media (see Supplementary File A.1 for an 
example of this procedure). The E. coli model predicted growth on all 12 media, mirroring the 
organism’s versatility to grow on many different carbon sources. The M. acetivorans model 
required modification to remove trace metals from the biomass objective function in order to 
predict growth on any medium. After the trace metals (which are not included in simulated E. 
coli media) were removed from the M. acetivorans model objective function, it accurately 
predicted growth on its own medium and on the E. coli medium with acetate as the carbon 
source, but not on any of the other media, reflecting the organism’s inability to grow on complex 
carbon sources.  
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This case study illustrates the use of MediaDB as a tool for investigating the differences in 
nutritional requirements between organisms and as a source for in silico medium formulation. 
The differences between cultivation media for E. coli and M. acetivorans were identified using 
MediaDB and explained using the organisms’ respective metabolic models, which include 
fundamental differences in carbon source and amino acid metabolism. In this example, the 
results of the comparisons between the media sources and metabolic models were quite parallel, 
as expected, because both models were manually constructed based on genomic information and 
information from the primary literature, including media formulation sources. In other cases, 
where there is disagreement between model simulation results and media information reported, 
MediaDB will support efforts to improve metabolic network reconstruction by providing 
information regarding experimentally determined media conditions.  
Organism clustering by compound similarity 
We used hierarchical clustering of pairwise Euclidean distance between binary vectors of 
compound inclusion in a medium (e.g., an entry is 1 if a given chemical is included in a medium, 
or 0 otherwise) to investigate the relationship between organisms in MediaDB based on 
published growth-supporting media. Figure 2.3 presents a heat map of chemical species in 
media, created from MediaDB data. The heat map shows bands of high-frequency compounds on 
the right side of the map and clusters of moderately frequent compounds on the left side; these 
compound groups are dominated by salts found in stock solutions and L-form amino acids, 
respectively. The overall sparsity of the heatmap reflects the fact that most compounds occur 
only once or twice across all species. 
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We compared this compound similarity tree (Figure 2.3) to a 16s rRNA phylogenetic tree 
constructed in the Biology Workbench [93–96](Figure 2.4) and found that there was little 
overlap between genetic similarity and compound similarity. Aside from the two 
Methanosarcina species, which were grown in the same exact media, we observed few parallels 
between these two trees. Three species in the taxonomic order Lactobacillales—Lactococcus 
lactis, Lactobacillus plantarum, and Streptococcus thermophilus—clustered closely together in 
both trees, but the majority of organisms that formed tight clusters in one tree did not show the 
same closeness in the other tree. For example, the four Aspergilli—A. nidulans, A. niger, A. 
oryzae, and A. terreus—were close in terms of phylogenetic distance, but dissimilar with respect 
to their media compounds. On the other end of the spectrum, Corynebacterium glutamicum, A. 
oryzae, Clostridium beijerinckii, and Zymomonas mobilis show high compound similarity with 
one another, but are far apart phylogenetically. This observation could be an indication that 
phylogeny does not correlate to similarity in media formulations, but a more parsimonious 
explanation is that the data in MediaDB reflect the literature bias towards positive growth results. 
Due to this lack of negative growth results (i.e. information on what an organism does not grow 
on, which is typically omitted by researchers), we are unable to assert that any organism is 
incapable of growth in another’s media based soley on comparisons of the collected data in 
MediaDB. This knowledge gap suggests a need for for futher experimental study of the 
relationship between phylogenetic distance and nutritional requirements for growth. Thus, 
information available in MediaDB describes whether a given medium has been reported to 
support a microbe’s growth, and may be useful for generating hypotheses of possible media 
formulations for future experimental efforts. Our analysis also revealed clusters of organisms 
with high media composition similarity (Figure 2.3) that do not have a clear connection to 
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observed biology. With further investigation, these similarities could reveal more complex 
biological relationships that do not fall under the obvious prisms of genetic or environmental 
similarity. MediaDB will support such comparative studies as the resource continues to grow.   
Future development 
Community-contributed growth conditions 
MediaDB currently contains 57 microbial species, but the scope of the fully-sequenced microbial 
world is much larger and continues to grow. We intend to expand the breadth of organisms and 
growth conditions in MediaDB by allowing users to submit their own experimentally verified, 
defined growth conditions. At this time, we encourage users to submit growth conditions for our 
review through direct contact with the authors (mediadb@systemsbiology.org), but expect to 
create an input form that encourages groups to add new data directly through the website.  
Analysis tool development 
We have demonstrated the potential for media-based comparative analysis using MediaDB with 
E. coli and M. acetivorans; however, we have designed MediaDB to support future development 
of additional tools to support research efforts. We have also made the entire database schema and 
its contents available for download to further facilitate tool development by MediaDB users. As 
such tools are developed in our group and others, we will integrate these tools into the website to 
assist users in their analyses.  
Discussion and conclusions 
We present MediaDB, a manually curated database of defined media that have been used to 
cultivate organisms with sequenced genomes. Our database offers several important new 
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capabilities for researchers through the following features: 1) brings together literature sources of 
experimentally verified media formulations into a centralized database; 2) contains chemically 
defined media, so that every compound can be linked to known metabolic pathways in metabolic 
network models, and so that every formulation is repeatable; 3) links with compound identifiers 
in existing databases for simple, repeatable and automatable cross-referencing with other 
sources; 4) focuses on organisms with existing in silico models, both encouraging researchers to 
use and improve such models and providing multiple media conditions to support the iterative 
development of in silico models; 5) serves as a set of organism-specific media conditions to help 
improve automated metabolic reconstruction methods by replacing more generic media 
formulations; 6) includes only species with fully-sequenced genomes to ensure that all media 
formulations can be tied back to genomic data; and 7) is a publically available resource that we 
expect will grow and increase in usage as growth conditions for more organisms are added. We 
anticipate that MediaDB will support the investigation of the relationship between organism 
growth media formulations and genomic information, and facilitate efforts to model microbial 
metabolism. 
  
 
 
33 
 
Tables and Figures 
 
Kingdom Genera Species Strains 
Archaea 4 5 14 
Bacteria 36 43 172 
Eukaryote 6 9 22 
TOTAL 46 57 208 
Table 2.1: Taxonomy of organisms currently in MediaDB 
 
Top 10 Compounds Top 5 Carbon Sources 
CaCl2 86% Glucose 47% 
MgSO4 72% Acetate 33% 
KH2PO4 65% Glycerol 19% 
NaCl 65% Pyruvate 12% 
FeSO4 61% Ethanol/Succinate 9% 
ZnSO4 61%  Top 5 Amino Acids 
K2HPO4 58% Cysteine 37% 
NH4Cl 53% Aspartate 33% 
Biotin 51% Arginine 33% 
CuSO4 49% Glutamate 32% 
  Leucine 32% 
Table 2.2: Highest frequency compounds in MediaDB. Percentages reflect the fraction of species that contain 
each compound in at least one growth medium. 
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Figure 2.1: Simplified database schema. This graph shows the connections between the 6 main tables, Organisms, 
Compounds, Media_Names, Biomass, Sources, and Growth_Data. Also shown are Media_Compounds and 
Biomass_Compounds, linking tables that connect the Compounds table to the Media_Names and Biomass tables, 
respectively. Arrows indicate foreign key relationships, in which the head of the arrow points to the primary key 
being referenced. A full map of the MediaDB schema containing all tables and their connections can be found in 
Figure A.1. 
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Figure 2.2: The MediaDB website. The database can be found at https://mediadb.systemsbiology.net. This page 
shows the composition of a media formulation and displays links to the organism, source, and growth record that 
use this medium.  The “Site Navigation” panel lists the different tables that can be browsed manually and also the 
“Downloads” tab, where the user can export a copy of the entire MediaDB schema. The search field is at the top 
right of the page.  
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Figure 2.3: Heat map and dendrogram showing hierarchical clustering of species based on media compositions. 
Red bars indicate compounds that occur in at least one medium for that species. Black bars indicate compounds 
that do not appear in any media for that species. This figure was generated using the Statistics Toolbox in Matlab. 
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Figure 2.4: Phylogenetic tree of 16S rRNA sequences for species in MediaDB. Phylogeny was inferred from a 
CLUSTAL W alignment generated in the Biology Workbench using 16S rRNA sequences from the SILVA database. 
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Chapter 3: Exploring Hydrogenotrophic Methanogenesis: A 
Genome Scale Metabolic Reconstruction of Methanococcus 
maripaludis S22  
Introduction 
Methane plays a critical role in the global carbon cycle and as a greenhouse gas, is 21 times more potent 
than carbon dioxide [97] in absorbing and emitting energy. Additionally, it is a candidate bridge fuel [98] 
because it burns comparatively cleaner than traditional fossil fuels. Advancing technology also enables 
this gas to be converted to high energy density liquid fuels with a lower carbon footprint [99]. Methane 
is the second most abundant greenhouse gas after carbon dioxide [100] and is produced in the 
environment by biological and non-biological sources [101]. Methanogens are the largest biological 
contributors of methane, producing about 1 Gt of methane gas per year [102]. This group of 
microorganisms from the domain Archaea grow on carbon dioxide or one or two carbon compounds 
using enzymes containing unique biological co-factors [103,104]. 
Though phylogenetically and metabolically diverse, methanogens can be separated into two groups 
based on the presence or absence of cytochromes [102]. The cytochrome-lacking methanogens 
(sometimes referred to as hydrogenotrophic methanogens) mainly use H2, and sometimes formate, as 
sources of electrons for CO2 reduction to methane. In contrast, cytochrome-containing (or 
methylotrophic) methanogens utilize acetate and methylated compounds for methanogenic growth 
with a minority also being able to use H2 and CO2. Although both groups have similar central pathways 
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of CO2 reduction, they possess differing modes of energy coupling [105] at the last methanogenic step 
involving heterodisulfide reductase (Hdr).  
The reduction of the CoM-S-S-CoB heterodisulfide with H2 or reduced electron carriers is exergonic and 
can be directly or indirectly coupled to energy generation. In the methylotrophic methanogens, a 
membrane-associated cytochrome-containing Hdr (HdrDE) receives reducing equivalents from a 
methanogen-specific membrane-soluble electron shuttle, methanophenazine, for reduction of the 
heterodisulfide. This results in proton extrusion and the creation of a membrane potential for ATP 
generation [106,107]. However, in the hydrogenotrophic methanogens, the Hdr (HdrABC) is cytoplasmic 
and no membrane potential is generated. Instead, Hdr mediates a bifurcation of electron flow in which 
the exergonic heterodisulfide reduction is coupled to and drives the endergonic reduction of a 
ferredoxin used for the first step of methanogenesis [108]. 
Methanococcus maripaludis [109] belongs to this group of hydrogenotrophic methanogens. Compared 
to the larger genomes of methylotrophic methanogens, its genome is relatively small and contains only 
1722 protein coding genes [110]. It grows robustly with a doubling time of 2 hours [109] and is 
genetically tractable [111], and thus has been an ideal candidate for studying methanogenesis, unique 
co-factors and their biosyntheses [112], and gene regulation [113].To avoid environmental fluctuations 
that can affect gene regulation, a system for continuous culture of M. maripaludis [114] has been 
established for steady state transcriptomic [115] and proteomic [116] studies of M. maripaludis strains. 
Several groups have also employed larger systems biology approaches to perform predictive studies 
using this organism [117]. With these tools in place, and the ability for expression of heterologous genes 
in M. maripaludis [118,119], the metabolic engineering of M. maripaludis for various industrial use is the 
obvious next step.  
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Genome scale metabolic reconstructions are powerful tools that map and elucidate metabolic 
pathways. They are organism-specific knowledge bases that can be used for simulating steady state 
growth via flux balance analysis (FBA) [83] by generating constraint-based models. Using these models, 
we can hypothesize different metabolic scenarios that can then be tested experimentally. They have 
helped guide metabolic engineering efforts to produce industrial biochemicals in multiple organisms 
[120,121]. Similarly, a genome scale metabolic reconstruction for M. maripaludis would not only 
promote a better understanding of methanogenesis but also support metabolic engineering efforts that 
could harness the unique metabolism of this hydrogenotrophic methanogen. Other groups have already 
created metabolic models of M. maripaludis; as part of a mutualistic community model with D. vulgaris 
[122] and under axenic conditions [123]. In the former case, the model of M. maripaludis represented 
only core metabolism and was used primarily to investigate interactions between the two different 
species rather than probe the depths of the organism’s metabolism [122]. The latter case was the first 
genome-scale metabolic reconstruction of M. maripaludis [123], an important step towards 
understanding M. maripaludis metabolism.  
In our model, iMR540, we made important updates and refinements to various pathways based on 
recent literature. The most critical was the electron bifurcation step that has been described above as it 
explains the ability for this organism to grow despite the lack of a proton-exporting electron transport 
chain. This also includes eliminating methanophenazine utilization and synthesis, which is part of the 
membrane bound electron transport system of the methylotrophic methanogens and is absent in 
hydrogenotrophic methanogens [102]. Additional features include a corrected sulfur assimilation 
pathway [124], and the addition of various biosynthesis pathways for all of the unique coenzymes 
involved in methanogenesis [125]. We increased genome coverage by employing likelihood-based gap 
filling, a technique that fills reaction gaps based on gene homology rather than on parsimony [126]. Our 
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reconstruction is the first manually-curated genome scale reconstruction to employ likelihood based gap 
filling. Furthermore, we expanded the scope of our reconstruction beyond stoichiometric considerations 
by creating a new method to approximate overall model free energy. This is an especially salient 
consideration for methanogenic archaea, which can grow close to the thermodynamic limits that 
support life [127]. A well-established method of applying free energy constraints involves applying the 
second law of thermodynamics to metabolic models to restrict reaction directionalities in the direction 
of negative free energy generation [128,129]. Rather than apply thermodynamic constraints to every 
metabolic reaction, we created a method that predicts overall free energy generated during steady state 
growth based solely on standard free energies and effective concentrations of external metabolites. In 
combining these novel thermodynamic considerations with stoichiometric information, iMR540 provides 
a means to predict energetically feasible strain designs, enhancing our metabolic engineering 
capabilities with M. maripaludis.  
Methods 
Genome Scale Reconstruction Procedure 
The process of genome scale metabolic network reconstruction has been reviewed previously [52] and 
begins with annotating an organism genome using gene-protein-reaction (GPR) relationships stored in a 
reaction database. Several databases are available for this purpose [10,51,130]; we chose the 
Department of Energy Systems Biology Knowledgebase (Kbase; www.kbase.us), a suite of tools that 
includes the Model SEED reaction database [51]. We created our first draft reconstruction using the 
stored Kbase genome for M. maripaludis S2 (genome id: kb|g.575) and the automated reconstruction 
method (“Reconstruct Genome-scale Metabolic Model”). For this initial reconstruction, we used the 
default gram negative biomass composition and filled knowledge gaps using likelihood based gap filling 
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(method currently not supported in Kbase Narrative Interface). This yielded the first full draft of the 
metabolic reconstruction that could predict growth when simulated as a model.  
We expanded and refined the model by manually adding information from literature sources. In cases 
where reactions from literature were part of the Model SEED database, we labeled the reactions using 
SEED identifiers, names, subsystems, and EC numbers. For other cases where we encountered reactions 
that were not part of the Model SEED we created unique reaction identifiers and names, then added 
subsystem information based on our knowledge of the metabolic network. We also adhered to SEED 
identifiers, names, formulas, and charges for metabolites whenever possible and had very few cases 
where we specified our own values. Metabolites were compartmentalized using standard tags for 
cytosol (“c0”) and extracellular (“e0”) compartments. These tags additionally identify M. maripaludis as 
“Organism 0” in the possible future case where we could add other organisms to create a community 
metabolic reconstruction. Exchange reactions used for introducing metabolites to the extracellular 
compartment were standardized in “EX_{metabolite ID}[e0]” format. Comprehensive information on the 
reactions, metabolites, and genes in our reconstruction can be found in Supplementary Materials.  
Model Simulations with Flux Balance Analysis 
To make rigorous quantitative growth predictions, a genome scale metabolic reconstruction can be 
simulated as a model. Reactions and their participating metabolites in the metabolic network are 
connected via the stoichiometric matrix (S), which contains the stoichiometric coefficients for each 
metabolite (row) in each reaction (column). The S-matrix is used as the basis of a model via the 
principles of metabolite mass conservation by recognizing that time-dependent accumulation of 
metabolites in the system (b) is equivalent to the product of the S-matrix and the vector of reaction 
fluxes (v)  
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𝑆𝑣 = 𝑏 [1] 
In flux balance analysis (FBA), we further simplify this differential system by assuming our organism is in 
steady state growth; thus b=0 and the system is linear [81]. This assumption bounds our model system 
to a large solution space that can further be constrained by applying upper and lower bounds to each 
reaction flux: 
𝑣𝑖,𝑙𝑜𝑤𝑒𝑟 ≤ 𝑣𝑖 ≤ 𝑣𝑖,𝑢𝑝𝑝𝑒𝑟 [2] 
To find feasible flux distributions that represent likely physiological states within this solution space, we 
solved our model by optimizing the biomass objective function, a simulation of maximum cell growth 
yield [131]. We further constrained possible flux distributions by minimizing the squared sum of fluxes, 
effectively forcing our model to find solutions that minimize the total flux in the system while 
maximizing growth. All model simulations were performed using the COBRA toolbox 2.0 [132] in 
MATLAB [7.14.0.739] (The MathWorks Inc., Natick, MA).  
To encourage model transparency [133] and assist future users in simulating condition-specific models, 
we created several functions that create these models, simulate maximum growth with the 
aforementioned constraints, and print relevant information from the flux distribution (Supplementary 
File B.1). We also wrote numerous functions to help modify the reaction network, retrieve specific 
useful pieces of information from model simulations, and diagnose issues that may arise during model 
use. For several of these functions, we used the Paint4Net toolbox [134] to draw flux maps that show 
the direction and magnitude of fluxes in a given FBA solution. A limited number of our functions are 
included with this manuscript in their current versions (Supplementary File B.1) with the full set of up-
to-date tools available on Github (https://github.com/marichards/methanococcus). 
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Gene Knockout Phenotype Simulations 
Because a model is based around the stoichiometry of reactions contained in the S-matrix, knocking out 
a gene is akin to knocking out all reactions that depend on the gene. Thus, performing a gene knockout 
phenotype simulation in a metabolic model requires that model reactions be linked to genes via GPR 
relationships. We performed gene knockout simulations using our function “simulateKOPanel.m” 
(Supplementary File B.1), which relies heavily on the “deleteModelGenes.m” function in the COBRA 
Toolbox 2.0 [132] as well as several of our own functions. Our experimental test set included 18 
knockout genotypes across 4 different growth conditions, with 30 total wet lab experiments across 
these conditions [135–140]. We simulated growth phenotypes for all 72 combinations of knockout 
genotypes and growth conditions and then evaluated these growth phenotypes as lethal/non-lethal 
with a threshold of 10% wild type growth. Predictive accuracy was assessed by comparing predictions on 
the 30 known phenotypes with wet lab data. We further evaluated our model’s performance using the 
Matthews correlation coefficient (MCC), a metric that evaluates correlation based on a -1 to 1 scale 
[141]:  
𝑀𝐶𝐶 =
(𝑇𝑃 × 𝑇𝑁) − (𝐹𝑃 × 𝐹𝑁)
√(𝑇𝑃 + 𝐹𝑃)(𝑇𝑃 + 𝐹𝑁)(𝑇𝑁 + 𝐹𝑃)(𝑇𝑁 + 𝐹𝑁)
 [3] 
 
Thermodynamic Calculations 
We added standard free energies of formation (1 mM, 25ºC, 1 bar, pH=7, ionic strength = 0.1 M) from 
the Equilibrator database [142] to all exchange reactions for which these values could be reliably 
estimated via the group contribution method [143]. To incorporate these values into our reconstruction, 
we expanded the standard model structure to include a “freeEnergy” numerical array with length equal 
that of the “reactions” array. For calculating overall free energy of a flux distribution, we created an 
“optimizeThermoModel.m” code (Supplementary File B.1) that is built around the 
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“optimizeCbModel.m” code in the COBRA Toolbox 2.0 [132]. Our script accepts effective concentrations 
(mM) for specified exchange metabolites, assumes standard activities of 1 mM for unspecified 
metabolites, and uses these values to calculate effective metabolite free energies based on the 
reconstruction’s stored values for each exchange reaction. Prior to performing FBA, we add these free 
energies to the exchange reactions, which ordinarily have the form: 
𝐴𝑒0 ⇌  
We alter these exchanges such that production of a metabolite “creates” free energy equivalent to the 
metabolite’s free energy of formation: 
𝐴𝑒0 ⇌  (𝛥𝐺𝐴𝑒0)𝑑𝐺 
Here, 𝛥𝐺𝐴𝑒0 is the stoichiometric coefficient of a new metabolite “dG” that is used to sum model free 
energy. Because exchange reactions must satisfy mass balance by necessarily entering or exiting the 
model without creating new metabolites, adding free energies to the model creates an imbalance that 
we must correct. We restore model balance by allowing “dG” to exit the model via its own exchange 
reaction (GIBBS_kJ_GDW): 
𝑑𝐺 ⇌ 
Measuring the total flux of the exchange reaction gives an estimation of total free energy being 
generated in an FBA solution on a per cell mass basis. We have incorporated this thermodynamic 
calculation into all of our available model simulations (Supplementary File B.1); thus by default, we 
calculate and print overall model free energy in every flux distribution.  
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Dry Cell Weight and Growth Yield Measurements 
Wild type M. maripaludis S2 cells were grown in McNA medium—a chemically defined medium for 
growth on H2 and CO2 supplemented with acetate (Table B.3)—using a 1-L chemostat under anaerobic 
conditions as described previously [114]. The chemostat was operated in steady state continuous mode 
under H2-limiting conditions to match model simulation conditions, with gas flows of 10-20 mL/min H2, 
40 mL/min CO2, 15 mL/min of a H2S:Ar mixture (1:99 v/v), and a balance of N2 up to a total 200 mL/min. 
We altered our growth rate of M. maripaludis during steady state by varying pump speeds to achieve 
dilution rates of approximately 0.045-0.090 h-1, checking OD660 periodically to ensure steady state at 
each data point. For each sample point, we measured growth rate based on dilution rate and methane 
evolution rate via a combination of a bubble flow meter to assess total gas outflow and a Buck Scientific 
model 910 gas chromatograph equipped with a flame ionization detector to quantify methane fraction. 
We recalculated calibration curves for dry cell weight versus optical density by measuring dry cell weight 
via cell filtering and OD660 via a UV/Vis spectrophotometer {Spectronic 20D+} blanked with water. After 
measuring chemostat optical density, we sampled 50 mL aliquots of cells in suspension directly from 
chemostat culture and centrifuged samples at 7000 RPM for 15 minutes. 40 mL of supernatant was 
removed by pipette, then cells were re-suspended in the remaining 10 mL of media. These concentrated 
aliquots were vacuum filtered through 0.45 µM pore filters to remove all non-cellular components, then 
dried at room temperature and weighed daily until their weights stabilized.  
Growth yields were calculated based on doubling time (td, equal to ln(2) x (dilution rate x 60)
-1) as 
described previously [144], but with our measured conversion between OD660 and cell density: 
𝑌𝐺𝐷𝑊/𝐶𝐻4 =
𝑂𝐷660
𝐶𝐻4(
𝑚𝐿
𝑚𝑖𝑛)
×
0.46𝑔/𝐿
1 𝑂𝐷660
×
1
𝑡𝑑(𝑚𝑖𝑛)
×
22,400 𝑚𝐿
𝑚𝑜𝑙
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ATP Maintenance and Predicted Growth Yields 
As described by Thiele and Palsson, the optimal way to obtain accurate ATP maintenance values is to 
plot ATP production versus growth data from chemostat growth experiments [52]. In practice, this 
requires measuring steady state growth rate in concert with an uptake rate or, in our case, a product 
secretion rate, as described above.  
To calculate ATP maintenance values in our model, we constrained our model to our measured growth 
rate and methane secretion rate at each sampling point and set the model objective to maximize ATP 
hydrolysis (rxn00062[c0]). We plotted each resulting value of ATP production as a function of growth 
rate and obtained the growth-associated (slope) and non-growth associated (y-intercept) ATP 
maintenance values using a linear model, as described by Thiele and Palsson [52]. The resulting plot can 
be found in Figure B.4.  
Our growth data points comprised a set of 9 measurements and we used them as both training and test 
data by employing leave one out cross validation (LOOCV). In the LOOCV approach, a set of N samples is 
divided into a training dataset of N-1 points and a test sample of 1 point. The model developed on the 
training set is then tested on the remaining point that was left out of the training data. In employing this 
method, we iteratively removed one point from our full dataset and determined ATP maintenance 
values for that N-1 dataset as described above to create a trained model. We then constrained our 
model’s methane secretion flux to the measured rate in the remaining test point and predicted 
maximum growth rate within that constraint using our trained model. Using these values, we calculated 
predicted growth yields for each point using the above formula and compared them to our measured 
values for each point. All simulations were performed using the default H2 + CO2 media formulation 
supplemented with acetate (McNA medium).  
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Reconstruction and Model Availability  
Reconstructing a metabolic network is an iterative process and therefore, it is paramount that 
reconstructions be as clear as possible to encourage future updates and expansions [133]. We have 
strived for clarity in both our nomenclature and in our decision making process for including each 
reaction present in our reconstruction. Reactions and metabolites in our network are based upon 
identifiers and names found in Kbase, but also include crosslinks to ChEBI [145] and KEGG identifiers 
[10], enzyme commission numbers, and reaction subsystems where available. Each reaction in the 
reconstruction is also connected to its literature and/or database source, plus its reaction confidence 
score when applicable (Table B.1).  
Additionally, we have sought to maximize usability of both our reconstruction and our model. The 
systems biology markup language (SBML) is a standard medium for distributing metabolic 
reconstructions [34]; thus, we have included our reaction network in SBML level 2, the highest version 
currently supported by the COBRA Toolbox [132]. In our experience using reconstructions from other 
groups, we have found a wide range of usability, from those that can easily be imported and simulated 
to those that are difficult to use and interpret. In the interest of making our simulations and results easy 
to reproduce, we have included our reconstruction in MATLAB data structure format and an example of 
our codes for simulating model growth on different media and gene knockout phenotypes 
(Supplementary File B.1).We have also made our codes and reconstruction available on Github 
(https://github.com/marichards/methanococcus). 
Results 
Reconstruction Statistics 
The basic statistics for iMR540 are displayed in Table 3.1. Notably, reactions are categorized as 1) 
internal reactions, occurring entirely within the cytoplasm; 2) transport reactions, involving 
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translocation of at least one chemical species across the cell membrane; 3) exchange reactions, which 
supply metabolites to or remove metabolites from the model. Of the 586 internal reactions in our 
network, over 85% of the internal reactions are associated with at least one gene. We suspect that a 
major reason for this high percentage of gene-associated reactions was our use of likelihood based gap 
filling, which resulted in the automated addition of 66 genes to our reconstruction before manual 
curation. Furthermore, we relied heavily on biochemical knowledge from literature sources, particularly 
regarding recently-elucidated biosynthesis pathways that were not initially available in annotation 
databases. Our combined use of maximum likelihood gap filling and reliance on published literature 
sources are the likely causes for our consistent ties to gene homology. 
Another salient detail of our reconstruction is that it includes many “dead-end” metabolites and 
reactions that cannot be synthesized or consumed. Thus, these metabolites and reactions are not part 
of our simulatable model, but we have included them in our reconstruction because they are all gene-
associated; all dead end internal reactions in our reconstruction have at least one gene association. This 
indicates that there is genetic evidence supporting the presence of each dead end reaction and 
metabolite, thus they should be involved in metabolism even though we have not yet elucidated full 
synthesis or consumption pathways. They represent excellent candidates for further exploration of M. 
maripaludis metabolism, particularly as iMR540 is updated and expanded in the future.  
Conversely, our reconstruction contains 86 internal reactions that lack genes, many of which were 
added during automated gap filling but some of which were added manually. All of our reactions are 
annotated with subsystems, allowing us to assess where each reaction fits into metabolism, including 
those without genes. Figure 3.1 shows the breakdown of reactions without genes, where the 
subsystems have been manually grouped into broader categories (e.g. “Amino Acid Biosynthesis” 
instead of “Glycine Biosynthesis”). The largest group of these reactions is the “Unique Coenzyme 
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Syntheses”, which includes reactions that synthesize coenzyme M, coenzyme B, 
tetrahydromethanopterin (H4MPT), methanofuran, coenzyme F420, and coenzyme F430. Although these 
24 reactions lack genes, all of them were added manually as hypothetical steps to complete essential 
biosynthetic pathways and are based on information from biochemical literature. These are distinct 
from, for example, the 11 reactions encompassed by “Vitamin and Cofactor Synthesis” that were added 
to fill biosynthesis gaps but have no supporting literature evidence. We expect that as experimental 
research groups uncover more biochemical phenomena, they will determine genes that tie to the 
reactions in the former group. The gap filling reactions, much like dead end reactions and metabolites, 
point us toward poorly-understood areas of metabolism in our organism and require more investigation 
into both the reaction pathways and their associated genes.  
As an additional feature of our reconstruction, our use of likelihood based gap filling also assigned 
likelihood scores for many of the reactions in the reconstruction. These confidence scores quantify the 
probability of a given reaction being part of the metabolic reconstruction on a scale of 0-1 and provide a 
new metric of evaluating our confidence in the reconstruction. We can then use the scores to quickly 
hone in on both reactions that lack genes and gene-associated reactions with low gene homology as 
possible targets for more experimental investigation. They also provide a logical starting point for future 
users looking to expand upon and improve the existing reconstruction.  
Electron Bifurcation and Acetate Metabolism 
Methanogenesis from H2 and CO2 has often been represented as a linear pathway with heterodisulfide 
reduction as the final step. This was demonstrated to be mediated by methanophenazine dependent 
membrane bound heterodisulfide (HdrDE) [106,107] for the cytochrome containing methanogens. 
However, the non-cytochrome containing obligate hydrogenotrophs do not contain the typical 
membrane associated heterodisulfide reductase but instead one that is most likely associated with the 
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cytoplasm [146,147]. Additionally, it is a three subunit complex (HdrABC) with a flavin adenine 
dinucleotide (FAD) containing co-factor in the HdrA subunit [148].HdrA and other FAD-containing 
enzymes have been increasingly recognized as sites for electron bifurcation, coupling an exergonic 
reaction with an endergonic reaction in a two-step transfer of one electron [149,150].  Recently, it has 
been demonstrated [108,151] that this heterodisulfide reductase mediates the coupling of exergonic 
heterodisulfide reduction with endergonic ferredoxin reduction. As shown in Figure 3.2, this ferredoxin 
is used for reduction of the CO2 via Fwd thereby linking the last step of methanogenesis with the first 
step in a cyclical fashion [152] 
The assumption of a linear pathway in M. maripaludis without accounting for electron bifurcation can 
affect the downstream predictions in the metabolic model. The default mechanism of energy 
conservation in our initial, uncurated model matched methylotrophic methanogens and utilized 
methanophenazine, an electron carrier known to be absent from M. maripaludis and other 
hydrogenotrophic methanogens. We removed methanophenazine-based electron flow and added the 
correct electron bifurcation pathway, linking heterodisulfide reduction with electrons from H2 to carbon 
dioxide reduction via reduced ferredoxin instead. This commonly-encountered reconstruction pitfall, in 
which information available in annotation databases does not sufficiently represent recently elucidated 
metabolic pathways, emphasizes the need to keep abreast of updated academic literature in spite of the 
improvement of automatic reconstruction methods.  
To demonstrate that the linear pathway cannot support growth of M. maripaludis, we altered the native 
electron bifurcating heterodisulfide reductase (HdrABC) reaction: 
𝐶𝑜𝐵 − 𝑆 − 𝑆 − 𝐶𝑜𝑀 + 2 𝐻2 + 𝐹𝑑𝑜𝑥 ⇌ 𝐻𝑆 − 𝐶𝑜𝐵 + 𝐻𝑆 − 𝐶𝑜𝑀 + 2 𝐻
+ + 𝐹𝑑𝑟𝑑   
by removing ferredoxin, balancing mass and charge to yield: 
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𝐶𝑜𝐵 − 𝑆 − 𝑆 − 𝐶𝑜𝑀 + 𝐻2 ⇌ 𝐻𝑆 − 𝐶𝑜𝐵 + 𝐻𝑆 − 𝐶𝑜𝑀  
This scenario represented a hypothetical case where M. maripaludis does not contain a membrane-
bound HdrDE complex but cannot perform electron bifurcation. We optimized this altered model for 
growth on CO2 + H2 and were unable to predict in silico growth, supporting the observation that the 
ferredoxin reduction via electron bifurcation is an essential part of our network. Lack of model growth 
can clearly be attributed to disruption of the central energy coupling mechanism in M. maripaludis, in 
which electron bifurcation must necessarily reduce ferredoxin for reducing CO2. The alternative source 
of reduced ferredoxin is the energy-converting Eha hydrogenase, which utilizes a sodium ion gradient to 
reduce ferredoxin with H2 on a 1:1 basis. CO2 reduction to methane requires reduced ferredoxin and 
pumps out sodium ions, also on a 1:1 basis. Thus, each cycle of methanogenesis in this scenario 
effectively produces no sodium ion gradient for synthesizing ATP, the central component necessary for 
biomass formation. Additionally, methanogenesis loses small amounts of carbon for biosynthesis; 
hence, reducing one ferredoxin effectively pumps less than one sodium ion across the cell membrane 
and creates an overall energy deficit. Overall, this simulation illustrates the essentiality of ferredoxin 
reduction via electron bifurcation and reinforces the idea that Eha hydrogenase can play only an 
anaplerotic role in methanogenesis [136].  
Taking this analysis one step further, we used our reconstruction to probe into acetate assimilation, a 
pathway in M. maripaludis that can enhance growth but cannot replace H2 and CO2 as an energy source 
[153]. This is in contrast to multiple methylotrophic methanogens such as Methanosarcina barkeri that 
can subsist using solely the aceticlastic pathway [154]. It is unknown why M. maripaludis cannot be 
grown on acetate alone, and our reconstruction did not reveal any strictly stoichiometric obstacle to 
growth. However, much like the pathway in M. barkeri, an aceticlastic pathway in M. maripaludis would 
require energy-converting hydrogenases (Eha and Ehb) to produce H2 using reduced ferredoxin, 
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pumping out sodium ions, and thrusting this reaction into a central stoichiometric role rather than an 
anaplerotic one. As shown in Figure 3.3, when we simulated our model and allowed Eha/Ehb unlimited 
flux, we could predict aceticlastic growth with Eha/Ehb oxidizing approximately two moles of ferredoxin 
per methane produced. We then constrained our model to enforce a solely anaplerotic or biosynthetic 
role of energy-converting hydrogenase by limiting flux through the Eha/Ehb reaction to 10% that of 
methane secretion rate. Doing so prevented our model from predicting growth from acetate alone, but 
did not restrict hydrogenotrophic growth or supplementary acetate uptake. This simulation supports the 
hypothesis that M. maripaludis cannot achieve aceticlastic growth because Eha or Ehb cannot assume a 
central role in methanogenesis. In keeping with this hypothesis, we have restricted flux through Eha/Ehb 
in our model to ≤ 10% of methane secretion as a default constraint.  
Interestingly, there is evidence that M. maripaludis uses multiple forms of ferredoxin as electron carriers 
and may link certain steps, particularly those involved in electron bifurcation, reduction of CO2 to 
formylmethanofuran, and certain biosynthetic reactions, using specific ferredoxins [155]. Presently, the 
full extent of this phenomenon is not well understood and requires more experimental investigation. 
However, in an effort to represent ferredoxin specificity in our model, we have included a function (see 
https://github.com/marichards/methanococcus) that replaces promiscuous ferredoxins with two types 
of specific ferredoxins. One type is used for the Eha hydrogenase, Hdr, and formylmethanfuran 
dehydrogenase (Fwd) and the other type for Ehb hydrogenase and biosynthetic carboxylating 
oxidoreductases, as suggested by [135]. Using this function tightens the coupling between the 
aforementioned reactions by restricting each set to one pool of electron carriers and allows us to predict 
how ferredoxin specificity could change possible model flux distributions. In wild type simulations, this 
change has minimal effects on predicted growth yields and fluxes but could have notable impact on 
gene knockout predictions, particularly those involving reactions that utilize ferredoxin. Moreover, 
 
 
54 
 
electron movement through different ferredoxin species could have important implications for 
hypothesizing strain designs, thus including multiple ferredoxins could be vital for effective metabolic 
engineering.  
Other Biochemistry Improvements 
A major part of our manual curation was adding biosynthesis pathways for the methanogenic 
coenzymes, sugars, and lipids. M. maripaludis utilizes a number of unusual coenzymes (methanofuran, 
H4MPT, coenzyme F420, coenzyme B, coenzyme M, coenzyme F430)  as carbon and electron carriers during 
methanogenesis [156]. It also contains recently characterized pathways for synthesizing a 
tetrasaccharide for N-linked glycosylation of archaellin (archeal flagellin) [157] and multiple forms of 
archaeol, an archaeal membrane ether lipid [158]. None of these pathways were included in our draft 
reconstruction and few were completely present in the Model SEED database, thus the bulk of these 
reactions were added manually. These synthesis pathways, particularly for coenzymes, are vital pieces 
of M. maripaludis metabolism that set it apart from the vast majority of known biochemistry. Hence, 
including these synthesis pathways and adding these metabolites as required biomass components was 
crucial for distinguishing our reconstruction from existing networks.  
In a similar vein, we sought to accurately represent sulfur assimilation, a pathway not yet fully 
understood in M. maripaludis. Sulfate is known not to be the sulfur source for M. maripaludis; 
moreover, sulfate reduction would produce sulfite, a methanogenesis inhibitor [159]. However, because 
sulfate is the default sulfur source for most microorganisms, our first draft reconstruction included a 
sulfate transporter and sulfate reduction pathway. We removed this default pathway and instead added 
a pathway to utilize hydrogen sulfide gas, the primary sulfur source for M. maripaludis. Our updated 
sulfur assimilation pathway includes sulfide oxidation to sulfite—an essential metabolite for multiple 
biosynthetic pathways—via a hypothesized dissimilatory sulfite reductase-like protein [124]. Taken 
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together with aforementioned syntheses, these modifications demonstrated the need for rigorous 
manual curation to add known biochemical pathways that were not part of the automated 
reconstruction and remove pathways that are known not to function in the organism. By employing 
these methods and by working collaboratively with M. maripaludis experts, we have created a 
reconstruction that maximizes consistency with biochemical literature of our organism.  
Growth Yield Validation and ATP Maintenance 
Evaluating a metabolic network reconstruction by qualitatively comparing it to known biochemical 
phenomena is a valuable way to gauge how close the network can represent actual biochemistry. To 
make more quantitative comparisons, we must convert the reconstruction to a metabolic model by 
imposing flux constraints on the network, enforcing mass balance on all metabolites, and optimizing to 
an objective function (Methods). A common way of quantitatively evaluating the resulting model is to 
simulate maximum cell growth under steady-state conditions and compare growth yield predictions to 
experimentally-determined values. Due to the narrow range of possible substrates for our 
hydrogenotrophic system and scarcity of growth yield data for our organism, we generated our own 
experimental measurements of growth yield. We conducted chemostat growth experiments under H2-
limiting conditions and measured growth yields as described previously [144], but varied our dilution 
rate to gather a range of different yield measurements. Cell density was assessed using optical density 
(OD) and was previously reported as OD600=1 corresponding to 0.34 mg(dry weight)∙ml
-1 [137]. We were 
unsure of the efficacy of this value, in part because we measured at 660 nm rather than 600 nm. We re-
measured this conversion factor using a combination of centrifugation and vacuum filtering (Methods) 
and plotted a new calibration curve (Figure B.3), determining that OD660=1 corresponded to 0.462 ± 
0.015 mg(dry weight)∙ml-1.  Using this value, we calculated measured growth yields based on growth 
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rates (equal to dilution rates) and measured methane evolution rates (Methods).  Measured growth 
yields are plotted in Figure 3.4 for 9 independent steady state time points. 
We then tested our model by generating growth yield predictions and comparing them to measured 
growth yields. Growth yield predictions depend not only on metabolic steps where ATP is generated or 
hydrolyzed, but more heavily on ATP maintenance energies [160].  From a modeling perspective, 
maintenance energies are regarded as the moles of ATP needed to support cellular processes not 
otherwise depicted in metabolism, including DNA replication, RNA transcription, protein synthesis, and 
other requirements. We recognized that our model was essentially untrained in terms of ATP 
maintenance and contained automated values from our first draft reconstruction. Thus it was crucial to 
train our model by fitting to our experimental dataset. However, we were also wary of overfitting our 
model by training and testing on the same set of samples. We addressed both concerns by performing 
leave one out cross validation (LOOCV) on our full dataset. Thus, for each of our nine growth rate values, 
we used the remaining eight growth rates and their associated measured methane evolution rates to 
derive ATP maintenance values. We then used that ATP maintenance value in our calculation of 
predicted growth yield for the given growth rate. Using this method allowed us to essentially test our 
model’s growth yield predictions on each separate test point while training on the remaining 8 
measurements. The resulting predicted growth yields are plotted in Figure 3.4 along with our measured 
growth yields.  As illustrated by this plot, our model was able to consistently predict growth yield within 
the 95% confidence interval of a measured test sample after being trained on a separate dataset. 
Though growth yield validation is not an absolute measure of model performance, our model’s ability to 
closely reproduce experimental results in a LOOCV setting that mitigated overfitting suggested a high 
propensity for generating viable growth predictions. Moreover, the relative consistency between 
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measured and predicted values indicated our model’s robustness for predicting growth yields across a 
range of different dilution and methane secretion rates.  
We also used the full dataset of growth rates and methane evolution rates to set final values for growth 
associated maintenance (GAM) and non-growth associated maintenance (NGAM). The GAM represents 
ATP hydrolysis required to support growth-related processes and NGAM represents ATP hydrolysis 
required for non-growth associated cellular upkeep. GAM was originally set as 40.11 (mmol per grams 
[cell mass]), a relatively low value when compared with that of a fast-growing bacterial species, such as 
the GAM of 59.81 in E. coli [161]. NGAM, represented by simple ATP hydrolysis, was unbounded in our 
first draft reconstruction and took on a value of 0 during all model simulations. After training on our full 
dataset, we set our GAM and NGAM values to 169.9  mmol ATP per gram [cell mass] and 5.0 mmol ATP 
per gram [cell mass] h-1, respectively (see Appendix B). Notably, these maintenance values are much 
higher than those in other methanogen models; for example, fellow methanogen Methanosarcina 
barkeri was reported to have a GAM of 65.00 (mmol per grams [cell mass]) [160], about 38% of our 
calculated value. This difference is reflective of the observed differences in growth yield for these 
organisms during growth on H2 and CO2. Using the same formula for growth yield in each case at nearly 
identical doubling times of 12 h, M. maripaludis grew at a yield of about 33% of that reported for M. 
barkeri [160]. Thus, though we calculated unusually high ATP maintenance requirements for growth, 
these high values reflect observed differences in growth data when comparing to a methylotrophic 
methanogen growing on the same substrates.  
Gene Knockout Validation 
Gene knockout experiments present a different method for validating a metabolic reconstruction based 
on its model. At its core, a constraint-based model is built around gene-protein-reaction relationships 
that connect genotype to growth phenotype. Thus, comparing model predictions of gene knockout 
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lethality provides an excellent way to quantitatively measure the qualitative content of the model. This 
process hinges on the availability of gene knockout data for the organism being modeled, ideally with 
the abundance of data found for a traditional model organism such as Escherichia coli [162]. M. 
maripaludis lacks this abundance of in vivo gene knockout data, but was used for transposon 
mutagenesis to calculate an essentiality index of all of its genes [163]. Although this dataset does not 
contain the same quality of knockout data as actual knockout experiments, it provides a valuable “first 
pass” test set for gene essentiality of our model. However, essentiality index is itself a model for 
predicting gene knockout lethality, thus although we compared our model’s predictions to this dataset 
(see Appendix B) it did not provide the same clear picture as targeted knockout experiments. 
Because much of methanogenesis revolves around the function of different hydrogenases, the bulk of 
available gene knockout data involves hydrogenase knockouts on different media. For our test set, we 
were able to assemble a knockout panel of 30 binary growth phenotypes based on previous publications 
[135–140]. Though the breadth of these knockout genotypes is limited, they are all vital pieces of central 
carbon metabolism and therefore, they give us a good idea of how well our model can predict knockouts 
in central catabolism. In comparing with these data, as shown in Figure 3.5, our model achieved 90% 
prediction accuracy and a Matthew’s correlation coefficient of 0.67. These high values suggested that 
our model is an excellent predictor of growth phenotype based on genotype changes in central carbon 
metabolism. This result was particularly encouraging because we avoided training our model on this 
dataset in the interest of preventing overfitting our model to the validation set.  
It is also worth noting that all 3 incorrect predictions have similar bases in the model. In these cases, 
knockouts of 5 or 6 hydrogenases are experimentally found to be lethal in formate-grown cells, or in 
formate + CO-grown cells lacking carbon monoxide dehydrogenase (CODH), yet our model predicts 
these knockouts to be non-lethal. The reason for this disagreement lies in our innate assumption that 
 
 
59 
 
every reaction performs at 100% efficiency, an ideal scenario that is not achievable in an actual 
organism. Methanogensis cannot be expected to operate at 100% enzyme efficiency, as some of 
substrates and electron carriers will not react, thus it can be considered as a “leaky” process where a 
portion of the metabolites are unused in every cycle. Specifically, in the Δ5H2ase and Δ6H2ase 
knockouts, small amounts of hydrogen are synthesized in biosynthetic reactions. Eha hydrogenase 
remains active in each mutant and can use this hydrogen to supply anaplerotic reduced ferredoxin for 
methanogenesis. However, in reality an additional non-stoichiometric amount of hydrogen is required. 
Thus, the actual mutants cannot grow on formate alone and require hydrogen.  [Notably, most of our 
knockout predictions were made with glyceraldehyde-3-phosphate ferredoxin oxidoreductase (GAPOR) 
constrained to carry zero flux. The GAPOR reaction is ferredoxin-reducing and can serve as a 
supplemental source of reduced ferredoxin for growth on formate in the case of Eha knockout [138]. 
However, in wild type strains the expression of GAPOR is not sufficient to support growth in the absence 
of other hydrogenases (e.g. the Δ5H2ase and Δ6H2ase mutants). As demonstrated previously, 
overexpression of the GAPOR operon allows for growth of these mutants (Δ6H2asesupp and Δ7H2asesup) 
on formate [138]. To best reflect these genotypic differences, we altered the bounds of the GAPOR 
reaction (rxn07191[c0]) in our knockout simulation code, constraining the reaction to zero flux in all 
cases except those of the Δ6H2asesupp and Δ7H2asesup mutants.]  
Thermodynamic Calculations 
Free energy plays a key role in biochemistry as all biological systems must have a sufficiently low overall 
free energy to support growth. When simulating optimal growth using a metabolic model we expect the 
same rules to apply to our system, hence we can apply thermodynamic constraints to the model based 
on metabolite free energies of formation. In a previous study, free energies of formation were used to 
constrain reversibility of all internal model reactions based on the second law of thermodynamics [128]. 
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This method, while rigorous, is highly dependent on concentration and can be overly restrictive with 
regard to predicted flux distributions; thus it is most effective when paired with metabolite effective 
concentration data [129]. Lacking extensive effective concentration data for M. maripaludis, we chose to 
represent free energy constraints in a novel approach where we add free energies only to exchange 
reactions, the set of metabolites that can be taken up or produced by the model. These metabolites 
effectively represent the organism’s overall biochemical “reaction”; therefore it is reasonable to expect 
this overall reaction must produce a negative overall free energy to support growth. Indeed, applying 
this method to our default model growing on H2 + CO2 with methane evolution rate of 50 mmol/g(dry 
weight)∙h, overall free energy production is predicted as -5.59 kJ/g(dry weight). Optionally, this 
calculation can be used as an additional model constraint that restricts overall free energy to be 
negative, the equivalent of imposing the second law of thermodynamics on the organism itself.  
We expect that this straightforward calculation (Methods) will be a useful addition to our model, 
particularly as we aim to use it as a platform for generating possible strain designs. With regard to free 
energy, methanogens are particularly notable in that they subsist close to the thermodynamic limit to 
support growth [127]. It follows that for any potential strain design, we must pay particular attention to 
the overall free energy of our system, lest it dip below this vital threshold. It may also provide a metric 
for differentiating between multiple feasible strain designs by ranking them in order of thermodynamic 
feasibility. At the very least, it serves as an additional capability of our model and as a checkpoint to 
ensure that our overall stoichiometry matches up with overall free energy. We have included example 
functions for adding metabolite free energies to our model and performing FBA with an additional free 
energy calculation (Appendix B). 
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Discussion 
Genome scale metabolic reconstructions provide a wide lens for studying the biochemical complexity in 
a computational setting. We used likelihood based gapfilling and meticulous manual curation to build 
iMR540, a comprehensive reconstruction of M. maripaludis that incorporates electron bifurcation to 
portray cyclical hydrogenotrophic methanogenesis. We incorporated many unique pathways that 
differentiate our network from those for other organisms, creating a novel tool for understanding and 
probing more deeply into hydrogenotrophic methanogenesis. The resulting network model compared 
favorably with measured growth yield and gene knockout data and provided a platform to develop a 
new method for estimating overall free energy generation during steady state growth.  
Electron bifurcation is the central energy conservation mechanism in M. maripaludis, thus it is fitting 
that this process takes a central role in our reaction network. This mechanism is in stark contrast to 
existing methanogen models that contain linear methanogenesis based on oxidative (electron transport) 
phosphorylation [92,123,160]. While the linear model is correct for methanogens with cytochromes, it is 
not correct for methanogens without cytochromes such as M. maripaludis. We have demonstrated that, 
in the absence of a membrane-bound HdrDE complex, ferredoxin reduction via electron bifurcation is 
essential for predicting growth in our network. Furthermore, constraining the energy-conserving 
Eha/Ehb reaction to a minor metabolic role provides a stoichiometric hypothesis for the inability of M. 
maripaludis to grow aceticlastically and will undoubtedly influence model predictions moving forward. 
Ferredoxin specificity for these and other reactions remains an open question that could profoundly 
affect electron carrier utilization and have implications in native and mutant genotypes, a possibility we 
have acknowledged by allowing either promiscuous or specific ferredoxins in our reconstruction. 
Beyond bifurcation itself, we added numerous uncommon biosynthetic pathways to our network from 
literature sources that further separate it from models of other organisms. These pathways included 
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syntheses for methanogenic coenzymes, archaellin sugars and archaeol lipids as well as a relatively 
novel sulfur assimilation pathway. Additionally, using likelihood-based gap filling helped us automatically 
identify 66 more genes, increasing the gene coverage of our reconstruction prior to the start of manual 
curation and assigning reaction likelihood scores for many reactions that lend a measure of confidence 
level to network. The efficacy of these methods is shown not only in the qualitative accuracy of our 
reconstruction, but also in the formidable quantitative capabilities of the resulting model. Our model 
performed well in a LOOCV analysis of growth yield data and compared favorably with experimental 
gene knockout data, suggesting a high propensity for generating predictions that are consistent with 
observed biology.  
For a methanogen living close to the edge of thermodynamic feasibility, we also thought it salient to 
include some calculation of overall free energy when simulating our model. We have thus introduced a 
novel method of predicting overall model free energy generation based solely on standard free energies 
and concentrations of exchange metabolites. Though a relatively trivial calculation, our method gives a 
quick assessment of whether a predicted flux distribution is thermodynamically possible and could 
prove a particularly useful tool for guiding future metabolic engineering designs.  
While considering our reconstruction’s consistency with existing literature and our model’s high 
performance on measured data, it is poignant that we acknowledge the limitations in our network. First, 
though we have attempted to address as many parts of metabolism as possible, many “dark areas” of 
M. maripaludis metabolism still exist in our reconstruction. For many of these cases, gene annotations 
from Kbase and likelihood based gap filling give us starting hypotheses for what may be occurring in 
these dark areas, but the accuracy of these predictions remains unknown until they have been 
biochemically characterized. We recognize that our reconstruction effort represents only an incremental 
step toward understanding M. maripaludis metabolism and that many other users may follow in our 
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footsteps. With these considerations in mind, we strived for maximum transparency in our metabolic 
network to make our reconstruction decisions apparent to future users and to make our results easily 
reproducible. There is ample opportunity for improving our reconstruction in the future by elucidating 
the missing information for these dark areas and we hope that by providing information on the origins 
and likelihoods of our reactions, we can encourage exploration of these as-yet-unknown pathways.  
Second, we recognize that even for the areas of metabolism that we understand well, our model is 
purely stoichiometric and therefore can only provide predictions from a metabolic perspective. This 
somewhat limits the scope of questions we can ask using our reconstruction because it does not 
explicitly include information for other cellular processes, e.g. transcriptional regulation. Given the wide 
expanse of unknown metabolism, we do not perceive this limitation as particularly crippling, as we can 
still ask a plentiful supply of questions just within the realm of stoichiometry. In the future, if we wish to 
address this limitation our stoichiometric predictions could be combined with those from other types of 
structures, thus providing the tools to probe questions that include other cellular processes.  
Lastly, we stress that even within the metabolic space, our model’s power lies in predicting the scope of 
metabolic possibility, not absolute biological reality. Any particular flux distribution should be 
considered a hypothesis about the what our organism can theoretically achieve, not a precise prediction 
about all metabolic fluxes. These predictions provide valuable insight into the potential metabolic 
capabilities of our organism, but it would be folly to accept any single prediction as a facsimile of reality. 
Such a consideration is vital when considering our model or any other model as a tool for facilitating 
metabolic engineering designs because any model prediction should be considered as a starting point 
rather than a final product. By explicitly acknowledging this limitation, we hope to realistically portray 
the capabilities of our reconstruction as a tool to better understand the unique biochemistry of 
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hydrogenotrophic methanogens, push forward biochemical discovery in these organisms, and unlock 
their potential as metabolic engineering targets. 
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Tables and Figures 
 
Methanococcus maripaludis S2 model statistics 
Protein Coding Genes 540 
% ORF Coverage 31 
Intra/Extracellular Metabolites 658/53 
Dead End Metabolites 259 
Internal Reactions 586 
Transport/Exchange Reactions 49/59 
Dead End Reactions 206 
Gene-Associated Reactions 500 
Table 3.1. General statistics for the iMR540 reconstruction. 
  
 
 
 
Figure 3.1: A chart showing broad subsystem groupings of the 85 reactions in iMR540 that are not associated 
with any genes. Reactions falling underneath the “None” subsystem grouping were present in the Model SEED 
database but had no subsystems listed there and no obvious membership in another subsystem. Reactions 
grouped within “Other” were dissimilar both from the other categories and from one another, thus we felt they 
did not merit creation of multiple additional categories.  
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Figure 3.2: The native pathway of hydrogenotrophic methanogenesis present in M. maripaludis. As shown, 
electrons from 2 moles of H2 are split between reducing ferredoxin and regenerating coenzymes B and M. Reduced 
ferredoxin from this reaction links it to CO2 reduction, the first step in the pathway. Enzyme names are shown in 
blue. Metabolites: Fdrd, reduced ferredoxin; Fdox, oxidized ferredoxin ; MFR, methanofuran; HSCoM, coenzyme M; 
HSCoB, coenzyme B; F420, coenzyme F420. Enzymes: Fwd, formylmethanofuran dehydrogenase; Ftr, 
formylmethanofuran/H4MPT formyl transferase; Mch, methenyl-H4MPT cyclohydrolase; Hmd, H2-dependent 
methylene-H4MPT dehydrogenase; Mtd, F420-dependent methylene-H4MPT dehydrogenase; Mer, methylene-
H4MPT reductase; Mtr, methyl-H4MPT coenzyme M methyltransferase; Mcr, methyl coenzyme M reductase; Hdr, 
heterodisulfide reductase;Eha/Ehb, energy-conserving hydrogenases; ATPS, ATP-synthase; Fru, F420-reducing 
hydrogenase (selenocysteine-containing); Frc. F420-reducing hydrogenase (cysteine-containing).   
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Figure 3.3: Hypothetical pathway for aceticlastic methanogenesis in M. maripaludis. As demonstrated, this 
scheme would require 2 cycles of Eha/Ehb in order to oxidize ferredoxin reduced by the CODH/ACS and Hdr 
reactions. By constraining the Eha/Ehb reaction to only 10% of methane efflux, this pathway becomes infeasible. 
Enzyme names are shown in blue.  Metabolites: Fdrd, reduced ferredoxin; Fdox, oxidized ferredoxin ; MFR, 
methanofuran; HSCoM, coenzyme M; HSCoB, coenzyme B; F420, coenzyme F420. Enzymes: CODH/ACS, carbon 
monoxide dehydrogenase/acetyl-CoA synthase complex; Mtr, methyl-H4MPT coenzyme M methyltransferase; Mcr, 
methyl coenzyme M reductase; Hdr, heterodisulfide reductase;Eha/Ehb, energy-conserving hydrogenases; ATPS, 
ATP-synthase.   
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Figure 3.4: Comparing growth yield predictions on hydrogen to measured data using LOOCV (Methods). All but 
two predicted growth rates fall within the 95% confidence interval of the measured values. Each of the two 
outlying points are predicted to grow to higher than measured growth yields. 
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Genotype H2 Formate H2 + Formate Formate + CO 
∆hmd N N N N 
∆mtd N N N N 
∆frcA N N N N 
∆fruA N N N N 
∆frcA∆fruA N N N N 
∆vhcAU∆vhuA N N N N 
∆hdrB2 N N N N 
∆fdhA1 N N N N 
∆fdhA2 N N N N 
∆fdhA1∆fdhA2 N L N L 
∆fdhA2∆fdhB2 N N N N 
∆ehbF N N N N 
∆3H2ase N N N N 
∆5H2ase L N N N 
∆6H2ase L N N N 
∆6H2ase∆cdh L N N N 
∆6H2asesupp L N N N 
∆7H2asesupp L N N N 
Total Correct:  10 of 10 14 of 16 2 of 2 1 of 2 
Figure 3.5: Knockout lethality predictions from running FBA on our models show close agreement with 
experimental results of hydrogenase knockouts. Green boxes indicate growth phenotypes where our models 
correctly replicated experimental results; red boxes indicate growth phenotypes where our models were incorrect; 
white boxes indicate growth phenotypes where we lacked experimental validation data. Across the full spectrum 
of conditions, our models correctly predicted 27 of 30 conditions (90%) accurately, resulting in a strong Matthews 
Correlation Coefficient of 0.67. This suggests that our reconstruction produces models that accurately depict the 
effects of genotype alterations on growth phenotypes. L = lethal, N = non-lethal. 
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Chapter 4: Guiding Strain Design with the iMR540 Metabolic 
Reconstruction 
Introduction 
There is currently great interest in harnessing non-sugar feedstocks to produce liquid fuels and value-
added chemicals. One such example is converting methane—a greenhouse gas—to liquid fuel, beginning 
with the activating step of making methanol. This is a particularly pertinent objective based on recent 
increases in known natural gas reserves; estimates now suggest an abundance of methane gas sufficient 
to meet current usage for over a century [97]. Technologies that achieve gas-to-liquid fuel (GTL) 
conversions could leverage these resources, creating end products that coalesce with the existing fuel 
economy.  
Current chemically-based GTL conversion depends upon Fischer-Tropsch synthesis, a method for 
converting synthesis gas into value-added liquid fuels [164]. Plants based around such conversions face 
numerous challenges, including high carbon emissions, large capital expenses, and a high level of 
technological complexity. On top of these difficulties, such processes achieve poor efficiency, typically 
using only 25-45% of fed carbon substrates and capturing only 30-50% of available energy. These 
deficiencies pose a substantial obstacle to making chemically-based GTL plants a viable option going 
forward.  
Biological systems present alternative ways to achieve GTL conversions that circumvent many of the 
obstacles facing chemically-based plants. Methane-consuming organisms, or “methanotrophs”, have 
been shown to oxidize methane with much greater carbon and energy efficiencies than those realized in 
Fischer-Tropsch GTL processes [99]. Methanotrophs fall into two categories based on O2 tolerance:  
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aerobic bacterial methanotrophs and ANaerobic MEthanotrophic archaea (ANME). Bacterial 
methanotrophs grow fairly quickly and achieve efficiencies greater than those realized via chemical 
synthesis, with up to 66.7% carbon efficiency and just over 50% energetic efficiency. However, the 
ANME are by far the most efficient organisms, theoretically able to convert 100% of available carbon to 
end products and achieve nearly 80% energetic efficiency. Their remarkable efficiency is tempered by 
painstakingly slow growth rates, with doubling times as lengthy as 7 months [165].  
Due to their exceedingly long doubling times compared with common industrial organisms, ANME 
organisms remain relatively uncharacterized systems, leaving something of a knowledge gap in this 
portion of the global carbon cycle [166]. They have thus far eluded efforts to grow them axenically, 
though several studies have been able to grow them as a highly enriched consortia [165,167]. In spite of 
culturing difficulties, these limited studies and some culture-independent studies have revealed vital 
pieces of ANME metabolism. Perhaps most notably, there is evidence that ANME achieve anaerobic 
methane oxidation (AOM) by performing reverse methanogenesis, using the same set of enzymes found 
in methanogenic archaea [168]. Considering the clear energetic favorability associated with forward 
methanogenesis, it is puzzling that ANME are able to subsist and even thrive on a seemingly unfavorable 
central catabolic process.  
Much of the answer to this puzzle appears to come from other organisms present in the ANME 
consortia, commonly sulfate-reducing bacteria [166]. Several different studies have demonstrated that 
bacterial partners reduce sulfate or another electron acceptor (e.g. nitrate), essentially coupling the 
reduction pathway to AOM [166,167,169,170]. The mechanism of electron movement between 
organisms is not completely understood, though recent publications have shown at least some degree 
of direct interspecies electron transfer between ANME-bacterial pairs [171,172]. Coupling AOM to a 
reduction pathway can render the overall transformation energetically favorable under standard 
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conditions, possibly even more so in specialized environments where ANME consortia thrive, such as 
deep sea sediments [173]. Thus, the mystery of achieving AOM seems to reduce to performing reverse 
methanogenesis and donating electrons from methane oxidation into a reduction pathway.  
Because of the aforementioned difficulty of growing viable ANME cultures in the lab, these organisms 
remain poor candidates for laboratory studies, not to mention industrial-scale GTL processes. However, 
because methanogenic archaea possess the same enzymes as ANME organisms but operate in reverse 
direction, they represent a viable alternative system for achieving large-scale AOM. Two methanogens in 
particular—Methanococcus maripaludis and Methanosarcina acetivorans—have well-developed genetic 
toolsets [111,174] and have been metabolically reconstructed at genome scale [92]. M. maripaludis in 
particular is an excellent candidate for industrial processes because, although it lacks the methanol 
utilization genes native to Methanosarcina [175], it grows much more rapidly, with doubling time of 
about 2 hours [109] resulting in ease of making mutations and studying their phenotypes. Moreover, it 
possesses a much smaller genome with just over 1700 genes compared to 4524 for M. acetivorans 
[110,176], indicating a smaller—and therefore simpler—metabolic reaction network. Based upon these 
qualities, we selected M. maripaludis as our organism of choice for achieving GTL conversion of 
methane to methanol.  
Our strain design strategy for M. maripaludis took the form of two basic phases. First, we aimed to 
insert a pathway for methanol utilization into our organism, enabling conversion of methanol into 
methane. Having verified growth and methane production on methanol, our objective would become 
finding a pathway or series of pathways which, when introduced into our methanol-consuming M. 
maripaludis, would enable reverse methanogenesis. To assist in these steps, we turned to iMR540, our 
genome scale metabolic reconstruction of M. maripaludis, as a guide in the metabolic engineering 
process (for reconstruction details, see Chapter 3). With its dual capabilities for predicting metabolic flux 
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distributions and overall free energy generation, iMR540 was an ideal platform for generating 
hypotheses on how to achieve our proposed GTL conversion. This chapter describes the ways in which 
we used the iMR540 network to explore native hydrogenotrophic methanogenesis and predict ways to 
alter metabolism for converting methane to methanol.   
Methods 
In silico Predictions of Genetic Perturbations 
In order to predict the effects of genetic perturbations—knockouts, adding non-native pathways, 
altering growth media—we simulated organism growth using flux balance analysis (FBA) [81] via the 
Cobra Toolbox 2.0 [132] in MATLAB [7.14.0.739] (The MathWorks Inc., Natick, MA). An in-depth 
description of using FBA to simulate maximum biomass production can be found in Chapter 3 Methods.  
To simulate the effects of an mmp1574 knockout, we utilized the “deleteModelGenes.m” function from 
the Cobra Toolbox, which restricts flux through affected reactions (i.e. those that rely on mmp1574 to 
function) to 0. We simulated addition of glycine to the detault in silico medium by allowing our model 
unlimited glycine uptake, which was previously not allowed during growth. 
We added non-native reactions using the “addReaction.m” function and specified free energy of 
formation for any new exchange reactions using values from the eQuilibrator database 2.0 [142]. 
Whenever possible, we took new reactions directly from the Kbase reaction database and conformed to 
Kbase nomenclature for metabolite and reaction identifiers. Our scripts for adding the described 
reduction pathways (see Results) are publically available on Github 
(https://github.com/marichards/methanococcus). 
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Estimating Overall Free Energy 
As described in Chapter 3, the iMR540 model is configured to generate overall free energy predictions 
when given standard free energies of formation for exchange metabolites. These standard free energies, 
taken from the eQuilibrator database 2.0 [142], assume effective metabolite concentrations of 1 mM, 
pH of 7, and ionic strength of 0.1 M, values that we considered reasonable for microbial systems. For 
each growth prediction described, we used the “optimizeThermoModel.m” script described in Chapter 
3, which calculates overall model free energy and optionally constrains predicted flux distributions to 
conform to overall ΔG ≤ 0.  
In all growth simulations prior to predicting reverse methanogenesis, we did not constrain overall ΔG 
because we were not concerned with the feasibility of these scenarios. For reverse methanogenesis in 
the absence of additional reduction pathways, we initially predicted growth and overall free energy 
without constraining free energy, preferring to gauge the magnitude of free energy produced by our 
predicted solution. We followed this unconstrained scenario by repeating the same simulation while 
constraining ΔG ≤ 0, but were unable to predict growth. Our sensitivity analysis of ΔG vs. equilibrium 
quotient (Q) for this model was performed without thermodynamic constraints. Instead, we varied Q 
from 10-200 to 100, plotting the values on a semi-log plot (see Figure 4.5) to determine the value of Q that 
would fulfill ΔG ≤ 0.  
For reverse methanogenesis simulations using reduction pathways, we constrained overall ΔG ≤ 0 for all 
simulations. This was necessary because if unconstrained, the model could simply achieve the same 
solution as it did without the reduction pathways (i.e. it would ignore the new reactions).  
Generating a Gene Knockout 
Strain MM902, a derivative of M. maripaludis S2, was used as the base strain.   It contains an in-frame 
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deletion of uracil phophoribosyltransferase (upt; mmp0680) similar to MM901 [139] for making 
markerless mutations [177]. However, it also contains ORF1 [178], a plasmid maintenance gene inserted 
into mmp0680. To construct a knockout of mmp1574, we first amplified the flanking genes with the 
following primers:  
5’ – AAG CGG CCG CAG GTC GTT TGA AAT TTC ATC G – 3’ 
5’ – AAG GCG CGC CCA TAA AGA CAC CTA ATA AAC AAT C – 3’ 
5’ – AAG GCG CGC CAT GAT TTA AAC GCT ATT TGT AAC G – 3’ 
5’ – AAG CGG CCG CTT GAT AAT AAT TAT ATA TAC CC – 3’ 
We connected these fragments via AscI digestion and sticky-end ligation, then digested and ligated the 
resulting construct and our vector with NotI. Our chosen plasmid to transform M. maripaludis was the 
suicide vector PCRUptNeoR, a construct indentical to PCRUptNeo [139] except with a deletion of the 
ampicillin and kanamycin cassette driven by an E. coli promoter. After transforming M. maripaludis, we 
selected for the mutant in McCas medium [177] containing 1 mg/mL neomycin. We then selected for 
cells containing the in-frame deletion of upt using medium containing 250 µg/mL 6-azauracil, allowing us 
to resolve the merodiploid. We sequenced the resulting mutant to confirm our desired genotype, 
naming the resulting strain “MM1426”.  
To test for glycine auxotrophy, we first grew M. maripaludis MM1426 cells in McCas medium, which 
contains casamino acids and therefore supplies glycine. Cells were then subcultured into tubes 
containing either minimal medium (McNA) or minimal medium supplemented with 10 mM glycine 
(McNA+Gly). Growth was evaluated via optical density as described previously (Chapter 3) and 
monitored daily until cell density plateaued.  
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Results 
Predicting Glycine Synthesis 
A particularly useful function of a metabolic reconstruction is its ability to elucidate new functions for 
hypothetical proteins or suggest alternate functions for known genes. Given the abundance of 
hypothetical proteins identified in the original complete genome sequence for M. maripaludis [110], the 
iMR540 could be an important tool for fully annotating the genome. The reconstruction contains 
numerous unverified predictions for gene functions, a natural set of hypotheses for biochemical 
characterization experiments to test their accuracy. By filling out genome annotations more completely, 
we could work towards mapping out all industrially-relevant pathways in M. maripaludis, greatly 
simplifying the task of harnessing its metabolism to produce desired chemicals. Amino acid biosynthesis, 
in particular, is an intriguing family of pathways in M. maripaludis that would have multiple applications 
as potential products. Although some of these synthesis pathways—the aspartate/glutamate family, the 
aromatic family, methionine, alanine—have already been characterized, the majority of these syntheses 
remain unknown. Hence, there is ample opportunity to use the iMR540 reconstruction to generate 
hypothesis for these unknown amino acid syntheses.  
Glycine is among the group of amino acids for which no biosynthesis pathway is currently known. Unlike 
most other amino acids, no clear synthesis pathway is predicted by either the MetaCyc or KEGG 
pathways databases [85,130]. Because glycine is defined as a component of biomass in iMR540, the 
reconstruction necessarily predicts a pathway for glycine synthesis, depicted in Figure 4.1. As shown, the 
mmp1574 gene is predicted to code for an enzyme that catalyzes the final step in this pathway,  
removing an acetyl group from L-2-amino-acetoacetate to synthesize glycine. Utilizing the reaction 
likelihood scores from our reconstruction, we found this reaction had a probability of 0.39, suggesting 
that although there was some genetic evidence for its inclusion, there is a large degree of uncertainty 
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with its place in the network. Notably, our reconstruction also associates mmp1574 with an 8-Amino-7-
oxononanoate synthesis reaction at a likelihood of 0.59, a higher value that still shows a fair amount of 
uncertainty. Thus, this gene could hypothetically code for an enzyme that catalyzes one, both, or neither 
of these reactions. By characterizing this gene via knockout experiment, we could potentially determine 
whether or not glycine synthesis is among its functions.  
As a first step in evaluating this predicted glycine synthase gene, we used iMR540 to simulate a 
knockout of mmp1574. We were unable to predict growth of this mutant on H2 + CO2 or on formate; 
however, when our in silico medium was supplemented with glycine, the mutant model was predicted 
to grow under both conditions. Based upon this computational prediction, we hypothesized that 
knocking out the mmp1574 gene in vivo would create a glycine auxotroph. We successfully created this 
Δmmp1574 mutant in vivo (see Methods) and have observed that it grows in medium supplemented 
with casamino acids. Encouragingly, our mutant strain grows more slowly under these conditions than 
do wild type cells, possibly suggesting that the mutant cannot grow as quickly due to limited glycine 
availability. However,  results from auxotrophy growth experiments (see Methods) have been 
inconclusive thus far, therefore we cannot currently determine whether or not our in silico prediction is 
correct. If the Δmmp1574 mutant can grow in both cases, this would suggest that M. maripaludis 
possesses a different glycine synthesis pathway and that mmp1574 may not be linked to any sort of 
glycine synthase function. However, if the mutant displays glycine auxotrophy, this would suggest that 
mmp1574 is essential for glycine synthesis, supporting the prediction of our model.  
Predicting Methanogenesis from Methanol 
Following our exploration of glycine synthesis in native metabolism, we began using our reconstruction 
to predict novel strain designs. As described in Chapter 3, M. maripaludis is a hydrogentrophic 
methanogen and does not contain the methanol methyl transfer pathway necessary to grow using 
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methanol. This is in contrast to other methanogens such as the Methanosarcina, which can grow using 
methanol and other 1-C substrates [154]. Prior to achieving our proposed overall conversion of methane 
to methanol, it was essential to ensure that we could introduce pathways for the reverse reaction; that 
is, reducing methanol to methane. Thus, our first metabolic engineering task was determining the 
necessary reactions for uptake and reduction of methanol.  
As illustrated by Welander and Metcalf for Methanosarcina barkeri [154], methanogenesis from 
methanol instead of carbon dioxide requires only one additional enzymatic reaction: a 
methanol:methyl-CoM methyltransferase (Mta). To test whether adding this reaction would enable M. 
maripaludis to catabolize methanol, we added the Mta reaction to the iMR540 model, plus methanol 
uptake and diffusion reactions that allowed us to introduce methanol into our in silico medium. Notably, 
methanogens are known to grow on both methanol alone and methanol plus H2 [154]; we configured 
our model in both growth scenarios to test our model’s ability to predict growth under both conditions. 
We considered our simulation with H2 as our default case because it presented a less constrained set of 
growth substrates than did methanol alone. Moreover, we hypothesized that supplying H2 would be 
more stoichiometrically favorable as it provides additional electrons that enable virtually all carbon in 
methanol to be converted to methane, rather than requiring that some carbon be oxidized to CO2. This 
is demonstrated by the overall chemical reactions, both with H2: 
𝐶𝐻3𝑂𝐻 + 𝐻2 → 𝐶𝐻4 + 𝐻2𝑂 
and without: 
4 𝐶𝐻3𝑂𝐻 → 3 𝐶𝐻4 + 𝐶𝑂2 + 2 𝐻2𝑂 
We simulated our model under both scenarios with no other changes to our reactions and were unable 
to predict growth in these cases. The cause of these non-growth predictions was our constraint on 
Eha/Ehb hydrogenase to ≤10% CH4 flux, a hypothesized flux constraint based on the observed 
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anaplerotic role of this enzyme (see Chapter 3). Much as in the case of aceticlastic methanogenesis 
discussed in the previous chapter, methylotrophic methanogenesis skips forward operation of methyl-
H4MPT:CoM methyltransferase (Mtr), the essential Na
+-translocating step of hydrogenotrophic 
methanogenesis. As illustrated in Figures 4.2 and 4.3, without function of Mtr the only remaining Na+ 
pump is Eha/Ehb, which requires reduced ferredoxin in order to create the ion gradient for ATP 
synthesis. Because the model is no longer supplied with CO2, the Fwd reaction must generate a small 
amount of biosynthetic CO2, somewhat more than is used by the CODH/ACS reaction to synthesize 
acetyl-CoA. This results in a net gain of reduced ferredoxin and with no other sink for this electron 
carrier, the Eha/Ehb hydrogenase reaction must operate at high capacity—slightly higher flux than 
methane secretion—in order to balance ferredoxin usage. With Eha/Ehb flux restricted, reduced 
ferredoxin cannot fulfill mass balance constraints, rendering the pathway infeasible and resulting in a 
prediction of non growth. 
Assuming that our hypothesized flux constraint is valid, our initial predictions suggested that even with 
the Mta reaction, methane production from methanol depends on removing the flux constraint from 
Eha/Ehb hydrogenase. Indeed, when we removed out 10% flux constraint from the model, we could 
predict growth on methanol both with and without H2. Our predicted rates and yields for these 
simulations are shown in Table 4.1 compared with native hydrogenotrophic predictions. Based upon this 
experiment, we suspect that achieving methanol to methane conversion in vivo will likely require 
supplementing native Eha/Ehb flux, either by overexpressing these enzymes or by adding a similar 
hydrogenase shown to be capable of supporting methylotrophic growth (e.g. Ech hydrogenase from M. 
barkeri [154]). Efforts to successfully express the Mta genes from M. acetivorans into M. maripaludis are 
ongoing; when this process is completed, we expect to characterize the resulting mutant to determine 
whether or not it can indeed subsist on methanol and H2 in the absence of CO2. This anticipated 
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experiment will not only reveal whether we created our proposed methanol-consuming construct, but 
also inform the validity of our hypothesized constraint on Eha/Ehb flux.  
An added benefit of this simulation is that it gives us a window into central metabolism for a methanol-
consuming methanogen without cytochromes, i.e. Methanosphaera stadtmanae. As proposed by 
Thauer [102], energy conservation in this metabolic pathway requires both electron bifurcation by Hdr 
and sodium gradient formation via ferredoxin oxidation in Eha/Ehb hydrogenase. Though we have 
essentially added only one internal reaction to the iMR540 model, our resulting reaction map of 
methanogenesis (see Figure 4.2) looks remarkably similar to that proposed for M. stadtmanae. This 
demonstrates an additional capability of our model as not only a representation of M. maripaludis 
metabolism but also a proxy for other closely-related organisms. There is great potential to leverage this 
sort of capability for further investigating other organisms, an avenue that is explored more deeply in 
Chapter 5.  
Strain Design for Reverse Methanogenesis    
Having successfully predicted methanogenesis from MeOH with the caveat of a fully-functional 
membrane bound hydrogenase, we turned out attention to the reverse process. As described, the 
primary known obstacle to reversing methanogenesis is achieving thermodynamic feasibility. Take, for 
example, the exact reverse reaction of methanogenesis from methanol: 
𝐶𝐻4 + 𝐻2𝑂 → 𝐶𝐻3𝑂𝐻 + 𝐻2  
This reaction produces ΔG = +98.4 ± 10.2 kJ/mol at standard conditions (see Methods) a highly 
unfavorable overall free energy attributable primarily to consuming water, which has very low free 
energy of formation (ΔGf = -157.6 ± 1.6 kJ/mol).   
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Stoichiometric issues are also a concern, particularly because backwards flux of native pathways could 
have an adverse effect on conserved pools of electron carriers. As previous efforts have shown, altering 
the ratios of reducing equivalents such as NAD and NADP in a metabolic network can profoundly impact 
the model [179,180]. This is particularly poignant for our model of M. maripaludis, which contains not 
only these traditional electron carriers but also several unique compounds such as coenzyme F420. The 
iMR540 metabolic model provided an excellent way to both examine the stoichiometric feasibility of 
AOM and determine ways to satisfy thermodynamic constraints. 
Stoichiometric Considerations 
From examining our methanol-consuming reaction network, we quickly zeroed in on a stoichiometric 
issue for operating this pathway in reverse. During reverse methanogenesis, we deduced that Hdr must 
function in reverse to regenerate heterodisulfide, thus oxidizing rather than reducing ferredoxin. Much 
like methanogenesis from methanol, the reverse methanogenesis pathway from methane to methanol 
did not activate forward operation of Mtr, requiring EhA/EhB as the primary sodium pump. As depicted 
in Figure 4.4, EhA/EhB also requires reduced ferredoxin, effectively placing a dual demand on this 
electron carrier and leaving catabolism without a way to reduce it. Simultaneously, we discovered that 
our model was predicted to produce a large amount of electron-rich hydrogen through Hdr; thus we 
hypothesized that we could supply necessary reduced ferredoxin by adding an Fd:H2 oxidoreductase 
(FHor) to shift electrons from hydrogen to ferredoxin. Indeed, when we added the FHor reaction to our 
model we found that we could predict flux of methanol from methane (see Figure 4.4).  
This effectively completed reverse methanogenesis as far as stoichiometry, but did not yet address our 
greater challenge of predicting a way to make AOM thermodynamically feasible. As anticipated, our 
model predicted our methane to methanol conversion to be energetically infeasible, generating +1.37 
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kJ/gDCW∙h to produce 10 mmol/gDCW∙h of methanol (or +97.7 kJ/mol CH4 oxidized). Free energy can 
also vary considerably with changes in effective intracellular concentrations, grouped into the 
equilibrium quotient (Q) and related to free energy by:  
∆𝐺 =  ∆𝐺° + 𝑅𝑇 ln 𝑄 
Given the difficulties of measuring intracellular concentrations, we simulated the effects of 
concentrations on free energy by performing a sensitivity analysis on predicted free energy based on 
varying Q. As shown in Figure 4.5, our analysis estimated that our overall chemical transformation would 
cross into thermodynamically feasible territory (ΔG ≤ 0) at Q ≈ 10-142. This exercise suggested two 
notable things: (1) free energy of reverse methylotrophic methanogenesis is predicted to be sufficiently 
endergonic such that even a reasonably steep concentration gradient would not make it a feasible 
process; (2) given that AOM cannot be driven by manipulating concentrations, our most promising 
avenue is to temper this unfavorable oxidation process by introducing a favorable reduction pathway to 
serve as an electron sink. 
Energetic Considerations 
As described by Mueller et al [99], a variety of electron sinks fill this need in nature, including sulfate, 
nitrate, and metal oxides. Recently, it was shown that reducing ferric ions to ferrous ions produced 
sufficient energy to drive AOM from methane to acetate in M. acetivorans [181]. Furthermore, the same 
group predicted that several other reduction pathways could theoretically achieve the same conversion, 
albeit with less favorable overall free energies [182]. We expected these reduction pathways could also 
make our proposed methane to methanol conversion feasible, thus we used these same reductions to 
predict reverse methanogenesis in the iMR540 model (excepting manganese oxide reduction, for which 
we could not reasonable estimate ΔGf ). The full reaction pathways added for each reduction are shown 
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in Figure 4.6. Simulations were performed assuming production of 10 mmol/g(dry weight)∙h methanol 
and using thermodynamically constrained FBA, as described in Methods.  
In troubleshooting these additional pathways, we immediately encountered a key difference between 
our organism and Methanosarcina acetivorans, the organism used in the previous study. Unlike M. 
acetivorans, which contains cytochromes and therefore has shown propensity for carrying out reducing 
reactions via membrane-bound complexes, we do not have evidence that M. maripaludis is capable of 
the same transformations. Thus, we assumed for our simulations that any hypothesized reduction 
pathway would have to proceed within the intercellular compartment. This raised an unanticipated 
issue with metabolite transport, particularly concerning nitrate reduction. The M. maripaludis genome is 
predicted to code for an ABC type (ATP dependent) nitrate transporter [14], implicating that every mole 
of nitrate reduced would require hydrolysis of a mole of ATP. Because ATP production is the key factor 
in synthesizing biomass in silico, this predicted transporter had a profound effect on predicted flux 
distributions that included nitrate reduction. In order to prevent nitrate reduction from effectively using 
up all intracellular ATP, we had to add either a non-ABC transporter for nitrate or an ABC transporter for 
nitrite. So long as both nitrate and nitrite possessed the same type of transporter, ATP balance was 
maintained in predicted flux distributions. With regard to this transporter issue, we ensured that our 
hypothetical sulfate transporter was not ATP-dependent to match our sulfide transporter; iron 
transporters were unaffected as both species possess ABC transporters. Though this transporter 
problem was primarily a mass balance obstacle for our in silico growth predictions, it suggested the 
possibility that transporter types could affect our ability to successfully reverse methanogenesis.  
Moving past our choice of transporter types, our simulations revealed that only nitrate reduction was 
predicted as a feasible way to achieve our proposed conversion. Using either NAD or NADP as an 
electron carrier, our model predicted that reducing 6.6 mmol/g(dry weight)∙h nitrate was sufficient to 
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offset production of 10 mmol/g(dry weight)∙h methanol, assuming standard conditions. To understand 
the mechanism driving this successful simulation, we compared this predicted flux distribution to that 
without energetic constraints. Compared to our energetically infeasible solution, our feasible nitrate-
utilizing solution predicted only ⅓ the biomass yield, despite approximately the same rate of AOM. This 
cutback in biomass production was vital for improving energetic feasibility because biosynthesis 
pathways necessitate influx of CO2, an energetically expensive reactant. By cutting down CO2 usage by 
about 33%, our model greatly improved its energetic outlook. Despite this reduction in growth rate, ATP 
production did not fall nearly as much, largely in part to the demand from non-growth associated 
maintenance (NGAM). Because we assume NGAM to be constant for our model regardless of other 
fluxes, our model must continue to produce extra ATP, subsequently producing extra water as well. 
Working with a small subset of biosynthetic reactions, our proposed nitrate reduction must necessarily 
produce water in order to maintain overall water balance withint he model. Thus, our nitrate reduction 
model was successful because it allowed us to simulate lower growth yield required for energetic 
feasibility while still maintaining mass balance. 
Considering the aforementioned requirements filled by nitrate reduction, it is rather trivial to see why 
reducing iron was predicted to be unsuccessful. Unlike nitrate reduction, iron reduction produces no 
water; hence, even though iron reduction is energetically more favorable than nitrate reduction, lack of 
water in the reduction pathway violated our constraint of mass balance and rendered the network 
stoichiometrically infeasible. This same issue did not plague sulfate reduction, which produces 3 moles 
of water per mole of sulfate reduced. Unfortunately, sulfate reduction suffers from too much ATP usage, 
similar to the problem encountered when using ABC transporters. Because sulfate reduction uses 1 
mole of ATP per sulfate reduced as shown in Figure 4.6, it places an enormous demand upon ATP that 
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competes with that required for biomass formation. Sulfate reduction is predicted to exhaust all ATP 
available for biomass, resulting in our prediction of no feasible solutions. 
Based upon these simulations, our model suggests that nitrate is the only stoichiometrically and 
energetically feasible pathway that we tested. Coupled together with our previously described FHor 
reaction, we predict that adding an NAD(P)-dependent nitrate reduction should be sufficient to drive 
AOM from methane to methanol at standard conditions. Moreover, we could also achieve more 
favorable conversion by affecting effective metabolite concentrations for major metabolites (methane, 
methanol, nitrate, nitrite). Though this designs has not yet been achieved in lab, our predictions lay the 
groundwork for achieving reverse methanogenesis to methanol in M. maripaludis  in the future and 
could have important implications for the strategies taken to achieve this conversion. 
Discussion 
Our uses of the M. maripaludis model demonstrate its promise for advancing understanding of 
methanogenesis and the factors needed to couple growth to reversal of the same pathway. By 
leveraging the iMR540 model, we made novel inferences about native M. maripaludis metabolism and 
went beyond the parameters of our wild type model to simulate hypothetical metabolic scenarios. The 
results of these studies allow for an understanding of the metabolic constraints and bottlenecks 
involved in engineering M. maripaludis for gas to liquid conversion.  
Our examination of hydrogenotrophic methanogenesis revealed a novel prediction of the essential gene 
for glycine synthesis, mmp1574. Using this prediction, we hypothesized that knocking out this gene, 
mmp1574, would result in a glycine auxotroph. Though testing hypothesis remains a work in progress, 
any outcome of the gene knockout experiment should advance our understanding of M. maripaludis. A 
positive outcome, in which we successfully determine that a Δmmp1574 mutant is a glycine auxotroph, 
 
 
86 
 
would support our model’s prediction and add this reaction pathway to the library of biochemically 
characterized reactions in M. maripaludis. A negative outcome, in which we determine that the 
Δmmp1574 mutant can survive without glycine supplementation, would point to an incorrect 
annotation model, whereby some other mechanism of glycine synthesis exists in the organism. This 
knowledge would allow us to revise the iMR540 model by finding a different pathway for glycine 
synthesis. Our glycine auxotrophy experiment is but one example of a myriad of biochemical 
characterization experiments suggested by the iMR540 model. Numerous gene-associated reactions in 
the model lack any sort of reference material, originating instead from Kbase annotations. By 
methodically characterizing many of these reactions, we hope to improve this first model iteration and 
pave the way for an updated model with better understood biosynthetic pathways. 
Going beyond the wild type model, we used iMR540 to predict the pathway of methylotrophic 
methanogenesis from methanol, mimicking the central catabolic pathway observed in M. stadtmanae. 
Our unsuccessful initial efforts forced us to consider the consequences of our model’s constraint on flux 
through Eha/Ehb hydrogenase and suggested that achieving this conversion may require overexpressing 
the enzyme or cloning in a more active hydrogenase. When relaxing this flux restriction, we successfully 
predicted growth from methanol, a result that we are currently working to replicate in lab. The disparity 
between progress with in silico predictions as compared to experimental wet lab work illustrates a 
drawback of the modeling approach. In our predictions, we innately assume full expression and function 
of all enzymes in our system, an ideal scenario that rarely plays out in such an efficient manner. Thus, 
our model predicts the scope of possible fluxes when all enzymes in the network are functioning at 
sufficiently high expression levels. Actual cloning procedures face many more challenges than are 
depicted in our model and its predictions, namely difficulties achieving high expression of recombinant 
proteins in a novel host organism. Although we have not yet achieved the same methanol to methane 
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conversion in vivo that we have shown here in silico, our predictions help bound the eventual construct 
so that we have a better system for troubleshooting our organism once protein expression reaches 
normal levels. 
Predicting methanogenesis from methanol laid the groundwork to reverse the process, finding ways to 
achieve AOM from methane to methanol. Our initial stoichiometric analysis revealed a deficiency of 
reduced ferredoxin, a gap that we filled by suggesting a ferredoxin:H2 oxidoreductase to reduced 
ferredoxin using electrons from hydrogen. This solved the stoichiometry of reverse methanogenesis to 
methanol, but was predicted to be energetically unfavorable and therefore infeasible as a final strain 
design. Using a group of candidate reduction pathways, we predicted that nitrate reduction to nitrite via 
NAD(P) could successfully offset the positive free energy from reverse methanogenesis, resulting in a 
design that is predicted to be both thermodynamically and stoichiometrically sound. Other designs 
resulted in unsuccessful predictions; sulfate reduction was predicted to require too much ATP 
investment to produce any cell mass, whereas iron reduction was predicted to be stoichiometrically 
infeasible because of its inability to produce water.  
In examining our final reduction path predictions, it is striking to note the differences between our 
recommendations and those made for M. acetivorans by Nazem-Bokaee et al [182]. Although they also 
predicted nitrate reduction as a viable electron sink for reverse methanogenesis, their most viable 
candidate was iron reduction, a pathway that we predicted to be infeasible. Some of the differences in 
our predictions can be attributed to different end goals; we produced methanol whereas they produced 
acetate, an end compound that results in generating 1 mole ATP per mole acetate. Considering that ATP 
usage is the chief factor preventing sulfate reduction from being effective in our model, it is reasonable 
to expect that producing acetate instead of methanol would enable us to feasibly use sulfate reduction. 
However, the majority of discrepancies in our predictions—particularly those linked to using iron 
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reduction—likely resulted more from differences in overall network topology. The M. acetivorans model 
contains many pathways that are not known to occur in M. maripaludis, particularly those involving 
membrane-associated electron transfers. By rigorously curating our model with non-generic 
information, we successfully diversified its hydrogenotrophic core metabolism from that of 
methanogens with cytochromes, like M. acetivorans. As a result, we cannot predict the same solutions 
as were realistic for the M. acetivorans model; however, because of the specificity of our model to M. 
maripaludis rather than to a more generic methanogenesis scheme, we have higher confidence in our 
predictions than if they matched those for M. acetivorans exactly.  
Overall, our reverse methanogenesis predictions yielded only one feasible strategy of the three different 
strategies we tested, giving us just one strain design. This scenario is not ideal; instead, we would prefer 
to have many different possible designs ranked against one another based upon thermodynamic and 
stoichiometric feasibilities. This result is largely due to our restricted space of possible reduction 
pathways, which was limited to three different options corresponding to pathways previously observed 
in methanotrophic archaea. On one hand, limiting ourselves to these strategies lends a measure of 
confidence to our predicted strain design because this same nitrate reduction pathway has been 
successful for AOM in other organisms. On the other hand, it is likely that other reduction pathways in 
the space of known metabolism could also fill the same stoichiometric and energetic needs of our 
process. As we look to expand our scope of possible strain designs, our path will inevitably lead toward 
automated methods that leverage reactions in annotation databases. These automated methods could 
increase our pool of metabolic engineering strategies by moving outside pathways known to partner 
with methanotrophy in AOM consortia. However, it is vital that as we embrace these methods, we 
subject each proposed design to the same rigorous standards of feasibility to realistically determine the 
viability of each strategy.  
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Tables and Figures 
Substrate(s) CO2 + H2 + Acetate CH3OH + H2 CH3OH 
CH4 Secretion Rate 50 mmol/gDCW∙h 50 mmol/gDCW∙h 50 mmol/gDCW∙h 
Overall Equation 
CO2 + 4 H2  → 
2 H2O + CH4 
CH3OH + H2  → 
H2O + CH4 
4 CH3OH  → 
2 H2O + 3 CH4 + CO2 
Biomass Flux 0.0973 0.0969 0.0969 
ΔG (kJ/gDCW) -5.59 -4.91 -4.43 
ATP Yield (per CH4) 0.55 0.475 0.475 
Yield (gDCW/mol CH4) 2.81 2.79 2.79 
Table 4.1: A comparison of predicted parameters for growth of M. maripaludis on different media.  
 
  
Figure 4.1: Path for glycine synthesis predicted by the iMR540 reconstruction. The mmp1574 gene, shown in red, 
was chosen for knockout based upon this hypothetical pathway. As shown by this reaction scheme, knockout of 
mmp1574 should prohibit glycine synthesis and render the organism unable to achieve growth. Metabolites: Pi, 
phosphate; O-P-L-Homoserine, ortho-phosphate-L-homoserine; CoA, coenzyme A; Ac-CoA, acetyl-CoA; 4-Phospho-
L-Asp, 4-phospho-L-aspartate; L-Asp-4-Semialdehyde, L-aspartate-4-semialdehyde 
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Figure 4.2: Pathway for methanogenesis from methanol and H2 in M. maripaludis as predicted by the iMR540 
model. Pathways shown in black are main pathways predicted to carry stoichiometric levels of flux; pathways 
shown in orange are secondary pathways predicted to carry small amounts of flux necessary for biosynthesis 
reactions. Importantly, pathways of the same color do not necessarily carry exactly the same flux. Enzyme names 
are shown in blue.  Metabolites: Fdrd, reduced ferredoxin; Fdox, oxidized ferredoxin ; MFR, methanofuran; HSCoM, 
coenzyme M; HSCoB, coenzyme B; F420, coenzyme F420. Enzymes: Fwd, formylmethanofuran dehydrogenase; Ftr, 
formylmethanofuran/H4MPT formyl transferase; Mch, methenyl-H4MPT cyclohydrolase; Hmd, H2-dependent 
methylene-H4MPT dehydrogenase; Mtd, F420-dependent methylene-H4MPT dehydrogenase; Mer, methylene-
H4MPT reductase; Mtr, methyl-H4MPT coenzyme M methyltransferase; Mcr, methyl coenzyme M reductase; Hdr, 
heterodisulfide reductase;Eha/Ehb, energy-conserving hydrogenases; ATPS, ATP-synthase; Fru, F420-reducing 
hydrogenase (selenocysteine-containing); Frc, F420-reducing hydrogenase (cysteine-containing); Mta, 
methanol:methyl-CoM methyltransferase; CODH/ACS, carbon monoxide dehydrogenase/acetyl-CoA synthase 
enzyme complex 
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Figure 4.3: Pathway for methanogenesis from methanol alone in M. maripaludis as predicted by the iMR540 
model. Pathways shown in black are main pathways predicted to carry stoichiometric levels of flux; pathways 
shown in orange are secondary pathways predicted to carry small amounts of flux necessary for biosynthesis 
reactions. Importantly, pathways of the same color do not necessarily carry exactly the same flux. Enzyme names 
are shown in blue. Metabolites: Fdrd, reduced ferredoxin; Fdox, oxidized ferredoxin ; MFR, methanofuran; HSCoM, 
coenzyme M; HSCoB, coenzyme B; F420, coenzyme F420. Enzymes: Fwd, formylmethanofuran dehydrogenase; Ftr, 
formylmethanofuran/H4MPT formyl transferase; Mch, methenyl-H4MPT cyclohydrolase; Hmd, H2-dependent 
methylene-H4MPT dehydrogenase; Mtd, F420-dependent methylene-H4MPT dehydrogenase; Mer, methylene-
H4MPT reductase; Mtr, methyl-H4MPT coenzyme M methyltransferase; Mcr, methyl coenzyme M reductase; Hdr, 
heterodisulfide reductase;Eha/Ehb, energy-conserving hydrogenases; ATPS, ATP-synthase; Fru, F420-reducing 
hydrogenase (selenocysteine-containing); Frc, F420-reducing hydrogenase (cysteine-containing); Mta, 
methanol:methyl-CoM methyltransferase; CODH/ACS, carbon monoxide dehydrogenase/acetyl-CoA synthase 
enzyme complex 
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Figure 4.4: Stoichiometric solution for converting methane to methanol in M. maripaludis as predicted by the 
iMR540 model. The added non-native reaction that replenishes reduced ferredoxin using electrons from hydrogen 
to complete the metabolic pathway is shown in red. Enzyme names are shown in blue. Metabolites: Fdrd, reduced 
ferredoxin; Fdox, oxidized ferredoxin; HSCoM, coenzyme M; HSCoB, coenzyme B. Enzymes: Mcr, methyl coenzyme 
M reductase; Hdr, heterodisulfide reductase;Eha/Ehb, energy-conserving hydrogenases; ATPS, ATP-synthase; Mta, 
methanol:methyl-CoM methyltransferase; FHor, ferredoxin:hydrogen oxidoreductase 
  
 
 
93 
 
 
 
Figure 4.5: Free energy predicted by the iMR540 model as a function of equilibrium quotient, Q, during reverse 
methanogenesis. These values were calculated in the absence of any additional reduction pathways, aimed at 
showing the effects of relative metabolite concentrations on free energy generation in the absence of other 
factors. As shown here, overall free energy generation does not cross into the realm of energetic feasibility (ΔG ≤ 
0) until Q ≈ 10
-142 
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Figure 4.6: Proposed reduction pathways tested in iMR540 to predict reverse methanogenesis. As shown, sulfate 
and nitrate reduction both produce water but iron reduction does not. Sulfate reduction is also the only pathway 
of the three that requires 1 mole of ATP per mole of substrate. 
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Chapter 5: A Method for Perpetuating a Metabolic 
Reconstruction 
Introduction 
As extensively covered in Chapter 1, creating a high quality GENRE or GEM is a laborious process, but 
the resulting model can be well worth the effort. Chapter 4 demonstrated just a few capabilities of a 
completed GENRE in advancing understanding of native metabolism and guiding metabolic engineering 
strategies. Applications of such networks far outnumber those discussed in the previous chapter, 
ranging from contextualizing omics data to discovering novel drug targets to predicting strategies for 
producing industrial biochemicals [121,183]. These applications can also be extended beyond singular 
organisms; models encompassing multiple organisms, such as the core metabolic model of Desulfovibrio 
vulgaris and Methanococcus maripaludis, open up the usefulness of GEMs to microbial communities 
[122]. The recent call for more “community systems biology” points to a strong possibility that GENREs 
and GEMs containing two or more organisms will soon become commonplace, enabling new avenues of 
discovery [184].  
In acknowledging the many applications of metabolic reconstructions, it is also important to note that 
they are also somewhat limited in so far as a GENRE applies only to the system being modeled. Given 
the time and effort put into creating a high quality network, it is reasonable to consider how we might 
better extend these manual efforts to other organisms and systems. As noted in Chapters 1 and 3, a 
GENRE is never considered a finished product, but rather a living database that must be iteratively 
updated to reflect new discoveries. One common way to extend a manually curated GENRE is by 
updating and expanding the existing reconstruction to create a new one. For example, the Palsson Lab 
has repeatedly updated its reconstruction of Escherichia coli by iteratively expanding its genome 
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annotations [91,161,162,185]. In some cases, multiple existing GENREs for the same organism have 
been combined to form a consensus model, as was done for Saccharomyces cerevisiae [186] and  more 
recently for Methanosarcina acetivorans  [182]. Updated reconstructions often incrementally improve 
upon the original network, as shown in a recent comparison of published S. cerevisiae models [187]. 
Thus, using an existing GENRE or GEM as the foundation for an improved model is an excellent way to 
extend high quality manual curation. However, although the updated model certainly leverages manual 
curations in a way that extends their impact, it is still confined to the same organism system.  
Perhaps the best example of extending a GENRE to another organism is found in model reconciliation, a 
technique that simultaneously utilizes two manually constructed GEMs to improve one another [188]. 
The Papin lab, which pioneered this method, used it to align two closely related organisms—
Pseudomonas putida and Pseudomonas aeruginosa—by eliminating discrepancies caused by subjective 
modeling decisions. By removing these modeling artifacts, such as arbitrarily using NAD in one network 
and NADP in the other, they illuminated the remaining differences in the models, believed to be actual 
biological differences between the organisms. This approach demonstrated the possibility of using two 
high quality manual GEMs to refine one another, provided they are closely related. Its main drawback is 
that, like creating a new reconstruction from scratch, reconciliation is a manual process that takes 
months of curation. Furthermore, although it produces two refined models, these models correspond to 
the same organisms as the starting models. Though model reconciliation certainly has appeal for 
comparing two models, a technique that uses a high quality metabolic model to create a model for a 
new organism, rather than refine an existing model, could potentially be even more informative.  
The potency of such a technique was demonstrated by ITEP, a suite of tools for examining microbial 
pangenomes [189]. The ITEP toolkit includes a tool that takes a GENRE and extends it to related 
organisms via proteome comparisons, creating partial networks for a clade of organisms based off one 
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source network. This method powerfully leverages manually curated information in the source GENRE, 
creating a high quality draft foundation that can be used to compare gene functions between organisms. 
ITEP itself is not designed as a metabolic modeling platform; rather, it is geared toward studying 
patterns of gene associations across pangenomes. But a similar approach could be quite effective for 
extending the benefits of manual curation to a new organism without expending the usual time and 
effort.  
A suitable modeling platform for developing such an approach is the Department of Energy Systems 
Biology Knowledgebase (Kbase; www.kbase.us). Built on top of the Model SEED database, the Kbase is a 
collection of data and methods including the Model SEED automated reconstruction algorithm [51]. As 
described in Chapter 1, automated reconstruction annotates a supplied genome using the RAST (Rapid 
Annotations using Subsystems Technology) Server [190] to create a draft reconstruction and gap-fills the 
network to create a GEM that can simulate growth on specified media. A major advantage of using the 
Kbase is that it supports gap-filling using probabilistic annotation (ProbAnno), a technique that assigns 
reaction likelihoods based on gene homology and synteny, then gap-fills by maximizing reaction 
pathway likelihoods [126]. Thus, ProbAnno can predict additional gene annotations for a reconstruction, 
maximizing the information gleaned from the genome sequence, as was demonstrated in Chapter 3. 
Taken together, these methods taken together form perhaps the best available model building tool to 
drive development of new modeling methods.  
A method that combines the deployment of the same type of proteome comparison strategy practiced 
in ITEP with the tools available in Kbase could harness the strengths of both platforms. Given a high 
quality GEM created through manual curation and the genome of a closely related organism, such a 
method could pull manually curated information from the source model and supplement it with 
automated annotations to create a high quality draft model of the related organism. This approach 
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could mitigate the effects of database misannotations by relying heavily on the manually curated model 
to inform annotations in the draft model. Simultaneously, such drafts would not be limited to partial 
network reconstructions but rather, could be extended to full genome-scale draft models using 
automated reconstruction and ProbAnno gap-filling. Thus, the output of this model morphing method 
would be a fully functional draft GEM for a previously un-modeled organism. This chapter describes the 
development of a methodology that attempts to achieve the aforementioned goal: leveraging the 
biochemical information present in a manually constructed metabolic model to create high quality draft 
genome scale models of related organisms. 
Methods 
Method Overview 
Scripts for our morphing method were written entirely using the Python programming language. We 
also used multiple functions in Kbase, including the built-in flux balance analysis (FBA) solver for 
simulating model growth. For a full description of FBA, refer to Chapter 3 Methods.  The Kbase tools 
described below are contained within the Kbase Application Programming Interface (Kbase API; 
https://kbase.us). All genomes used for our method were also taken from the Kbase repository.  
Proteome Comparisons 
The “Compare Two Proteomes” tool compares two entire proteomes to one another based on BLAST 
output [37,191]. Using the BLAST hits, it finds bidirectional best hits for genes in both proteomes, 
allowing for many-to-many mappings between genes. The method requires input of two different 
genome objects and outputs a proteome comparison object containing the results of the analysis. 
Though the “Compare Two Proteomes” method contains optional parameters that allow users to tune 
the threshold for matches, here we ran it with default parameters for our purposes.  
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Automated Reconstruction 
We used the “Build Metabolic Model” tool to construct our automated Kbase reconstruction models. 
The only required input for this tool is a Kbase genome, from which the model builds a draft network 
using gene annotations. The method optionally allows users to gap-fill the draft network to create a 
model that simulates growth. For this added functionality, the user must also specify a media 
formulation for gap-filling. Models are automatically assigned one of four default biomass compositions: 
Gram positive microbe, Gram negative microbe, Core pathways microbe, or Plant. Optionally, the user 
can specify one of these biomass objective functions for the final model. The biomass composition 
affects the gap-filling process because it determines what metabolites are necessarily synthesized to 
achieve model growth. For our automated reconstructions, we use the default biomass assigned by 
Kbase. This is distinct from our translated and morphed models, which use the same biomass as our 
manual model.  
Probabilistic Gapfilling 
We used the ProbAnno method for likelihood based gap-filling to add reactions with high likelihood to 
our morphed models and to gap-fill on new media formulations. ProbAnno is based upon gene 
homology; it estimates the likelihood of multiple possible gene annotations for each gene in the 
supplied genome, then maps these genes to reactions using the annotations in Kbase. Thus, not every 
reaction in the database is assigned a likelihood, but those that do scale from 0-1 (1 being most likely). 
The gap-filling process uses a penalty function to incorporate likelihoods, with smaller penalties for high 
likelihoods to increase the chances of including these reactions in the final model. A more in-depth 
overview of ProbAnno is provided by the method’s authors, Benedict et al [126]. Notably, the ProbAnno 
method is not currently supported by the Kbase Narrative Interface and must be run through the Kbase 
API.  
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Results 
Workflow Description 
Our final method, shown in Figure 5.1, requires a manually curated model (Model A), a complete 
genome for that organism (Genome A), a complete genome for a related organism (Genome B), and a 
growth medium for the related organism (Media B). The two genomes are fed into the Kbase “Compare 
Two Proteomes” tool, yielding a map of proteins from Genome A onto Genome B. This essentially 
predicts which genes in Organism A are also present in Organism B and, conversely, which genes in 
Organism A do not have homologs in Organism B (“A not B” genes). Using the GPRs in Model A together 
with our proteome mapping, we flag reactions that are likely to also appear in Model B, creating 
“Translated Model B” (see Figure 5.2). Notably, we do not discard the remainder of Model A in this step; 
these other reactions are carried over into the “Super Model B” construct, but are flagged either as gap-
filling reaction s(i.e. they lack genes in either organism) or as “A not B” reactions. We consider the latter 
group to be the candidates most likely to reflect biochemical differences between the organisms. 
Regardless of phylogenetic similarity, we expect Organism B to contain features that are not present in 
Organism A; hence, we also feed Genome B into the Kbase “Build Metabolic Model” tool, which returns 
an automated draft reconstruction of Organism B (“Reconstruction B”). Reconstruction B is also fed into 
Super Model B to add genomic information that was not present in Model A, increasing our total pool of 
candidate reactions. We also feed Genome B into the ProbAnno tool to create a list of reaction 
probabilities, P (0 ≤ P ≤ 1), for Organism B. This allows us to identify reactions missed by Reconstruction 
B that are likely to be present in Organism B and add these reactions to Super Model B.  
Due to differences between GPRs and Reconstuction B and Translated Model B, many shared reactions 
contain dissimilar gene rules, a discrepancy that must be resolved when merging them to create Super 
Model B. We resolved these discrepancies using OR relationships, which minimize the constraints 
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imposed on the final model. Examples of implementing these rules are shown in Table 5.1. In addition to 
resolving the GPR discrepancies as shown, we also flagged these reactions as high priority targets for 
manual curation. We created a list of these conflicting GPR reactions, thereby directing the user toward 
specific pieces of the model that require special attention. This flagging process makes manual curation 
more directed and streamlined by better prioritizing reactions and genes most likely to require revisions.  
After assembling our Super Model B structure, we enforce specific growth conditions for Organism B to 
ensure that our final morphed model can predict growth. Although biomass composition affects growth 
predictions and can vary considerably between organisms, we assume that Organisms A and B are 
sufficiently similar that their biomass compositions can be assumed the same unless measured biomass 
composition is available for the target organism. Media composition is also quite organism-dependent 
and despite the fact that many organisms have not yet been cultured, most well-characterized 
organisms possess defined media conditions. In cases where media composition is unknown, the Kbase 
contains many generic media conditions that can be used to simulate growth. External databases, such 
as MediaDB [46] and the KOMODO database [47], also compile known media for sequenced organisms 
and can be used to select a suitable medium for predicting growth.  Using Media B, we gap-filled Super 
Model B using ProbAnno gap-filling to create Gap-filled Model B.  Notably, if Media B is identical or 
sufficiently similar to the growth conditions used to successfully simulate growth of Model A (Media A), 
Super Model B will already be able to predict growth. However, if Media B is sufficiently different from 
Media A, the Super Model B network will contain gaps that prevent successful simulation of biomass 
formation.  
Up to this point in the process, no reactions have been removed from the model, thus Gap-filled Model 
B contains many more components than any of its source materials. At this juncture, we begin testing 
candidate reactions for removal from the model by testing each reaction without a gene (gap-fill 
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reactions). We test essentiality of these reactions via single reaction deletion, working through all gap-
fill reactions in order of priority. The priority list is a necessary component of the method because 
removal order could impact reaction essentiality; reactions tested for removal later are more likely to be 
essential because degenerate pathways are more likely to have been removed earlier in the process. We 
begin the list with reactions in Model A that were identified as unlikely to be present in Model B—
reactions classified as “A not B”—because these reactions could potentially represent actual functional 
differences between the two organisms. These are followed by the remaining list of reactions that lack 
genes in both models, ranked in order of increasing likelihood. Once we test all gap-fill reaction 
essentiality and remove unessential gap-fills, we arrive at the final product of our method: Morphed 
Model B (Figure 5.1). 
Application to Methanogenic Archaea 
To demonstrate the efficacy of our method, we required a group of related organisms with at least one 
high quality manual model; the methanogenic archaea or “methanogens” are a good candidate for this 
purpose. In Chapter 3, I reconstructed a model of Methanococcus maripaludis based mostly on Kbase 
annotations and identifiers, allowing us to sidestep some of the nomenclature and formatting issues 
described in Chapter 1 that would be magnified if we used a model reconstructed from a different 
database. The iMR540 model of M. maripaludis includes considerable manual curation, providing a 
sizeable candidate list of manually added reactions that offer depth on top of Kbase annotations. 
Though methanogens are less studied than many bacterial clades, a number of methanogens have been 
fully sequenced and characterized to some extent because of the interest in tapping into their unique 
methane-producing metabolisms.  
In addition to M. maripaludis, we chose three candidate organisms for testing our method. One obvious 
candidate was Methanocaldococcus jannaschii, a hydrogenotrophic methanogen like M. maripaludis 
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that has been used for numerous biochemical characterization experiments. Indeed, much of the 
literature based information included in iMR540 was linked to studies in M. jannaschii. For this reason, 
morphing our manual model to a draft of M. jannaschii presented an excellent opportunity to observe 
how much of that manual information we could automatically transfer to the new model. We also 
selected Methanosphaera stadtmanae, a somewhat more distant relative to the first two organisms as 
per Garcia et al [192] that consumes methanol and H2 rather than CO2 and H2. It also possesses a smaller 
genome than the other two methanogens, giving us an opportunity to study effects from phylogenetic 
difference, growth conditions, and genome size. Finally, we chose Methanosarcina barkeri, a much more 
distant relative of the other three organisms with a far larger genome and large range of possible 
growth substrates. Notably, M. barkeri can achieve growth on CO2 and H2, enabling us to study the 
effects of genome size and phylogenetic distance on our method while controlling for media.  
Finally, we also used our method to morph M. maripaludis itself, giving us something akin to a control 
case. From reconstructing the iMR540 model, we understood that it incorporated many gene 
annotations and reactions that were absent from the Kbase automated model. We were curious to 
observe the overlap in the models and compare this to what we saw for the other organisms. We were 
somewhat concerned that by greedily compiling information to create our Super Model B structure, we 
might run the risk of retaining too much information, a problem that is difficult to assess when creating 
a model for a different organism. This control afforded us the opportunity to ensure that our methods 
were not overly greedy and that we erred more toward capturing biological differences between 
organisms than grabbing all possible information. To assess these effects, we created an automatically 
reconstructed model for each morphed organism using the default Kbase “Build a Metabolic Model” 
tool. Each set of organisms ended up with 3 different models for comparison: (1) Morphed Model B, the 
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final result of our method; (2) Reconstruction B, the automated Kbase model; (3) Model A the iMR540 
M. maripaludis model. 
Morphing to New Organisms 
As a first measure of assessing our morphed models, we compared the features in the finished morphs 
with the other two models for each organism (Figures 5.3-5.5). Looking first at M. jannaschii (Figure 5.3), 
we observed that the final morph contained more genes than either the automated model or the 
iMR540 model. This seemed to indicate a combination of the larger genome of M. jannaschii compared 
to our source organism and their similarity; the latter would result in many genes being matched to 
iMR540, whereas the former would explain the slight increase. Examining the features of M. 
stadtmanae appeared to confirm this trend (Figure 5.4), as the final morph contained fewer genes than 
did iMR540. The smaller genome and greater phylogenetic distance associated with M. stadtmanae 
could account for this observation, as fewer genes would mean less information to add to the morph 
and less overlap with M. maripaludis would mean fewer genes taken from iMR540. Our final candidate, 
M. barkeri, ended up with many more genes than either of the other two morphs (Figure 5.5) despite its 
greater phylogenetic distance from M. maripaludis. Though this seemingly resulted in matching fewer 
genes with iMR540, the much larger genome size meant that many more gene annotations were added 
from the automated Kbase reconstruction. Across all three organism morphs, we observed a sizeable 
jump in the number of metabolites when compared to the other two models, but no corresponding gain 
in number of reactions. This trend suggests that the morphing process likely removed much network 
degeneracy, wherein multiple pathways can achieve the same essential chemical transformation. In 
these cases, where there are N gap-fill reactions to convert one metabolite to another in a necessary 
pathway step, our essentiality requirement would remove N-1 reactions, leaving only the final reaction 
tested. This demonstrates the importance of sorting our priority list of reactions to remove; by ordering 
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our list such that high likelihood reactions are tested last, we increase our chances of keeping these 
reactions in our model. 
Our overviews of model features were somewhat informative, but did not fully explain the trends we 
saw in gene numbers. We were unsure whether a larger genome size necessarily meant having more 
genes from iMR540, or whether the final number of genes was more independent from genome size. To 
better understand the trend, we examined the gene origins for each organism’s morph, shown in 
Figures 5.6-5.8. As demonstrated by Figure 5.6, the morph for M. jannaschii takes about 60% of its genes 
from iMR540, though only a small portion of those genes intersect those from the Kbase model. The M. 
stadtmanae morph (Figure 5.7) displayed some slight differences, with just under 50% of its genes 
coming from iMR540 and 65% coming from the Kbase model but with similarly poor overlap between 
the two source models. Somewhat strikingly, the M. stadtmanae Kbase reconstruction contained more 
genes than did the M. jannaschii Kbase reconstruction despite having a smaller genome, an observation 
that was not consistent with our morphed models. The M. barkeri morph (Figure 5.8) took only 42% of 
its final genes from iMR540, compared to 69% from the Kbase model. Its total model contained the 
smallest proportion of genes from M. maripaludis, though it matched more genes in sheer number than 
did M. stadtmanae. This points to the idea that genome size played a role in the final morph in so far as 
M. barkeri had more proteome matches with M. maripaludis simply because its larger genome gave it 
more matching opportunities. Perhaps most importantly, phylogenetic distance seemed to play a role in 
the portion of the final model that matched the source model. Greater similarity lent itself to a higher 
percentage of matching genes in the final model and greater distance between organisms resulted in 
more influence from the automated Kbase model. Also quite telling was the exceedingly poor overlap 
between iMR540 matches and Kbase genes, which ranged from 10-13%. This observation was 
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particularly surprising for the M. jannaschii morph, which we expected would show some similarity 
between genes from automated reconstruction and those added from our manual model.  
As a final evaluation of our morphs, we examined the reactions in all 3 model types for each organism 
(see Figures 5.9-5.11). Much as we saw in the previous analyses, M. jannaschii showed a bias toward the 
iMR540 model, sharing the vast majority of its reactions with the manual model. This included nearly 3 
times as many reactions from the manual model that were absent from the automated Kbase model as 
there were in the reverse case. Notably, the 3 different model types still shared a core of about 350 
reactions, the majority of the reactions in the morph. As we expected, M. stadtmanae did not show 
nearly as much favor toward iMR540. Although it shared a similarly sized core of about 350 reactions 
with both source models and a similar number of reactions with just the manual model, it borrowed 
much more equally from the manual and automated models. Furthermore, fewer reactions taken from 
the manual model were associated with genes in the final morph, whereas more reactions from the 
Kbase model were gene-associated (Table 5.2). This same trend was amplified in the M. barkeri model, 
which again shared the same core of about 350 reactions but favored the Kbase model slightly over the 
manual model. Just like M. stadtmanae, the M. barkeri morph took many more gene-associated 
reactions from Kbase alone than it did from the manual model. These observations seem to point again 
to the increased influence of automated gene annotations with increased phylogenetic distance.  
Studying reaction overlap for all models at once, we saw that all morphed models borrowed fairly 
equally from the manual model, but the M. stadtmanae and M. barkeri morphs took many fewer gene-
associated reactions and had to supplement much more using Kbase. We also noticed the gap-filling 
process ended up adding 15 reactions unique to the morph for both M. jannaschii and M. stadtmanae, 
which were grown on slightly different media from iMR540. This is distinct from M. barkeri, which we 
simulated on the same media as used in iMR540 and thus required no gap-filling. In any case, the gap-
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filling reactions represent a very small portion of the other two models and played a very minor role in 
the morphing process. Conversely, our models all removed approximately 20 reactions that overlapped 
between both the Kbase and manual models. Compared to the core of about 350 reactions shared by all 
3 models for each organism, these ~20 reactions comprise a small subset, showing that we removed 
very little of the reaction information that agreed between the two source models.  
Morphing to M. maripaludis 
We performed the same set of analyses for our “control” scenario, shown in Figures 5.12-5.14. Despite 
morphing our M. maripaludis model to itself, a process we expected would change the manual model 
very little, the features in this experiment showed very similar patterns to the other three cases. We 
were surprised to observe that like M. barkeri, our M. maripaludis morph added many new genes to 
iMR540, resulting in over 700 genes in the final morph. As demonstrated by Figure 5.13, the reason for 
this large gene increase was poor gene overlap between iMR540 and the Kbase model; only 83 genes, 
about 11% of those in the morph, occurred in both models. Although nearly 70% of the final morph 
matched the manual model—easily the highest percentage for any of the morphs—the remaining 30% 
represented a sizeable set of genes in Kbase that did not occur in our model.  This discrepancy 
reinforced the notion that the manual curation required to create iMR540 added much biochemical 
detail not captured by Kbase and discarded many parts of the Kbase reconstruction that lacked 
sufficient evidence. Based on our experience assembling iMR540, which began with the Kbase 
reconstruction itself, we think most of these additional genes represent mis-annotations and that in this 
case, the morphing process has somewhat muddled the final morph by including these genes.  
Reactions and metabolites also show similar patterns to the other morphed organisms, with a modest 
increase in metabolites accompanied by a slight decrease in reactions when comparing the morph to the 
manual model. In examining reaction overlap (Figure 5.14), we saw a continuation of the relationship 
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between phylogenetic distance and morph reliance on the Kbase automated model. Indeed, when 
morphing the M. maripaludis model to itself, we counted only 37 reactions from the automated model 
that did not occur in iMR540, the lowest number of these reactions for any morph. Among the reactions 
taken from only iMR540, this morph also had the highest percentage of gene-associated reactions by 
far, unsurprising considering that it matched all genes in the manual model. Like the other morphs, this 
one also contained a large reaction core shared between all three model types, though slightly larger 
than the others at 392 reactions. Interestingly, our morph discarded 56 gap-filling reactions from the 
manual model, presumably replacing them with higher likelihood reactions from the Kbase model. 
These replacements may be an artifact of removal order, particularly because some reactions in iMR540 
lack any likelihood scores or genes and are therefore among the first reactions tested for removal. 
Discussion 
With our novel model morphing method, we have created a new way to extend a high-quality manual 
reconstruction to closely related organisms. By basing our final model on a proteome comparison with 
the manual source model, we can capture much information that would likely be missed by an 
automated draft reconstruction. Our method could have applications not only morphing one organism 
to another but also in larger scale clade reconstruction, whereby one high-quality seed model could be 
transformed into a collection of related models and enable pangenomic analyses.  
As we demonstrated by morphing the iMR540 model to three functionally-related organisms, our 
method is able to reflect similarity between organisms. Our morphed model for M. jannaschii, a close 
relative of M. maripaludis, displayed much more consistency with the source model than either of the 
other morphed models, both of which were more distant relatives. Yet, we caution that regardless of 
phylogenetic or functional distance between organisms, our final morphs are still only draft models. 
Although our morphing process should drastically reduce the time needed to locate reaction pathway 
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information compared to starting with an automatically reconstructed model, our morphs still contain a 
fair amount of redundancy, particularly for reaction GPRs with disagreements between source model 
and Kbase annotations. Accordingly, we copiously flagged reactions in the final morphs to direct 
modelers beginning with these drafts toward the areas in most need of manual curation. Based upon 
our own experience with metabolic reconstructions, these outputs should be a boon to model creation, 
cutting down significantly on manual curation time.  
The need for continuing to employ manual curation is underscored by morphing M. maripaludis itself, 
an exercise that highlighted the differences between our source model and the Kbase automated 
version. Overlap between these models was much smaller than reasonably expected, a difference that 
manifested in a final morph with many more genes than either of these two contributing models. It is 
quite telling that despite the manual model possessing 528 genes and the automated model possessing 
322 genes, they share only 83 of them, or 15.7% and 25.8% of their respective gene totals. Though it is 
possible that some genes from the Kbase model could represent information missed by the manual 
model, many of them were deliberately removed during manual curation, as described in Chapter 3. 
This calls into question the ubiquity of the automated reconstruction process, which takes gene 
annotations from a centralized database, much of which is based off well known pathways in model 
organisms. For an organism like the methanogens used in this study, it is quite possible that these 
generalized annotations create draft models dominated by misinformation and could end up slowing 
manual curation efforts. If indeed an automatically reconstructed draft model can only correctly capture 
in the range of 10-20% of genes present in a high quality model, it could be folly to use such a draft 
model, as the small gain in correctly annotated genes could be greatly muddled by the larger gain in mis-
annotations. These potential shortcomings further point to the need for a method such as the one 
presented here to extend the benefits reaped from manual model curation and use that information as 
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the basis for a new high quality reconstruction rather than relying on automated reconstruction alone. 
Thus, our model morphing tool could provide a viable alternative for organisms that are dissimilar to 
those that populate annotation databases, provided a high quality manual model of a closer relative 
already exists.  
On a related note, we do not recommend applying our morphing method for organisms outside a 
reasonable phylogenetic distance. Just in our small set of organisms, we observed a large difference 
when morphing to our most distant organism, M. barkeri, compared to the other organisms. The final 
morph relied more on Kbase annotations than on those from the manual model, and we would expect 
this trend to continue with increased phylogenetic and functional distance. Correspondingly, as our 
target organism for morphing becomes more dissimilar to our source organism, we are concerned that 
annotations gleaned from the manual model may supply misinformation in the resulting morph.  
Attempting to morph a manual model to an essentially unrelated organism could result in numerous 
misannotations. These annotation errors may greatly cloud any useful information gleaned from the 
morphing process, resulting in a draft model that hinders the reconstruction process. Instead, model 
morphing should only be performed using a manual model from a close relative, otherwise, in cases 
where no such model exists, an automated reconstruction method would likely prove most efficacious.  
As with any automated method in metabolic modeling, it is vital to exercise caution when using model 
morphing and to meticulously examine the resulting product to ensure that its quality is satisfactory.   
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Tables and Figures 
GPR Discrepancy Type Translated Model B Reconstruction B Super Model B 
Single Gene Disagreement G1 G2 G1 OR G2 
OR Subset Disagreement G1 OR G2 G1 G1 OR G2 
Multiple OR Disagreement G1 OR G2 G2 OR G3 G1 OR G2 OR G3 
AND Subset Disagreement G1 AND G2 G1 (G1 AND G2) OR G1 
Multiple AND 
Disagreement 
G1 AND G2 G2 AND G3 
(G1 AND G2) OR (G2 AND 
G3) 
Complex Mixed 
Disagreement 
(G1 AND G2) OR G3 (G2 AND G3) OR G4 
(G1 AND G2) OR G3 OR (G2 
AND G3) OR G4 
Table 5.1: Examples of GPR discrepancy reconciliation from combining the Translated Model B construct and 
Reconstruction B construct to form Super Model B. These examples display what we consider to be the full 
spectrum of different cases. Any GPR we encountered could be expressed as a combination of these examples and 
resolved in the Super Model B structure based on the rules outlined here 
 
 
Total Reactions % Reactions with Genes 
M. jannaschii Morph 631 86% 
iMR540 190 78% 
Kbase 70 79% 
Both 356 95% 
M. stadtmanae Morph 696 81% 
iMR540 185 59% 
Kbase 146 90% 
Both 354 92% 
M. barkeri Morph 741 87% 
iMR540 183 67% 
Kbase 198 94% 
Both 359 94% 
M. maripaludis Morph 597 93% 
iMR540 167 90% 
Kbase 37 68% 
Both 392 97% 
Table 5.2: The reaction origins for all of our final morphs. Percentages reflect the fraction of reactions from each 
source model that are gene-associated (e.g. 190 reactions in the M. jannaschii morph came only from iMR540 and 
of those 190, 78% of them were associated with at least one gene) 
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Figure 5.1: A flowchart showing the basic workflow of our model morphing method.  
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Figure 5.2: A visual representation of the proteome comparison between Organism A and Organism B. Genes in 
Organism A are matched with corresponding genes in Organism B, creating a mapping between the two genomes 
illustrated by the double-sided arrows. Using this mapping and the reaction network for Organism A (on left), the 
matching reads can be mapped onto the same network for Organism B (on right). Reactions with no genetic 
evidence in Organism B are shown in red, flagging them as prime candidates for removal and potentially creating 
gaps in the network.  
 
Figure 5.3: A comparison of basic model features for M. jannaschii. This includes the manual source model of M. 
maripaludis, our final morphed model of M. jannaschii, and an automated reconstruction of M. jannaschii 
generated using Kbase. The final morph contains more genes and many more metabolites than either of the other 
models, but slightly fewer reactions.   
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Figure 5.4: A comparison of basic model features for M. stadtmanae. This includes the manual source model of 
M. maripaludis, our final morphed model of M. stadtmanae, and an automated reconstruction of M. stadtmanae 
generated using Kbase. The final morph contains fewer genes than the source model but more than the 
automated model. It also contains many more metabolites and slightly more reactions than either of the other 
models.   
 
Figure 5.5: A comparison of basic model features for M. barkeri. This includes the manual source model of M. 
maripaludis, our final morphed model of M. barkeri, and an automated reconstruction of M. barkeri generated 
using Kbase. The final morph contains fewer genes than the source model but more than the automated model. It 
also contains many more metabolites and slightly more reactions than either of the other models.   
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Figure 5.6: Gene origins for M. jannaschii morphed model. Percentages reflect the portion of total genes 
contributed by a particular subcategory (e.g. 11.0% of the genes in the M. jannaschii morph are from both source 
models) 
 
 
Figure 5.7: Gene origins for M. stadtmanae morphed model. Percentages reflect the portion of total genes 
contributed by a particular subcategory (e.g. 12.0% of the genes in the M.stadtmanae  morph are from both 
source models) 
 
Figure 5.8: Gene origins for M. barkeri morphed model. Percentages reflect the portion of total genes contributed 
by a particular subcategory (e.g. 9.6% of the genes in the M. barkeri morph are from both source models) 
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Figure 5.9: Reaction overlap for M. jannaschii model forms. Gene associations for reations in the final morph can 
be found in Table 5.2 
 
 
117 
 
 
Figure 5.10: Reaction overlap for M. stadtmanae model forms. Gene associations for reations in the final morph 
can be found in Table 5.2 
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Figure 5.11: Reaction overlap for M. barkeri model forms. Gene associations for reations in the final morph can 
be found in Table 5.2 
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Figure 5.12: A comparison of basic model features for M. maripaludis. This includes the manual source model of 
M. maripaludis, our final morphed model of M. stadtmanae, and an automated reconstruction of M. maripaludis 
generated using Kbase. The final morph contains many more genes and slightly more metabolites than either of 
the other models. It contains fewer reactions than the manual model, but more than the automated model. 
 
 
Figure 5.13: Gene origins for M.maripaludis morphed model. Percentages reflect the portion of total genes 
contributed by a particular subcategory (e.g. 10.8% of the genes in the M. maripaludis morph are from both source 
models) 
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Figure 5.14: Reaction overlap for M. maripaludis model forms. Gene associations for reations in the final morph 
can be found in Table 5.2 
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Chapter 6: Discussion and Conclusions 
In the previous chapters, I described various efforts to increase usage of manual data in concert with 
automated approaches. Though these projects all aimed to explore the need for developing more 
techniques that blend manual and automated methods, they are all threads in the much larger tapestry 
of improving metabolic engineering. From the standpoint of chemical engineering, biological systems 
present a unique challenge when compared to traditional chemical processes. Unlike purely chemical 
systems, which have generally been known for decades, living systems present a whole new litany of 
poorly understood phenomena. Thus as we try to engineer such systems to perform desired metabolic 
processes akin to those we can achieve chemically, we are encountering novel obstacles that require 
much more characterization.  
My investigations into chemically defined media and metabolic reconstructions are both important 
pieces to improve our community’s capabilities for metabolic engineering. Media formulations are the 
substrates for our proposed processes, the raw materials that ultimately dictate the possible products of 
our systems. Hence, it is essential that as we hone our metabolic engineering tools, we greatly expand 
upon our understanding of what organisms use to grow and why. If media conditions are the raw 
materials to a biological process, then metabolic reconstructions and models are a facsimile of the unit 
operations in a chemical process, the series of mechanisms through which the inputs reach their end 
products. Although the reconstruction is innately bound by available substrates in media formulations, 
the chemical reactions therein are the engine that drives overall transformations. The two are inherently 
linked to one another, necessitating a better understanding of both if we hope to truly master metabolic 
engineering.   
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The work I presented in the previous chapters underscored the importance of leveraging all available 
knowledge for formulating media and modeling metabolism. Summing up the knowledge I have gained 
from my studies, I believe there are several conclusions to be drawn regarding both my completed work. 
These takeaways have salient implications for the future of media development and metabolic 
modeling, as well as for metabolic engineering as a whole. 
Takeaways from Completed Work 
Balancing Databases and Other Resources 
Most of the work I have presented relates in some way to using databases to organize and centralize 
information. As computational resources rapidly grow in their processing and storage capabilities, 
databases are increasingly thrust into a central role, both inside and outside of science. There is much to 
be said for a database’s ability to bring together many disparate information sources, a benefit I 
harnessed when creating MediaDB. At the outset of that project, two things seemed readily apparent: 
(1) the biological community was acutely aware of the fact that the unknown microbial world greatly 
exceeds the known one; (2) details on how to grow the characterized part of the biosphere were 
scattered throughout published literature. Putting together those two observations, it was clear that a 
database could help accrue much of this information, addressing what I saw as a deficiency in how we 
store microbial growth media. MediaDB was the first step toward consolidating that information and 
making it more widely accessible to researchers without requiring them to scour countless reference 
materials. By bringing together many sources to create a larger dataset, my database enabled larger 
scale analyses of growth media that were previously more difficult due to the widely dispersed nature of 
media information.  
Databases in the metabolic modeling space fill a similar function, gathering many different genome 
annotations into centralized resources that fuel high throughput analyses. And yet, my work with these 
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databases has served to illustrate many of the dangers involved with relying solely upon them. The 
differences between my manually curated model, iMR540, and a model of M. maripaludis created using 
automated reconstruction demonstrated how much information we could lose if we neglect manual 
curation, and how much clearly remains unknown about cellular metabolisms, even after extensive 
studies. That is not to say that there is no value in the automated reconstruction, which served as the 
basis for my manual model and contributed many genes that I could not have found through literature 
searches. But it is crucial to recognize the limitations of any database, particularly that the 
understanding gained from the database is bound by the information contained therein.  
Creating my own model required adding reactions and genes not contained in the Department of Energy 
Knowledgebase (Kbase; www.kbase.us) to supplement the database information. Else, I would not have 
captured the same depth of biochemical information inherent in my finished model. Correspondingly, 
MediaDB could be a useful resource for studying trends in media formulation, perhaps for creating a 
new medium to culture a novel organism. However, using MediaDB alone would likely miss many details 
not present in the database and would have much lower likelihood of success than an approach that 
encompasses more sources. Databases are excellent at compiling data, but it is critical that database 
users not be blinded to external resources. When using such databases it is vital to recognize their 
limitations and seek out information from other resources.  For example, one major limitation is that 
negative results from media that were tried unsuccessfully are rarely published, and thus do not often 
appear in databases. The key is finding a way to achieve a balance of resources, with database 
information providing a solid starting foundation and external literature sources filling in knowledge 
gaps to create a high quality end product. 
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Applying General Knowledge to Lesser Known Organisms 
A readily apparent feature of biological databases is the degree to which they are dependent on a 
relatively small core group of organisms. We typically refer to these as “model organisms”, oftentimes 
industrial workhorses like Escherichia coli and Saccharomyces cerevisiae, but also representatives from 
other clades, such as the Methanosarcina genus for methanogens. If we critically examine the organisms 
in MediaDB for example, the 200+ strains we collected comprise a very small group of organisms, 
especially when compared to the nearly 58,000 organisms in RefSeq. My studies have highlighted some 
of the consequences involved with applying knowledge gleaned from these organisms to lesser known 
species.  
In addition to containing media from a small portion of known organisms, MediaDB displays fairly low 
diversity in media compounds. Perhaps the largest takeaway from studying the data in MediaDB was 
that the compounds we saw most frequently in media were those that appear in trace mineral and 
vitamin solutions. Indeed, these types of solutions are rather ubiquitous in traditional growth media 
development and provide many of the same nutrients to every organism. Presumably, the aim of such 
solutions is to fill the organism’s every need by supplying it with every conceivable component. This has 
worked quite well for the organisms we have grown thus far, allowing us to culture numerous organisms 
without necessarily determining what in the multi-component solutions is actually required for growth. 
However, this subset of organisms that has been cultured is a necessarily biased subset, in part based on 
somewhat arbitrary and pervasive choices of similar growth media. 
There are a couple of problems that arise out of this approach. First, because we have used many of the 
same compounds in different media, it is difficult to study trends across different organisms. When I 
attempted to cluster our organisms based on their media compounds, I was unable to discover any 
particular pattern, largely because many disparate organisms shared many of the same components. 
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This complicates our ability to infer new media formulations from existing ones, because known media 
may lack defining characteristics that could inform new media designs. Second, our success with 
growing many organisms in similar media could actually prove to be a hindrance when trying to culture 
new isolates. One reason we have been able to culture the subset of organisms we have isolated to this 
point is because most of them grow well on rich media with lots of available nutrients. This success has 
primed me to believe that culturing a new organism comes down to adding more components to an 
established medium; to try to add the missing pieces to a mostly finished puzzle. But it is entirely 
possible that reason behind our inability to culture most organisms is that they employ markedly 
different growth strategies than the organisms we have already isolated. If we continue to employ 
strategies that encourage growth of microbial “weeds”, we will succeed in growing more weeds, but 
may very well fail at coaxing growth out of our actual targets. Thus, as I consider the information 
contained within MediaDB, I realize this information may not apply to novel systems and may only be 
descriptive of the organisms contained therein.  
My experience with metabolic modeling echoes the same message drawn from assembling and 
analyzing MediaDB. Just as media formulations tend to contain many of the same compounds, 
metabolic models and reconstructions tend to contain many of the same reactions, a point that was well 
illustrated in a review by Monk et al. [23]. Despite the accelerated growth of completed metabolic 
reconstructions, the majority of known enzymatic reactions have never appeared in a published 
reconstruction. Undoubtedly, this is partially due to the relatively small scope of organisms that have 
been modeled to this point; the roughly 200 different modeled organisms pales in comparison to the 
nearly 58,000 complete genomes. Hence, organisms lacking models likely contain many reactions that 
we simply have not encountered to this point. However, I would argue that the larger factor is that most 
models are heavily based on existing models from model organisms. In the aforementioned review, the 
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authors show that most models fall very close to E. coli in terms of metabolites and reactions, 
demonstrating the extent to which other organisms merely borrow annotations from the E. coli model. 
Even when expanding out to the more broad range of model organisms that form the basis for 
annotation databases like Kbase, we cover a fairly narrow scope of gene annotations. We illustrated this 
poignantly in Chapter 5 by showing how much our manual model of Methanococcus maripaludis 
diverged from the automated Kbase model. Using automated annotations from a database may work 
well for organisms that are similar to model organisms, but for something further from the beaten path, 
these same annotations appeared to fit much more poorly. This is not necessarily surprising; we would 
expect that although databases and automated approaches work well on new test cases that bear 
strong similarity to the training set, they can fair quite poorly on test cases that are quite different. Such 
methods are inherently biased by their training sets, thus when we apply a new test case, we get back 
information that looks like what we have encountered before. But as we look to expand our knowledge 
about biological processes, we must necessarily break free of relying on these methods, lest we lose out 
on the increased diversity we could add by using more meticulous manual methods.  
Recognizing the Limitations of Predictive Automated Methods for Complex Problems 
With the boom in sequencing information covered in Chapter 1, we now have more genomic data than 
ever and enormous potential for applying these data to address some quite challenging problems. 
Though this wealth of data presents numerous opportunities to discover new phenomena and emergent 
properties, we must be cautious when evaluating predictive models and methods that utilize these data. 
The sheer volume of analyses we can perform with such tools are valuable to be sure, but it would be 
folly to believe they can capture the full range of phenomena occurring within a biological system. 
Rather, automated methods relying on large datasets give some idea of a subset of these phenomena 
and rely on rigorous manual methods to fill in the rest.  
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It is somewhat sobering to look back at the origins of the MediaDB project and recall that my initial goal 
was to create a method that predicts growth media directly from sequenced genomes. Drawn in by the 
potential power of this proposed automated method, I did not necessarily consider the many different 
factors that can impact culturing. I assumed that if given a large enough training set, I could devise some 
model that would work toward my end. Looking back at this juncture, my intentions were somewhat 
naïve because they oversimplified the culturing problem, conjecturing that the only missing piece was a 
bridge between genome and media formulations. Media are influenced not only by substrates present, 
but also substrate concentrations, pH, temperature, signaling compounds, and a host of other factors. 
Having now considered the limitations of what we can predict based on our limited knowledge, such a 
method can offer a starting set of candidate growth substrates but should not be counted on to produce 
working media formulations. Designing working growth media still requires manual work, both to scour 
reference materials for factors other than substrate diversity and to troubleshoot candidate 
formulations in the experimental lab.  
As for metabolic reconstructions, the bevy of functions served by a finished reconstruction does not 
include the ability to completely determine metabolic engineering strategies. If we closely examine 
metabolic modeling and its application to strain design, it is remarkable to note the relatively small 
number of success stories compared to the number of completed models and methods. That is not to 
say that such tools cannot serve useful functions; as I demonstrated in Chapter 4, I was able to use 
iMR540 to make a series of useful predictions for M. maripaludis. And yet, at the end of the day the 
results from those predictions can be somewhat unsatisfying because all of them still require verification 
from manual wet lab experiments. Our metabolic models may be powerful for contextualizing metabolic 
processes, but they overlook a wealth of biological phenomena to focus in on metabolism. A number of 
factors—protein expression levels, regulatory effects from environmental factors, unknown metabolic 
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pathways—could be responsible for our inability thus far to reproduce our predictions in actual cells and 
it is quite difficult to determine the factors responsible.  
When combined with the database bias toward model organisms, the limited scope of automated 
methods cannot possibly predict the full spectrum of phenomena in uncharacterized organisms. Much 
as was the case when evaluating iMR540, it is important to temper our expectations of such methods 
and realistically understand their capabilities. Ultimately, these methods will not solve complex 
biological problems all on their own, but they can still serve as important cogs in more involved 
solutions. Metabolic models can help bound the space of metabolism, helping us predict what to expect 
from a system and giving us a rough idea of what is metabolically feasibly. Media prediction provides a 
starting point for designing new media that draws on successful formulations, cutting down on time 
spent scouring literature for these data. Each of these approaches can play an important role as we 
strive to better understand organisms for the purpose of metabolic engineering, so long as we do not 
rely solely on these methods.  
Future Directions 
The work I presented in this dissertation represents several steps toward untangling the web of 
metabolic phenomena in biological systems, yet much more remains to be done. If we hope to 
understand the mechanisms that drive metabolism well enough to intelligently design and optimize new 
strains, then it is crucial to continue to employ manual methods in concert with automated tools.  
Much of this work must come in utilizing and expanding our existing tools. In the case of MediaDB, I 
have provided the first repository intended to compile defined growth media, but my database and 
others like it are only as useful as the information they contain. If we truly want to study existing media 
formulations and use that knowledge to formulate new media, we need a larger community buy-in to 
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media databases and high-throughput unbiased screens that present evenly both positive and negative 
growth outcomes. By contributing more data to these resources, we will increase our dataset, providing 
more chances to uncover emergent trends that govern organisms’ nutrient requirements.  
One aspect of growth media that often goes unmentioned is collecting negative results; that is, records 
of unsuccessful growth media. Biochemical literature is plentiful with examples of successful growth 
experiments and rarely contains details of failed culturing attempts. Yet these data could prove to be 
even more valuable than successful media formulations, providing known growth constraints in the 
form of toxic or inhibitory compounds. With the relatively recent introduction of Biolog phenotype 
microarrays for high-throughput culturing experiments, we now have an engine with which to quickly 
compile unsuccessful growth conditions. If we collect these data into a database similar to MediaDB, we 
can increase our chances of learning more about microbial growth requirements.   
Similar to growth media experiments, the future of metabolic modeling for metabolic engineering is 
seemingly in the hands of the community. Judging by the perpetuation of recent perspective 
manuscripts about the state of metabolic modeling, modelers are becoming increasingly aware of the 
need to better organize ourselves. We have built many manually curated models without strictly 
enforcing standards on their formats and nomenclature, complicating comparative studies that use 
multiple models in disparate formats. As I laid out in Chapter 1, it is clear that we need to come together 
on a set of standards and a repository to house manually curated models. Doing so will increase the 
usefulness of future models and allow us to convert existing models into the same language. This 
development would better unify metabolic modelers, trivializing the process of using another group’s 
model and lowering the barrier to using that model for comparative studies.  
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Arguably the greatest challenge to metabolic modeling is the aforementioned general nature of 
databases dominated by model organisms. When we base new models on gene annotations from these 
model organisms, it can sabotage our ability to use such models to discover new phenomena. We would 
do well to target a wider breadth of organisms that span the tree of life, particularly those that carry out 
unusual metabolic functions. If we put the effort into creating manually curated reconstructions for 
these organisms, particularly by relying heavily on biochemical characterization experiments, we can 
greatly enhance the richness in our annotation databases. Ultimately, such characterizations rely on wet 
lab experiments, necessitating that we continue to progress in our ability to isolate new organisms. 
Thus, diversifying metabolic models goes hand in hand with developing new growth media; we must 
progress substantially on both fronts if we hope to uncover more about the inner workings of microbial 
metabolism.  
Coming back to metabolic engineering itself, I envision a future where we can design organisms 
completely from a computational platform. In this idealized future, I imagine we will compile sufficient 
metabolic information that for any desired set of substrates and products, we will be able query our 
database of metabolism to rank the best microbial host based on its growth rate, byproduct tolerance, 
and various other features. Though this sounds somewhat farfetched given the enormity of the 
unknown microbial world, we are working toward this goal every day. Each new growth medium we 
create, each manually curated metabolic network we build is a new piece in our understanding of 
microbial capabilities. 
Based on the lessons taken from my dissertation work, it is clear that we still have a long way to go on 
this front. But by tapping into these lessons, I believe we can devise a better roadmap for reaching this 
goal than the path we are currently on. If we recognize the strengths and limitations of our data-rich 
automated tools and resources, we can better understand how to supplement these approaches with 
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manual data and open our eyes to the gaps in our knowledge rather than glossing over them. Employing 
such a strategy, where we utilize faster and more precise automated methods in concert with 
meticulous manual methods, we can move toward completely in silico strain design as a guiding force 
for metabolic engineering. Though we will likely never divorce ourselves completely from time-intensive 
manual methods, if we are cognizant of our abilities and deficiencies in computation, we can create 
hybrid methods that reap the benefits of both approaches and completely change the way we interact 
with the microbial world.  
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Appendix A: Supporting Information for Chapter 2 
 
Figure A.1: Full MediaDB schema. Dashed lines indicate foreign key relationships, oriented such that arrows point 
towards the referenced primary key. Each table is represented by a box headed by the table name and described 
by a list of column names and column types. This diagram was created using MySQL Workbench 
(www.mysql.com/products/workbench). 
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Table A.1: Full compound frequency results. Listed below is every compound that appears in at least one media 
formulation in MediaDB and the number of organism species known to utilize that compound (frequency). 
Compound Frequency 
Calcium chloride anhydrous 49 
Magnesium sulfate 41 
Potassium dihydrogen phosphate 37 
Sodium chloride 37 
Ferrous sulfate 35 
Zinc sulfate 35 
Potassium dibasic phosphate 33 
Ammonium chloride 30 
Biotin 29 
Cupric sulfate 28 
Glucose 27 
Sodium molybdate 24 
Manganese sulfate 23 
Boric acid 22 
Magnesium chloride 22 
Potassium chloride 22 
Cobalt chloride 21 
Cysteine 21 
Manganese chloride 21 
Thiamine HCl 20 
Acetate 19 
Arginine 19 
Aspartate 19 
4-Aminobenzoate 18 
Glutamate 18 
Leucine 18 
Isoleucine 17 
Histidine 16 
Nicotinate 16 
Phenylalanine 16 
Alanine 15 
Ammonium sulfate 15 
Calcium pantothenate 15 
Glycine 15 
Lysine 15 
Proline 15 
Valine 15 
Iron(III) chloride 14 
Riboflavin 14 
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Table A.1 (cont.) 
Compound Frequency 
Thiamine 14 
Threonine 14 
Folate 13 
Cupric chloride 12 
Dibasic sodium phosphate 12 
Methionine 12 
Vitamin B12 12 
Citrate 11 
Glycerol 11 
Pyridoxine HCl 11 
Asparagine 10 
Nickel chloride 10 
Zinc Chloride 10 
Serine 9 
Sodium sulfate 9 
Tromethamine 9 
Tryptophan 9 
Tyrosine 9 
Glutamine 8 
Lipoate 8 
Molybdic acid ammonium salt tetrahydrate 8 
Nitrilotriacetic acid 8 
Pantothenate 8 
Sodium bicarbonate 8 
Sodium citrate 8 
DL-Serine 7 
DL-Tyrosine 7 
Pyruvate 7 
Sodium dihydrogen phosphate 7 
Urea 7 
Cobaltous sulfate 6 
EDTA 6 
MOPS 6 
Sodium nitrate 6 
Uracil 6 
Aluminum potassium sulfate 5 
Ammonium nitrate 5 
Ammonium phosphate 5 
DL-methionine 5 
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Table A.1 (cont.) 
Compound Frequency 
Ethanol 5 
Fe(III)dicitrate 5 
Potassium hydroxide 5 
Pyridoxine 5 
Resazurin 5 
Succinate 5 
Ascorbate 4 
D-Fructose 4 
D-Gluconic acid 4 
D-Mannose 4 
Inosine 4 
Lactose 4 
Potassium sulfate 4 
Sodium borate 4 
Sodium selenite 4 
Sodium sulfide 4 
Thymine 4 
Tween 80 4 
Xanthine 4 
myo-Inositol 4 
(S)-Malate 3 
Adenine 3 
Ammonium citrate 3 
Cellobiose 3 
Cl- 3 
Ferrous chloride 3 
Guanine 3 
HEPES 3 
Hemin 3 
Lactate 3 
Maltose 3 
Methanol 3 
Nitrate 3 
Orotate 3 
Pyridoxal HCl 3 
Pyridoxamine HCl 3 
Sodium EDTA 3 
Sodium ammonium phosphate 3 
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Table A.1 (cont.) 
Compound Frequency 
Sodium selenate 3 
Sodium tungstate 3 
Sucrose 3 
Sulfate 3 
Thymidine 3 
(9Z)-Octadecenoic acid 2 
(R)-Lactate 2 
(S)-Lactate 2 
1-Butanol 2 
2-Methylpropanoate 2 
3-Methylbutanoic acid 2 
4-Hydroxy-L-proline 2 
4-Hydroxybenzoate 2 
ATP 2 
Ammonium Acetate 2 
Cobalt nitrate 2 
D-Glutamate 2 
Fe2+ 2 
Ferrous ammonium sulfate 2 
Glutathione 2 
Hypoxanthine 2 
L-Sorbose 2 
Magnesium 2 
Mannitol 2 
Menadione 2 
NH4+ 2 
Nicotinamide 2 
Orthophosphate 2 
Pentanoate 2 
Potassium 2 
Potassium iodide 2 
Potassium nitrate 2 
Pyridoxamine 2 
Sodium 2 
Sodium Glutamate 2 
Sodium L-lactate 2 
Sodium Succinate 2 
Sodium carbonate 2 
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Table A.1 (cont.) 
Compound Frequency 
Sodium hydroxide 2 
Sodium iodide 2 
Sodium pyruvate 2 
Starch 2 
Toluene 2 
Tricine 2 
Xylose 2 
Zinc Acetate 2 
sodium silicate 2 
(R,R)-Butane-2,3-diol 1 
2-Mercaptoethanesulfonate 1 
2-methylbutanoic acid 1 
3,4-Dihydroxybenzoate 1 
3,4-Dihydroxyphenylacetate 1 
3-Hydroxypropanal 1 
3-Sulfolactate 1 
4-Cresol 1 
4-Hydroxybenzaldehyde 1 
4-Hydroxyphenylacetate 1 
5-Hydroxyectoine 1 
ACES 1 
Adenosine sulfate 1 
Ampicillin 1 
Benzaldehyde 1 
Benzoate 1 
Benzyl alcohol 1 
Borate 1 
Butanoic acid 1 
Calcium 1 
Calcium carbonate 1 
Calcium sulfate 1 
Chloramphenicol 1 
Cholesterol 1 
Choline 1 
Chromium(III) Chloride 1 
Cobalt ion 1 
Copper 1 
Cyanocob(III)alamin 1 
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Table A.1 (cont.) 
Compound Frequency 
D-Alanine 1 
D-Aspartate 1 
D-Galactose 1 
D-Glucarate 1 
D-Methionine 1 
D-Ribose 1 
D-Xylose 1 
Deoxyribose 1 
Diammonium tartrate 1 
Diuron 1 
EDDHA 1 
Ectoine 1 
Ethyl octanoate 1 
Ethylene glycol 1 
Fe3+ 1 
Ferric ammonium citrate 1 
Ferric nitrate 1 
Ferric nitrilotriacetate 1 
Ferric oxide 1 
Fumarate 1 
GDP 1 
Galactitol 1 
Glycolate 1 
Guanine HCl 1 
Hexadecane 1 
Hydrochloric acid 1 
IPTG 1 
Kanamycin 1 
L-Arabinose 1 
L-Citrulline 1 
L-Inositol 1 
L-Rhamnose 1 
Maleic acid 1 
Manganese 1 
Manganese(IV) oxide 1 
Molybdenum 1 
Molybdenum trioxide 1 
NAD+ 1 
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Table A.1 (cont.) 
Compound Frequency 
Nickel Sulfate 1 
Nickel(II) ammonium sulfate 1 
PIPES 1 
Phenol 1 
Polyvinyl alcohol 1 
Potassium Gluconate 1 
Propane-1-ol 1 
Propanoate 1 
Propenoate 1 
Quinate 1 
Retinol 1 
Sodium Pantothenate 1 
Sodium bromide 1 
Sodium thiosulfate 1 
Spectinomycin 1 
Spermine phosphate 1 
Streptomycin 1 
Strontium chloride 1 
TES 1 
Triethanolamine 1 
Uridine 1 
Vitamin D3 1 
Zinc 1 
alpha,alpha-Trehalose 1 
alpha-Tocopherol 1 
beta-D-Fructose 1 
dTMP 1 
p-Hydroxybenzyl alcohol 1 
sodium fumarate 1 
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Table A.2: Full organism media compound counts. Listed below is every species in MediaDB and the number of 
compounds that appear in at least one media formulation for that species (i.e. the union of its media compounds).  
Organism Compound Number 
Escherichia coli 81 
Lactococcus lactis 65 
Leishmania major 63 
Shewanella oneidensis 53 
Bacillus subtilis 51 
Geobacter metallireducens 51 
Streptococcus thermophilus 51 
Deinococcus radiodurans 43 
Lactobacillus plantarum 41 
Albidiferax ferrireducens 40 
Acinetobacter baylyi 37 
Thermotoga maritima 37 
Bacillus megaterium 36 
Candida glabrata 35 
Haemophilus influenzae 35 
Streptomyces Coelicolor 33 
Ketogulonicigenium vulgare 31 
Chromohalobacter salexigens 30 
Geobacter sulfurreducens 30 
Halobacterium salinarum 30 
Saccharomyces cerevisiae 29 
Salmonella enterica 29 
Yersinia pestis 28 
Klebsiella  pneumoniae 27 
Methanococcus maripaludis 27 
Bacillus amyloliquefaciens 25 
Mycobacterium tuberculosis 25 
Synechocystis PCC6803 25 
Aspergillus nidulans 24 
Aspergillus terreus 24 
Bradyrhizobium japonicum 24 
Cyanothece 24 
Mannheimia succiniciproducens 24 
Pseudomonas putida 23 
Francisella tularensis 22 
Staphylococcus aureus 22 
Clostridium acetobutylicum 20 
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Table A.2 (cont.) 
Organism Compound Number 
Chlamydomonas reinhardtii 18 
Hydrogenobacter thermophilus 16 
Komagataella pastoris 16 
Neiserria meningitidis 16 
Pseudomonas aeruginosa 16 
Aspergillus niger 15 
Clostridium thermocellum 15 
Corynebacterium glutamicum 14 
Cupriavidus necator 14 
Rhizobium etli 14 
Natronomonas pharaonis 13 
Clostridium beijerinckii 12 
Methanosarcina acetivorans 12 
Methanosarcina barkeri 12 
Neurospora crassa 12 
Porphyromonas gingivalis 12 
Vibrio vulnificus 11 
Aspergillus oryzae 10 
Acinetobacter baumannii 9 
Zymomonas mobilis 7 
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Supplementary File A.1: Model simulation on known media.  An example Matlab script (growEcoliOnMedia.m) 
that demonstrates how to simulate growth of a model on media from MediaDB. This script simulates growth of the 
iJR904 model of E. coli on 11 different carbon sources corresponding to 11 different media in MediaDB. 
function growth_rates = growEcoliOnMedia() 
 
%%%%%%%%%%%%%%%%% 
%There are 11 different media formulations for E.coli 
%The default medium contains glucose, ammonium, phosphate, and sulfate 
%Each medium contains all of these components, plus a carbon source 
%Simulate growth on each medium by turning off the glucose uptake and turning on the proper 
carbon source 
% 
% 
% 
%Outputs 
%growth_rates - an array of the growth rates predicted for maximum biomass yield on each 
carbon substrate 
% 
%Matthew A. Richards 06/10/2014 
 
%Load the iJR904 model 
load('iJR904.mat'); 
 
%Create array to store growth rates 
growth_rates =zeros(11,1); 
%Create a cell array of the 11 Carbon Sources 
substrates = {'Glucose';'Fructose';'Gluconate';'Acetate';'Pyruvate';... 
    'Glycerol';'Succinate';'Lactose';'Malate';'Mannose';'Lactate'}; 
 
%Glucose is the default substrate; simulate the model as is 
glc_model = model; 
solution=optimizeCbModel(glc_model); 
growth_rates(1)=solution.f; 
 
%Fructose 
frc_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
frc_model = changeRxnBounds(frc_model,'EX_fru(e)',-10,'l'); 
solution=optimizeCbModel(frc_model); 
growth_rates(2)=solution.f; 
 
%Gluconate 
glu_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
glu_model = changeRxnBounds(glu_model,'EX_glcn(e)',-10,'l'); 
solution=optimizeCbModel(glu_model); 
growth_rates(3)=solution.f; 
 
%Acetate 
ac_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
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Supplementary File A.1 (cont.) 
 
ac_model = changeRxnBounds(ac_model,'EX_ac(e)',-10,'l'); 
solution=optimizeCbModel(ac_model); 
growth_rates(4)=solution.f; 
 
%Pyruvate 
pyr_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
pyr_model = changeRxnBounds(pyr_model,'EX_pyr(e)',-10,'l'); 
solution=optimizeCbModel(pyr_model); 
growth_rates(5)=solution.f; 
 
%Glycerol 
gly_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
gly_model = changeRxnBounds(gly_model,'EX_glyc(e)',-10,'l'); 
solution=optimizeCbModel(gly_model); 
growth_rates(6)=solution.f; 
 
%Succinate 
suc_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
suc_model = changeRxnBounds(suc_model,'EX_succ(e)',-10,'l'); 
solution=optimizeCbModel(suc_model); 
growth_rates(7)=solution.f; 
 
%Lactose 
lco_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
lco_model = changeRxnBounds(lco_model,'EX_lcts(e)',-10,'l'); 
solution=optimizeCbModel(lco_model); 
growth_rates(8)=solution.f; 
 
%Malate 
mal_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
mal_model = changeRxnBounds(mal_model,'EX_mal-L(e)',-10,'l'); 
solution=optimizeCbModel(mal_model); 
growth_rates(9)=solution.f; 
 
%Mannose 
man_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
man_model = changeRxnBounds(man_model,'EX_man(e)',-10,'l'); 
solution=optimizeCbModel(man_model); 
growth_rates(10)=solution.f; 
 
%Lactate 
lca_model = changeRxnBounds(model,'EX_glc(e)',0,'l'); 
lca_model = changeRxnBounds(lca_model,'EX_lac-D(e)',-10,'l'); 
solution=optimizeCbModel(lca_model); 
growth_rates(11)=solution.f; 
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Supplementary File A.1 (cont.) 
 
%Print out the responses 
fprintf('\n\n'); 
for i=1:length(growth_rates) 
   fprintf('%s: %f\n',substrates{i},growth_rates(i)) 
end 
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Appendix B: Supporting Information for Chapter 3 
Table B.1: iMR540 Reaction Information.  A list of every reaction in the iMR540 reconstruction, including the 
subsystem, ProbAnno likelihood score (if applicable), and the origin tag. The origin tag shows how a particular 
reaction was added to the reconstruction; “Kbase” reactions were part of the automated Kbase reconstruction and 
are associated with genes; “Exchange” reactions are non-enzymatic reactions that allow for uptake or secretion of 
a particular compound by the model; “Physiological” reactions are transport reactions that lack genes but are 
known to function in the organism; “GapFill” reactions lack any genetic information and were added only to enable 
growth of the model; “Manual Addition” reactions were added during manual curation and tie to a particular 
literature reference. 
Reaction ID Subsystem Likelihood Origin Tag 
rxn02483[c0] 
Protocatechuate branch of beta-ketoadipate 
pathway 
0.88062 KBase 
rxn00802[c0] Arginine Biosynthesis 0.9853 KBase 
rxn03638[c0] Peptidoglycan Biosynthesis 0.48895 KBase 
rxn06078[c0] Methionine Biosynthesis 0.50441 KBase 
rxn12636[c0] Protein Degradation 0.96997 KBase 
rxn12644[c0] Protein Degradation 0.96997 KBase 
rxn03492[c0] Coenzyme B12 Biosynthesis 0.9489 KBase 
rxn05616[c0] Transport 0.97285 KBase 
rxn02212[c0] Chorismate Synthesis 0.97879 KBase 
rxn03419[c0] Folate Biosynthesis 0.97092 KBase 
rxn03052[c0] Methionine Biosynthesis 0.94502 KBase 
rxn00248[c0] Glyoxylate Bypass 0.8752 KBase 
rxn01302[c0] Methionine Biosynthesis 0.98208 KBase 
rxn00048[c0] Riboflavin, FMN, and FAD Metabolism 0.94926 KBase 
rxn05229[c0] De Novo Purine Biosynthesis 0.00333 KBase 
rxn12637[c0] Protein Degradation 0.96997 KBase 
rxn00321[c0] Lysine Degradation 0.99311 KBase 
rxn07586[c0] Coenzyme B12 Biosynthesis 0.94767 KBase 
rxn00902[c0] Branched Chain Amino Acid Biosynthesis 0.90003 KBase 
rxn00952[c0] Methionine Biosynthesis 0.50441 KBase 
rxn10230[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn02056[c0] Heme and Siroheme Biosynthesis 0.80225 KBase 
rxn00459[c0] Glycolysis and Gluconeogenesis 0.99813 KBase 
rxn10225[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn08311[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn01101[c0] Serine Biosynthesis 0.98582 KBase 
rxn00302[c0] Folate Biosynthesis 0.97092 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn05145[c0] Transport 0.97637 KBase 
rxn02988[c0] NAD/NADP Cofactor Biosynthesis 0.9893 KBase 
rxn07307[c0] Coenzyme M Biosynthesis 0.67663 KBase 
rxn02937[c0] De Novo Purine Biosynthesis 0.98495 KBase 
rxn00558[c0] Glycolysis and Gluconeogenesis 0.9821 KBase 
rxn01406[c0] Polyamine Metabolism 0.98966 KBase 
rxn00187[c0] 
Glutamine/Glutamate/Aspartate/Asparagine 
Biosynthesis 
0.99374 KBase 
rxn01200[c0] Pentose Phosphate Pathway 0.99527 KBase 
rxn05232[c0] Ribonucleotide Reduction 0.98946 KBase 
rxn00835[c0] Purine Conversions 0.20243 KBase 
rxn12844[c0] Protein Degradation 0.96997 KBase 
rxn01678[c0] Purine Conversions 0.98101 KBase 
rxn09208[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn10060[c0] NAD/NADP Cofactor Biosynthesis 0.98373 KBase 
rxn00100[c0] Coenzyme A Biosynthesis 0.90055 KBase 
rxn01018[c0] De Novo Pyrimidine Synthesis 0.99141 KBase 
rxn00806[c0] Branched Chain Amino Acid Biosynthesis 0.99416 KBase 
rxn02834[c0] Histidine Biosynthesis 0.95873 KBase 
rxn02341[c0] Coenzyme A Biosynthesis 0.97835 KBase 
rxn03175[c0] Histidine Biosynthesis 0.99177 KBase 
rxn00786[c0] Glycolysis and Gluconeogenesis 0.87243 KBase 
rxn01637[c0] Arginine Biosynthesis 0.94924 KBase 
rxn12640[c0] Protein Degradation 0.96997 KBase 
rxn05596[c0] Transport 0.95817 KBase 
rxn02569[c0] Selenocysteine Metabolism 0.96793 KBase 
rxn00710[c0] De Novo Pyrimidine Synthesis 0.93781 KBase 
rxn02775[c0] Coenzyme B12 Biosynthesis 0.96483 KBase 
rxn07589[c0] Coenzyme B12 Biosynthesis 0.88424 KBase 
rxn00717[c0] Creatine and Creatinine Degradation 0.77609 KBase 
rxn10308[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn05249[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn02897[c0] Coenzyme B12 Biosynthesis 0.95937 KBase 
rxn03409[c0] Peptidoglycan Biosynthesis 0.99374 KBase 
rxn01301[c0] Methionine Biosynthesis 0.98208 KBase 
rxn07191[c0] Glycolysis and Gluconeogenesis 0.96817 KBase 
rxn04046[c0] Coenzyme B12 Biosynthesis 0.96483 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn13782[c0] Ribosome LSU (Bacteria) 0.00038752 Exchange 
rxn03407[c0] Peptidoglycan Biosynthesis 0.99374 KBase 
rxn01682[c0] Tryptophan Synthesis 0.98441 KBase 
rxn02474[c0] Riboflavin, FMN, and FAD Metabolism 0.94073 KBase 
rxn10311[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn01486[c0] Archaeal Lipids 0.45251 KBase 
rxn00898[c0] Branched Chain Amino Acid Biosynthesis 0.99544 KBase 
rxn01069[c0] Threonine and Homoserine Biosynthesis 0.98565 KBase 
rxn02113[c0] Acetoin, Butanediol Metabolism 0.96586 KBase 
rxn00117[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn00555[c0] 
Formaldehyde Assimilation: Ribulose 
Monophosphate Pathway 
0.99786 KBase 
rxn00260[c0] Amino Acid Biosynthesis 0.70583 KBase 
rxn02484[c0] Thiamin Biosynthesis 0.93366 KBase 
rxn00527[c0] Amino Acid Biosynthesis 0.73289 KBase 
rxn05171[c0] Transport 0.85897 KBase 
rxn04052[c0] Coenzyme B12 Biosynthesis 0.9769 KBase 
rxn13783[c0] DNA-Replication 0.11123 Exchange 
rxn04045[c0] Coenzyme B12 Biosynthesis 0.74202 KBase 
rxn01974[c0] Lysine Biosynthesis DAP Pathway 0.97692 KBase 
rxn12645[c0] Protein Degradation 0.96997 KBase 
rxn00299[c0] Folate Biosynthesis 0.97092 KBase 
rxn00839[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn03020[c0] Methanogenesis 0.94658 KBase 
rxn00283[c0] Alanine Biosynthesis 0.99196 KBase 
rxn01022[c0] Methionine Salvage 0.84713 KBase 
rxn10221[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn09177[c0] Coenzyme A Biosynthesis 0.9768 KBase 
rxn03437[c0] Branched Chain Amino Acid Biosynthesis 0.99544 KBase 
rxn02320[c0] Histidine Biosynthesis 0.73289 KBase 
rxn07587[c0] Coenzyme B12 Biosynthesis 0.98662 KBase 
rxn02507[c0] Tryptophan Synthesis 0.97169 KBase 
rxn00669[c0] Protein Acetylation and Deacetylation in Bacteria 0.048616 KBase 
rxn01333[c0] 
Folate Biosynthesis; Pentose Phosphate 
Pathway 
0.99215 KBase 
rxn00714[c0] Pyrimidine Conversions 0.94633 KBase 
rxn01434[c0] Arginine Biosynthesis 0.99306 KBase 
rxn01116[c0] Pentose Phosphate Pathway 0.98379 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn08308[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn00409[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn02213[c0] Chorismate Synthesis 0.92886 KBase 
rxn03062[c0] Branched Chain Amino Acid Biosynthesis 0.51651 KBase 
rxn03446[c0] Threonine and Homoserine Biosynthesis 0.98565 KBase 
rxn01519[c0] Folate Biosynthesis 0.85571 KBase 
rxn00029[c0] Heme and Siroheme Biosynthesis 0.99335 KBase 
rxn03491[c0] Coenzyme B12 Biosynthesis 0.88424 KBase 
rxn01964[c0] Tryptophan Synthesis 0.98441 KBase 
rxn12510[c0] Coenzyme A Biosynthesis 0.91028 KBase 
rxn09207[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn02380[c0] Glycolysis and Gluconeogenesis 0.9821 KBase 
rxn00474[c0] Tryptophan Synthesis 0.98441 KBase 
rxn03435[c0] 
Coenzyme A Biosynthesis; Branched Chain 
Amino Acid Biosynthesis 
0.99321 KBase 
rxn01673[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn12845[c0] Protein Degradation 0.96997 KBase 
rxn00085[c0] 
Glutamine/Glutamate/Aspartate/Asparagine 
Biosynthesis 
0.018434 KBase 
rxn00832[c0] De Novo Purine Biosynthesis 0.90124 KBase 
rxn00295[c0] N-Linked Glycosylation in Bacteria 0.90807 KBase 
rxn02187[c0] Valine, Leucine, and Isoleucine Biosynthesis 0.99321 KBase 
rxn01219[c0] Pyrimidine Conversions 0.013479 KBase 
rxn03514[c0] Coenzyme B12 Biosynthesis 0.99463 KBase 
rxn01270[c0] 
Phenylalanine and Tyrosine Branches from 
Chorismate 
0.61235 KBase 
rxn08309[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn08312[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn05144[c0] Pyridoxin(Vitamin B6) Biosynthesis 0.99374 KBase 
rxn00410[c0] Pyrimidine Conversions 0.98711 KBase 
rxn05221[c0] Transport 0.93923 KBase 
rxn09210[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn00782[c0] Glycolysis and Gluconeogenesis 0.97885 KBase 
rxn01607[c0] Isoprenoid Biosynthesis; Archaeal Lipids 0.88752 KBase 
rxn01000[c0] 
Phenylalanine and Tyrosine Branches from 
Chorismate 
0.96216 KBase 
rxn00675[c0] Protein Acetylation and Deacetylation in Bacteria 0.95498 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn02305[c0] Thiamin Biosynthesis 0.93774 KBase 
rxn02296[c0] Biotin Biosynthesis 0.84669 KBase 
rxn12641[c0] Protein Degradation 0.96997 KBase 
rxn10315[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn00711[c0] De Novo Pyrimidine Synthesis 0.57872 KBase 
rxn10309[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn12633[c0] Protein Degradation 0.96997 KBase 
rxn05250[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn03174[c0] Folate Biosynthesis 0.97092 KBase 
rxn00763[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.70296 KBase 
rxn00138[c0] NAD/NADP Cofactor Biosynthesis 0.95103 KBase 
rxn03136[c0] De Novo Purine Biosynthesis 0.98898 KBase 
rxn05165[c0] Transport 0.42544 KBase 
rxn00988[c0] 
Branched Chain Amino Acid Degradation 
Regulons 
0.38842 KBase 
rxn05236[c0] Ribonucleotide Reduction 0.98946 KBase 
rxn02835[c0] Histidine Biosynthesis 0.95605 KBase 
rxn00726[c0] Tryptophan Synthesis 0.78102 KBase 
rxn03147[c0] De Novo Purine Biosynthesis 0.98117 KBase 
rxn00650[c0] Protein Degradation 0.96997 KBase 
rxn01241[c0] TCA Cycle 0.79008 KBase 
rxn10229[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn00776[c0] 
tRNA Modification (Bacteria); rRNA Modification 
(Bacteria) 
0.69547 KBase 
rxn12646[c0] Protein Degradation 0.96997 KBase 
rxn09296[c0] 
Glycine Reductase, Sarcosine Reductase, and 
Betaine Reductase 
0.88497 KBase 
rxn01255[c0] Chorismate Synthesis 0.98883 KBase 
rxn03194[c0] 
Branched Chain Amino Acid Biosynthesis; 
Acetoin, Butanediol Metabolism 
0.99106 KBase 
rxn10222[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn11938[c0] Methanogenesis 0.72926 KBase 
rxn02287[c0] Coenzyme B12 Biosynthesis N/A KBase 
rxn02475[c0] Riboflavin, FMN, and FAD Metabolism 0.58589 KBase 
rxn00147[c0] Glycolysis and Gluconeogenesis 0.99536 KBase 
rxn02774[c0] Heme and Siroheme Biosynthesis N/A KBase 
rxn05172[c0] Transport 0.85897 KBase 
rxn03057[c0] Methionine Salvage 0.97695 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn01485[c0] Sialic Acid Metabolism 0.92655 KBase 
rxn13784[c0] tRNA Modification (Bacteria) 0.0056246 Exchange 
rxn00245[c0] None 0.65051 KBase 
rxn01629[c0] Heme and Siroheme Biosynthesis 0.98625 KBase 
rxn06874[c0] Nitrogen Fixation 0.79028 KBase 
rxn06299[c0] Methanogenesis 0.5754 KBase 
rxn05313[c0] Transport 0.93518 KBase 
rxn00966[c0] Ubiquionine Biosynthesis 0 KBase 
rxn00785[c0] Pentose Phosphate Pathway 0.99527 KBase 
rxn03084[c0] De Novo Purine Biosynthesis 0.98232 KBase 
rxn00011[c0] Methionine Degradation 0.99106 KBase 
rxn00292[c0] Sialic Acid Metabolism 0.92219 KBase 
rxn05252[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn05155[c0] Transport 0.0081148 KBase 
rxn01513[c0] Pyrimidine Conversions 0.93655 KBase 
rxn02476[c0] Chorismate Synthesis 0.98355 KBase 
rxn01575[c0] Amino Acid Biosynthesis 0.99416 KBase 
rxn09206[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn00781[c0] Glycolysis and Gluconeogenesis 0.97885 KBase 
rxn05181[c0] Transport 0.54463 KBase 
rxn00775[c0] NAD/NADP Cofactor Biosynthesis 0.73175 KBase 
rxn00364[c0] Pyrimidine Conversions 0.013479 KBase 
rxn00515[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn01025[c0] Pyrimidine Conversions 0.77609 KBase 
rxn02186[c0] 
Coenzyme A Biosynthesis; Branched Chain 
Amino Acid Biosynthesis 
0.99321 KBase 
rxn10227[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn12846[c0] Protein Degradation 0.96997 KBase 
rxn05201[c0] Transport 0.93382 KBase 
rxn02789[c0] Branched Chain Amino Acid Biosynthesis 0.93134 KBase 
rxn00830[c0] Isoprenoid Biosynthesis; Archaeal Lipids 0.98633 KBase 
rxn08180[c0] Biotin Biosynthesis 0.97418 KBase 
rxn00800[c0] De Novo Purine Biosynthesis 0.98898 KBase 
rxn05234[c0] Ribonucleotide Reduction 0.98946 KBase 
rxn01465[c0] De Novo Pyrimidine Synthesis 0.97705 KBase 
rxn00863[c0] Histidine Biosynthesis 0.99292 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn09449[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn03436[c0] 
Coenzyme A Biosynthesis; Branched Chain 
Amino Acid Biosynthesis 
0.99321 KBase 
rxn08307[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn05555[c0] Transport 0.9818 KBase 
rxn02159[c0] Histidine Biosynthesis 0.99292 KBase 
rxn00727[c0] Tryptophan Synthesis 0.78102 KBase 
rxn04385[c0] Coenzyme B12 Biosynthesis 0.56063 KBase 
rxn01300[c0] Methionine Biosynthesis 0.96931 KBase 
rxn00175[c0] 
Pyruvate Metabolism II: Acetyl-CoA, 
Acetogenesis from Pyruvate 
0.95498 KBase 
rxn06979[c0] Coenzyme B12 Biosynthesis 0.9818 KBase 
rxn12642[c0] Protein Degradation 0.96997 KBase 
rxn05247[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn00986[c0] Protein Acetylation and Deacetylation in Bacteria 0.95498 KBase 
rxn07588[c0] Coenzyme B12 Biosynthesis 0.75984 KBase 
rxn10473[c0] Transport 0 Physiological 
rxn05559[c0] Transport 0.53231 KBase 
rxn03068[c0] 
Coenzyme A Biosynthesis; Branched Chain 
Amino Acid Biosynthesis 
0.99321 KBase 
rxn12634[c0] Protein Degradation 0.96997 KBase 
rxn01269[c0] Chorismate Synthesis 0.69666 KBase 
rxn04048[c0] Coenzyme B12 Biosynthesis 0.99463 KBase 
rxn00278[c0] Pyruvate Alanine Serine Interconversions 0.9872 KBase 
rxn00790[c0] De Novo Purine Biosynthesis 0.99413 KBase 
rxn00060[c0] Heme and Siroheme Biosynthesis 0.972 KBase 
rxn04050[c0] Coenzyme B12 Biosynthesis 0.9489 KBase 
rxn02473[c0] Histidine Biosynthesis 0.99173 KBase 
rxn00834[c0] Purine Conversions 0.96349 KBase 
rxn12639[c0] Protein Degradation 0.96997 KBase 
rxn03080[c0] Riboflavin, FMN, and FAD Metabolism 0.96251 KBase 
rxn03085[c0] Methanogenesis 0.94026 KBase 
rxn02297[c0] Sphingolipid Biosynthesis; Biotin Biosynthesis 0.59355 KBase 
rxn05040[c0] Riboflavin, FMN, and FAD Metabolism 0.67922 KBase 
rxn00105[c0] NAD/NADP Cofactor Biosynthesis 0.95417 KBase 
rxn00799[c0] TCA Cycle 0.68542 KBase 
rxn00313[c0] Lysine Biosynthesis DAP Pathway 0.98454 KBase 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn10226[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn05248[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn10223[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn00285[c0] TCA Cycle 0.98828 KBase 
rxn10307[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn00770[c0] 
Pentose Phosphate Pathway; De Novo Purine 
Biosynthesis 
0.97264 KBase 
rxn00192[c0] Arginine Biosynthesis 0.9197 KBase 
rxn05938[c0] Pyruvate:Ferredoxin Oxidoreductase 0.95261 KBase 
rxn00211[c0] 
Sucrose Metabolism; Teichuronic Acid 
Biosynthesis 
0.84935 KBase 
rxn04783[c0] De Novo Purine Biosynthesis 0.98317 KBase 
rxn01739[c0] Chorismate Synthesis 0.93 KBase 
rxn00543[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.70296 KBase 
rxn05235[c0] Ribonucleotide Reduction 0.98946 KBase 
rxn06591[c0] Heme and Siroheme Biosynthesis 0.98094 KBase 
rxn00126[c0] Methionine Biosynthesis 0.98957 KBase 
rxn00414[c0] De Novo Pyrimidine Synthesis 0.99921 KBase 
rxn06937[c0] 
tRNA Aminoacylation; Heme and Siroheme 
Biosynthesis 
0.60018 KBase 
rxn03127[c0] Methanogenesis 0.9704 KBase 
rxn10312[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn02508[c0] Tryptophan Synthesis 0.92342 KBase 
rxn00127[c0] Polyamine Metabolism 0.95061 KBase 
rxn05251[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn02938[c0] De Novo Purine Biosynthesis 0.98415 KBase 
rxn00139[c0] cAMP Signaling in Bacteria; Purine Conversions 0.98654 KBase 
rxn05736[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn05527[c0] Transport 0.76394 KBase 
rxn02465[c0] Arginine Biosynthesis 0.9949 KBase 
rxn09205[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn05957[c0] Methionine Biosynthesis 0 KBase 
rxn03513[c0] Coenzyme B12 Biosynthesis 0.97411 KBase 
rxn00549[c0] Glycolysis and Gluconeogenesis 0.97936 KBase 
rxn01257[c0] Folate Biosynthesis; Tryptophan Synthesis 0.78102 KBase 
rxn01740[c0] Chorismate Synthesis 0.82226 KBase 
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rxn12847[c0] Protein Degradation 0.96997 KBase 
rxn00416[c0] 
Glutamine/Glutamate/Aspartate/Asparagine 
Biosynthesis 
0.9234 KBase 
rxn01620[c0] L-Fucose Utilization 0.15504 KBase 
rxn00903[c0] Amino Acid Biosynthesis 0.99416 KBase 
rxn00947[c0] HMG CoA Synthesis 0.51238 KBase 
rxn10310[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn00838[c0] Histidine Biosynthesis; Purine Conversions 0.98617 KBase 
rxn00297[c0] Sialic Acid Metabolism 0.92219 KBase 
rxn00065[c0] cAMP Signaling in Bacteria 0.88581 KBase 
rxn00141[c0] Methionine Biosynthesis/Degradation 0.99086 KBase 
rxn01454[c0] Isoprenoid Biosynthesis; Archaeal Lipids 0.97027 KBase 
rxn00337[c0] 
Lysine Biosynthesis DAP Pathway; Threonine 
and Homoserine Biosynthesis 
0.71791 KBase 
rxn00777[c0] Pentose Phosphate Pathway 0.98497 KBase 
rxn01512[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn01466[c0] Archaeal Lipids 0.12187 KBase 
rxn02185[c0] 
Branched Chain Amino Acid Synthesis; Acetoin, 
Butanediol Metabolism 
0.99106 KBase 
rxn03406[c0] 
Peptidoglycan Biosynthesis; Amino Acid 
Biosynthesis 
0.99374 KBase 
rxn01106[c0] 
Glycolysis and Gluconeogenesis; Theronine and 
Homoserine Biosynthesis 
0.6879 KBase 
rxn00293[c0] Peptidoglycan Biosynthesis 0.48895 KBase 
rxn05740[c0] Glycogen Metabolism 0.96109 KBase 
rxn11544[c0] Coenzyme B12 Biosynthesis 0.9818 KBase 
rxn02277[c0] Biotin Biosynthesis 0.95841 KBase 
rxn12638[c0] Protein Degradation 0.96997 KBase 
rxn02480[c0] Methanogenesis 0.97999 KBase 
rxn12643[c0] Protein Degradation 0.96997 KBase 
rxn03079[c0] Methanogenesis 0.96121 KBase 
rxn02264[c0] Heme and Siroheme Biosynthesis 0.92227 KBase 
rxn05209[c0] Transport 0.2944 KBase 
rxn08306[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn00148[c0] Glycolysis and Gluconeogenesis 0.99132 KBase 
rxn00214[c0] N-Linked Glycosylation in Bacteria 0.90807 KBase 
rxn05197[c0] Transport 0.2031 KBase 
rxn05289[c0] 
Thioredoxin-disulfide Reductase; Pyrimidine 
Conversions 
0.95363 KBase 
rxn10228[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
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Reaction ID Subsystem Likelihood Origin Tag 
rxn01977[c0] Glycolysis and Gluconeogenesis 0.9821 KBase 
rxn09448[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn03421[c0] Folate Biosynthesis 0.97092 KBase 
rxn12635[c0] Protein Degradation 0.96997 KBase 
rxn00213[c0] Sucrose Metabolism 0.98642 KBase 
rxn10314[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn00493[c0] Amino Acid Biosynthesis 0.61235 KBase 
rxn00789[c0] Histidine Biosynthesis 0.98209 KBase 
rxn06077[c0] Peptide Methionine Sufoxide Reductase 0.95249 KBase 
rxn02895[c0] De Novo Purine Biosynthesis 0.99089 KBase 
rxn09211[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn02312[c0] Biotin Biosynthesis 0.94916 KBase 
rxn00438[c0] Thiamin Biosynthesis 0.9588 KBase 
rxn10474[c0] Transport 0.97285 KBase 
rxn01643[c0] 
Lysine Biosynthesis; Threonine and Homoserine 
Biosynthesis 
0.98215 KBase 
rxn09209[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn02431[c0] Methanogenesis 0.94866 KBase 
rxn01999[c0] None 0 KBase 
rxn01362[c0] De Novo Pyrimidine Synthesis 0.9532 KBase 
rxn06493[c0] Glycine and Serine Utilization 0.79008 KBase 
rxn02402[c0] NAD/NADP Cofactor Biosynthesis 0.96992 KBase 
rxn10224[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn10231[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.98565 KBase 
rxn02811[c0] Branched Chain Amino Acid Biosynthesis 0.93134 KBase 
rxn05939[c0] TCA Cycle 0 KBase 
rxn01019[c0] Arginine Biosynthesis 0.9882 KBase 
rxn00412[c0] Pyrimidine Conversions 0.98711 KBase 
rxn08310[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn03135[c0] Histidine Biosynthesis 0.99701 KBase 
rxn00469[c0] Arginine Biosynthesis 0.7241 KBase 
rxn12512[c0] Coenzyme A Biosynthesis 0.9768 KBase 
rxn00791[c0] Tryptophan Synthesis 0.98709 KBase 
rxn08040[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn01636[c0] Arginine Biosynthesis 0.988 KBase 
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rxn00914[c0] Purine Conversions 0.20243 KBase 
rxn03843[c0] Isoprenoid Biosynthesis 0.40242 KBase 
rxn01329[c0] Mannose Metabolism 0.84904 KBase 
rxn04047[c0] Coenzyme B12 Biosynthesis 0.97411 KBase 
rxn05177[c0] Transport 0.031108 KBase 
rxn01353[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn00077[c0] NAD/NADP Cofactor Biosynthesis 0.98373 KBase 
rxn05667[c0] Transport 0 Physiological 
rxn09450[c0] 
Unsaturated Fatty Acid Biosynthesis; Biotin 
Biosynthesis 
0.51238 KBase 
rxn01213[c0] Archaeal Lipids 0.12187 KBase 
rxn01917[c0] Arginine Biosynthesis 0.99531 KBase 
rxn01100[c0] Glycolysis and Gluconeogenesis 0.98697 KBase 
rxn02339[c0] Amino Acid Biosynthesis 0.70583 KBase 
rxn02175[c0] Coenzyme A Biosynthesis 0.87611 KBase 
rxn00288[c0] Succinate Dehydrogenase 0.59016 KBase 
rxn01790[c0] 
Coenzyme A Biosynthesis; Branched Chain 
Amino Acid Biosynthesis 
0.99321 KBase 
rxn03075[c0] Thiamin Biosynthesis 0.98662 KBase 
rxn00747[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.95959 KBase 
rxn00707[c0] Pyrimidine Conversions 0.013479 KBase 
rxn03108[c0] Thiamin Biosynthesis 0.93366 KBase 
rxn03512[c0] Coenzyme B12 Synthesis 0.9769 KBase 
rxn00237[c0] Purine Conversions; Pyrimidine Conversions 0.98101 KBase 
rxn00420[c0] 
Glycine and Serine Utilization; Serine 
Biosynthesis 
0.9911 KBase 
rxn00001[c0] HPr Catabolite Repression System 0.9822 KBase 
rxn10313[c0] Teichoic and Lipoteichoic Acids Biosynthesis 0.39392 KBase 
rxn01268[c0] Chorismate Synthesis 0.69666 KBase 
rxn10220[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.15173 KBase 
rxn00858[c0] 
Polyamine Metabnolism; Arginine and Ornithine 
Degradation 
0.98397 KBase 
rxn10571[c0] Transport N/A Physiological 
rxn05195[c0] Transport N/A Physiological 
rxn00062[c0] Non-Growth Associated Maintenance N/A Gapfill 
rxn01208[c0] None N/A Gapfill 
rxn05319[c0] Transport N/A Physiological 
rxn05467[c0] Transport N/A Physiological 
rxn03393[c0] Hydroxyaromatic Decarboxylase Family 0.96944 KBase 
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rxn00623[c0] Sulfate Assimilation 0.004751 KBase 
rxn02832[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn10052[c0] Purine Conversions 0 Gapfill 
rxn05388[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn05359[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn02288[c0] Heme and Siroheme Biosynthesis 0.91453 KBase 
rxn08766[c0] None 0.0027405 KBase 
rxn08019[c0] None N/A Gapfill 
rxn00737[c0] Branched Chain Amino Acid Biosynthesis 0 Gapfill 
rxn05396[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn05029[c0] Coenzyme B12 Biosynthesis 0 Gapfill 
rxn10181[c0] Transport 0 Physiological 
rxn01675[c0] dTDP-Rhamnose Synthesis 0.19741 KBase 
rxn01644[c0] Lysine Biosynthesis DAP Pathway 0.021161 KBase 
rxn01997[c0] dTDP-Rhamnose Synthesis 0.015835 KBase 
rxn05379[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn05371[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn00300[c0] Riboflavin, FMN, and FAD Metabolism 0.39555 KBase 
rxn00392[c0] Ubiquionine Biosynthesis 0 Gapfill 
rxn03397[c0] Ubiquionine Biosynthesis 0.68382 KBase 
rxn10481[c0] Transport 0.92767 KBase 
rxn13477[c0] None N/A Gapfill 
rxn10954[c0] None N/A Gapfill 
rxn02914[c0] 
Glycine and Serine Utilization; Serine 
Biosynthesis; Pyridoxin Biosynthesis 
0.0098046 KBase 
rxn00350[c0] 
Glutathione: Biosynthesis and gamma-Glutamyl 
Cycle 
0 Gapfill 
rxn03536[c0] Coenzyme B12 Biosynthesis 0 Gapfill 
rxn05054[c0] Coenzyme B12 Biosynthesis 0.8679 KBase 
rxn02160[c0] Histidine Biosynthesis 0.2019 KBase 
rxn12008[c0] Polyprenyl Diphosphate Biosynthesis 0.12187 KBase 
rxn05039[c0] Riboflavin, FMN, and FAD Metabolism 0 Gapfill 
rxn02269[c0] None N/A Gapfill 
rxn03891[c0] Polyprenyl Diphosphate Biosynthesis 0.12187 KBase 
rxn01256[c0] Chorismate Synthesis; Phenylalanine Synthesis 0 Gapfill 
rxn00102[c0] CO2 Uptake, Carboxysome 0.91831 KBase 
rxn09562[c0] Purine Conversions 0 Gapfill 
rxn01972[c0] Lysine Biosynthesis DAP Pathway 0 Gapfill 
rxn05513[c0] Transport N/A Physiological 
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rxn03537[c0] Coenzyme B12 Biosynthesis 0 Gapfill 
rxn03030[c0] Lysine Biosynthesis DAP Pathway 0.8817 KBase 
rxn00119[c0] None 0.81695 KBase 
rxn01265[c0] NAD/NADP Cofactor Biosynthesis 0 Gapfill 
rxn03919[c0] LOS Core Oligosaccharide Biosynthesis 0.033534 KBase 
rxn01068[c0] Threonine Degradation; Glycine Biosynthesis 0 Gapfill 
rxn05384[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn02831[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn11650[c0] Coenzyme B12 Biosynthesis 0.75905 KBase 
rxn00137[c0] Inorganic Sulfur Assimilation 0 Gapfill 
rxn03150[c0] Coenzyme B12 Biosynthesis 0 Gapfill 
rxn00172[c0] 
Pyruvate Metabolism II: Acetyl-CoA, 
Acetogenesis from Pyruvate 
0.020916 KBase 
rxn00917[c0] Purine Conversions 0.89297 KBase 
rxn00274[c0] 
Glycine and Serine Utilization; Threonine 
Degradation; Glycine Biosynthesis 
0.39144 KBase 
rxn05400[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn03540[c0] Coenzyme B12 Biosynthesis 0.81527 KBase 
rxn01538[c0] Thiamin Biosynthesis 0 Gapfill 
rxn05404[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn05392[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn05367[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn03408[c0] Peptidoglycan Biosynthesis 0.59921 KBase 
rxn06729[c0] KDO2-Lipid A Biosynthesis 0.0012682 KBase 
rxn00470[c0] 
Polyamine Metabolism; Arginine and Ornithine 
Degradation 
0 Gapfill 
rxn06023[c0] Fatty Acid Biosynthesis 0 Gapfill 
rxn00086[c0] Glutathione: Redox Cycle 0.034515 KBase 
rxn03086[c0] Lysine Biosynthesis DAP Pathway 0.17646 KBase 
rxn01332[c0] Chorismate Synthesis 0.0087099 KBase 
rxn03904[c0] Peptidoglycan Biosynthesis 0.080091 KBase 
rxn08618[c0] LOS core oligosaccharide biosynthesis 0.0097104 KBase 
rxn00833[c0] None N/A Gapfill 
rxn01258[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn00611[c0] Isoprenoid Biosynthesis; Archaeal Lipids 0 Gapfill 
rxn00122[c0] Riboflavin, FMN, and FAD Metabolism 0 Gapfill 
rxn01117[c0] KDO2-Lipid A Biosynthesis 0.23112 KBase 
rxn04675[c0] None N/A Gapfill 
rxn05735[c0] 
Glycerolipid and Glycerophospholipid 
Metabolism (Bacteria) 
0.26823 KBase 
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rxn02929[c0] Lysine Biosynthesis DAP Pathway 0.34429 KBase 
rxn05375[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn09128[c0] Triacylglycerol Metabolism 0.0016864 KBase 
rxn05363[c0] Fatty Acid Biosynthesis 0.012453 KBase 
rxn02898[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn03538[c0] 
Coenzyme B12 Biosynthesis; Heme and 
Siroheme Biosynthesis 
0.86044 KBase 
rxn08349[c0] None N/A Gapfill 
rxn05023[c0] None 0 Gapfill 
rxn00471[c0] 
Threonine Degradation; Arginine and Ornithine 
Degradation 
0 Gapfill 
rxn09429[c0] None N/A Gapfill 
rxn00346[c0] Coenzyme A Biosynthesis 0 Gapfill 
rxn00351[c0] Glutathione Biosynthesis 0.025131 KBase 
rxn01791[c0] Coenzyme A Biosynthesis 0.0038642 KBase 
rxn01501[c0] Isoprenoid Biosynthesis; Archaeal Lipids 0.96521 KBase 
rxn00250[c0] 
Pyruvate Metabolism I: Anaplerotic Reactions, 
PEP 
0.34522 KBase 
rxn00646[c0] Glutathione Biosynthesis 0.14345 KBase 
rxn05466[c0] Transport 0.84551 KBase 
rxn09433[c0] None N/A Gapfill 
rxn05287[c0] Polyprenyl Diphosphate Biosynthesis 0.13405 KBase 
rxn11703[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn05108[c0] Methionine Salvage 0.093935 KBase 
rxn11702[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn05744[c0] None N/A Gapfill 
rxn03892[c0] Polyprenyl Diphosphate Biosynthesis 0.13405 KBase 
rxn02155[c0] NAD/NADP Cofactor Biosynthesis 0 Gapfill 
rxn00258[c0] None N/A Gapfill 
rxn05104[c0] Methionine Salvage 0.035948 KBase 
rxn05909[c0] None N/A Gapfill 
rxn00157[c0] Formate Hydrogenase 0.030184 KBase 
rxn00178[c0] 
Branched Chain Amino Acid Degradation 
Regulons 
0.39658 KBase 
rxn05024[c0] Menaquinone and Phylloquinone Biosynthesis 0 Gapfill 
rxn00134[c0] Purine Conversions 0.32194 KBase 
biomass0 Exchange N/A Physiological 
EX_cpd00254[e0] Exchange N/A Exchange 
EX_cpd00009[e0] Exchange N/A Exchange 
EX_cpd00067[e0] Exchange N/A Exchange 
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EX_cpd00205[e0] Exchange N/A Exchange 
EX_cpd00209[e0] Exchange N/A Exchange 
EX_cpd00971[e0] Exchange N/A Exchange 
EX_cpd00129[e0] Exchange N/A Exchange 
EX_cpd00210[e0] Exchange N/A Exchange 
EX_cpd00053[e0] Exchange N/A Exchange 
EX_cpd00540[e0] Exchange N/A Exchange 
EX_cpd00226[e0] Exchange N/A Exchange 
EX_cpd10515[e0] Exchange N/A Exchange 
EX_cpd00099[e0] Exchange N/A Exchange 
EX_cpd00047[e0] Exchange N/A Exchange 
EX_cpd00307[e0] Exchange N/A Exchange 
EX_cpd15302[c0] Exchange N/A Exchange 
EX_cpd00092[e0] Exchange N/A Exchange 
EX_cpd00149[e0] Exchange N/A Exchange 
EX_cpd00305[e0] Exchange N/A Exchange 
EX_cpd00073[e0] Exchange N/A Exchange 
EX_cpd10516[e0] Exchange N/A Exchange 
EX_cpd00001[e0] Exchange N/A Exchange 
EX_cpd00011[e0] Exchange N/A Exchange 
EX_cpd11416[c0] Exchange N/A Exchange 
EX_cpd00034[e0] Exchange N/A Exchange 
EX_cpd01741[e0] Exchange N/A Exchange 
EX_cpd00355[e0] Exchange N/A Exchange 
EX_cpd00058[e0] Exchange N/A Exchange 
EX_cpd00558[e0] Exchange N/A Exchange 
EX_cpd00030[e0] Exchange N/A Exchange 
EX_cpd00063[e0] Exchange N/A Exchange 
EX_cpd00655[e0] Exchange N/A Exchange 
EX_cpd15269[e0] Exchange N/A Exchange 
EX_cpd03422[e0] Exchange N/A Exchange 
EX_cpd01080[e0] Exchange N/A Exchange 
EX_cpd00111[e0] Exchange N/A Exchange 
EX_cpd03847[e0] Exchange N/A Exchange 
EX_cpd00013[e0] Exchange N/A Exchange 
EX_cpd01024[e0] Exchange N/A 
Manual 
Addition 
EX_cpd11640[e0] Exchange N/A 
Manual 
Addition 
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HdrABC Methanogenesis N/A 
Manual 
Addition 
Eha/Ehb Methanogenesis N/A 
Manual 
Addition 
rxn04042[c0] Glycolysis N/A 
Manual 
Addition 
rxn04043[c0] Glycolysis N/A 
Manual 
Addition 
rxn04026[c0] Coenzyme M Biosynthesis N/A 
Manual 
Addition 
rxn04934[c0] Coenzyme M Biosynthesis N/A 
Manual 
Addition 
rxn04036[c0] Coenzyme M Biosynthesis N/A 
Manual 
Addition 
rxn07741[c0] None N/A 
Manual 
Addition 
rxn05109[c0] None N/A 
Manual 
Addition 
rxn02749[c0] None N/A 
Manual 
Addition 
rxn02751[c0] None N/A 
Manual 
Addition 
rxn00735[c0] None N/A 
Manual 
Addition 
rxn08043[c0] None N/A 
Manual 
Addition 
rxn08764[c0] None N/A 
Manual 
Addition 
rxn00405[c0] Arginine and Ornithine Degradation 0.0051898 
Manual 
Addition 
EX_cpd00029[e0] Exchange N/A 
Manual 
Addition 
rxn10904[c0] Transport N/A 
Manual 
Addition 
rxn10561[c0] Amino Acid Biosynthesis N/A 
Manual 
Addition 
rxn06696[c0] Methanogenesis N/A 
Manual 
Addition 
ATPS Methanogenesis N/A 
Manual 
Addition 
Fdh Methanogenesis N/A 
Manual 
Addition 
Hdr_formate Methanogenesis N/A 
Manual 
Addition 
rxn00249[c0] None N/A 
Manual 
Addition 
Tfr None N/A 
Manual 
Addition 
EX_cpd00035[e0] Exchange N/A 
Manual 
Addition 
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EX_cpd00117[e0] Exchange N/A 
Manual 
Addition 
rxn05215[c0] Transport 0.0012794 
Manual 
Addition 
rxn13660[c0] Transport N/A 
Manual 
Addition 
EX_cpd00528[e0] Exchange N/A 
Manual 
Addition 
rxn10577[c0] Transport N/A 
Manual 
Addition 
rxn10541[c0] Transport N/A 
Manual 
Addition 
EX_cpd00239[e0] Exchange N/A 
Manual 
Addition 
Dsr-LP Sulfur Assimilation N/A 
Manual 
Addition 
rxn10434[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10608[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10599[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10472[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10612[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10433[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10595[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10468[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10610[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10435[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10596[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10469[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10611[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn11855[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10424[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10425[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
rxn10475[c0] Coenzyme B Biosynthesis N/A 
Manual 
Addition 
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MptA Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
rxn10490[c0] Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
rxn03168[c0] Tetrahydromethanopterin Biosynthesis 0 
Manual 
Addition 
rxn02504[c0] Tetrahydromethanopterin Biosynthesis 0.4811 
Manual 
Addition 
rxn02503[c0] Tetrahydromethanopterin Biosynthesis 0.00024841 
Manual 
Addition 
rxn10446[c0] Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
rxn10491[c0] Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
H4MPTs Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
rxn10432[c0] Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
ADTHs Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
ADTHOR Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
3DHQAT Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
4ADSs Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
4ASDH Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
4ASDHT Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
ABEEs Tetrahydromethanopterin Biosynthesis N/A 
Manual 
Addition 
rxn00979[c0] Glycolate, Glyoxylate Interconversions 0.064954 
Manual 
Addition 
rxn00512[c0] Glycolate, Glyoxylate Interconversions 0.06606 
Manual 
Addition 
rxn00272[c0] Serine-Glyoxylate Cycle 0.25782 
Manual 
Addition 
COMs Coenzyme M Biosynthesis N/A 
Manual 
Addition 
rxn00529[c0] Methanofuran Biosynthesis 0.11606 
Manual 
Addition 
MfnD Methanofuran Biosynthesis N/A 
Manual 
Addition 
MfnB Methanofuran Biosynthesis N/A 
Manual 
Addition 
MfnC Methanofuran Biosynthesis N/A 
Manual 
Addition 
F1Pp Methanofuran Biosynthesis N/A 
Manual 
Addition 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
F1PPc Methanofuran Biosynthesis N/A 
Manual 
Addition 
MFs Methanofuran Biosynthesis N/A 
Manual 
Addition 
rxn10508[c0] Coenzyme F430 Biosynthesis N/A 
Manual 
Addition 
rxn10509[c0] Coenzyme F430 Biosynthesis N/A 
Manual 
Addition 
rxn10510[c0] Coenzyme F430 Biosynthesis N/A 
Manual 
Addition 
rxn10511[c0] Coenzyme F430 Biosynthesis N/A 
Manual 
Addition 
rxn10512[c0] Coenzyme F430 Biosynthesis N/A 
Manual 
Addition 
EX_cpd00244[e0] Exchange N/A 
Manual 
Addition 
rxn05174[c0] Transport 0 
Manual 
Addition 
rxn00097[c0] Purine Conversions 0 
Manual 
Addition 
rxn10499[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn01053[c0] Coenzyme F420 Biosynthesis 0.10008 
Manual 
Addition 
rxn10567[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn10420[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn10566[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn10525[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn10526[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn10527[c0] Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn05734[c0] Methylglyoxal Metabolism 0.26823 
Manual 
Addition 
rxn01361[c0] De Novo Pyrimidine Synthesis N/A 
Manual 
Addition 
CODH None N/A 
Manual 
Addition 
ACS None N/A 
Manual 
Addition 
rxn10480[c0] Transport N/A 
Manual 
Addition 
EX_cpd00204[e0] Exchange N/A 
Manual 
Addition 
FNO None N/A 
Manual 
Addition 
 
 
179 
 
Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
EX_cpd00131[e0] Exchange N/A 
Manual 
Addition 
Mot Transport N/A 
Manual 
Addition 
HcyS Methionine Biosynthesis N/A 
Manual 
Addition 
MetS Methionine Biosynthesis N/A 
Manual 
Addition 
rxn02430[c0] None N/A 
Manual 
Addition 
H4MPT3M2Om Coenzyme A Biosynthesis N/A 
Manual 
Addition 
H4MPTdUMPm Pyrimidine Conversions N/A 
Manual 
Addition 
FH4MPTAf De Novo Purine Biosynthesis N/A 
Manual 
Addition 
HPAr Coenzyme F420 Biosynthesis N/A 
Manual 
Addition 
rxn02377[c0] None 0 
Manual 
Addition 
rxn00298[c0] Archaellin Synthesis N/A 
Manual 
Addition 
UGAor Archaellin Synthesis N/A 
Manual 
Addition 
UGNAa Archaellin Synthesis N/A 
Manual 
Addition 
UGNAna Archaellin Synthesis N/A 
Manual 
Addition 
UGNAe Archaellin Synthesis N/A 
Manual 
Addition 
UMNAat Archaellin Synthesis N/A 
Manual 
Addition 
2NACmt Archaellin Synthesis N/A 
Manual 
Addition 
TSot Archaellin Synthesis N/A 
Manual 
Addition 
GLCgt Archaellin Synthesis N/A 
Manual 
Addition 
MANgt Archaellin Synthesis N/A 
Manual 
Addition 
2NACgt Archaellin Synthesis N/A 
Manual 
Addition 
TSost Archaellin Synthesis N/A 
Manual 
Addition 
TSf Transport N/A 
Manual 
Addition 
GALgt Archaellin Synthesis N/A 
Manual 
Addition 
EX_NAC[c0] Exchange N/A 
Manual 
Addition 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
EX_Membrane_lipid[
c0] 
Exchange N/A 
Manual 
Addition 
EX_Flagellin[e0] Exchange N/A 
Manual 
Addition 
rxn10560[c0] Transport N/A 
Manual 
Addition 
rxn10559[c0] Transport N/A 
Manual 
Addition 
rxn10587[c0] Transport N/A 
Manual 
Addition 
rxn10586[c0] Amino Acid Biosynthesis N/A 
Manual 
Addition 
rxn01946[c0] Amino Acid Biosynthesis N/A 
Manual 
Addition 
rxn01842[c0] Amino Acid Biosynthesis 0.043068 
Manual 
Addition 
rxn10563[c0] Amino Acid Biosynthesis N/A 
Manual 
Addition 
rxn10562[c0] Amino Acid Biosynthesis N/A 
Manual 
Addition 
rxn00483[c0] Amino Acid Biosynthesis 0 
Manual 
Addition 
EX_cpd00430[e0] Exchange N/A 
Manual 
Addition 
EX_cpd00489[e0] Exchange N/A 
Manual 
Addition 
EX_cpd00703[e0] Exchange N/A 
Manual 
Addition 
rxn05166[c0] Transport N/A 
Manual 
Addition 
rxn10447[c0] Transport N/A 
Manual 
Addition 
rxn01491[c0] Methylglyoxal Metabolism N/A 
Manual 
Addition 
F6PG3Pl Methylglyoxal Metabolism N/A 
Manual 
Addition 
2OPs Methylglyoxal Metabolism N/A 
Manual 
Addition 
DKFPs1 Methylglyoxal Metabolism N/A 
Manual 
Addition 
DKFPs2 Methylglyoxal Metabolism N/A 
Manual 
Addition 
rxn01618[c0] Methylglyoxal Metabolism 0 
Manual 
Addition 
LAFor Methylglyoxal Metabolism N/A 
Manual 
Addition 
GLYPs Methylglyoxal Metabolism N/A 
Manual 
Addition 
rxn00149[c0] None N/A 
Manual 
Addition 
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Table B.1 (cont.) 
Reaction ID Subsystem Likelihood Origin Tag 
rxn00150[c0] None N/A 
Manual 
Addition 
rxn09249[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
rxn11751[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
rxn11752[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
rxn11950[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
rxn11571[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
rxn07210[c0] Selenocysteine metabolism N/A 
Manual 
Addition 
SELt Transport N/A 
Manual 
Addition 
EX_cpd03396[e0] Exchange N/A 
Manual 
Addition 
EX_cpd15573[c0] Exchange N/A 
Manual 
Addition 
rxn01217[c0] None 0 
Manual 
Addition 
rxn00915[c0] Purine conversions 0.0022985 
Manual 
Addition 
rxn00836[c0] Purine conversions 0.0022985 
Manual 
Addition 
rxn13772[c0] Isoprenoid Biosynthesis; Archaeal Lipids N/A 
Manual 
Addition 
IPk Isoprenoid Biosynthesis; Archaeal Lipids N/A 
Manual 
Addition 
rxn11998[c0] Archaeal Lipids N/A 
Manual 
Addition 
rxn03114[c0] Archaeal Lipids N/A 
Manual 
Addition 
rxn14345[c0] Archaeal Lipids N/A 
Manual 
Addition 
ARCSs Archaeal Lipids N/A 
Manual 
Addition 
CDPDGGR Archaeal Lipids N/A 
Manual 
Addition 
ASDGGR Archaeal Lipids N/A 
Manual 
Addition 
rxn10542[c0] Transport N/A 
Manual 
Addition 
rxn10471[c0] Transport N/A 
Manual 
Addition 
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Table B.2: iMR540 Metabolite Information.  A list of every metabolite in the iMR540 reconstruction, including the 
metabolite ID, name, formula, and charge. Metabolites with the “[c0]” tag are part of the cytosol compartment; 
metabolites with the “[e0]” tag are part of the extracellular compartment.  
Metabolite ID Metabolite Name Formula Charge 
cpd02255[c0] 3-oxoadipate-enol-lactone[c0] C6H5O4 -1 
cpd00067[c0] H[c0] H 1 
cpd00011[c0] CO2[c0] CO2 0 
cpd00938[c0] 4-Carboxymuconolactone[c0] C7H4O6 -2 
cpd02152[c0] L-Argininosuccinate[c0] C10H17N4O6 -1 
cpd00106[c0] Fumarate[c0] C4H2O4 -2 
cpd00051[c0] L-Arginine[c0] C6H15N4O2 1 
cpd03671[c0] D-Glucosamine1-phosphate[c0] C6H14NO8P 0 
cpd02611[c0] N-Acetyl-D-glucosamine1-phosphate[c0] C8H15NO9P -1 
cpd00010[c0] CoA[c0] C21H33N7O16P3S -3 
cpd00022[c0] Acetyl-CoA[c0] C23H35N7O17P3S -3 
cpd11420[c0] trdox[c0] C6H7NO2R2S2 0 
cpd00790[c0] O-Acetyl-L-homoserine[c0] C6H11NO4 0 
cpd00135[c0] Homocysteine[c0] C4H9NO2S 0 
cpd00081[c0] Sulfite[c0] HO3S -1 
cpd00029[c0] Acetate[c0] C2H3O2 -1 
cpd00268[c0] H2S2O3[c0] S2O3 -2 
cpd11421[c0] trdrd[c0] C6H9NO2R2S2 0 
cpd00060[c0] L-Methionine[c0] C5H11NO2S 0 
cpd00001[c0] H2O[c0] H2O 0 
cpd00035[c0] L-Alanine[c0] C3H7NO2 0 
cpd11590[c0] met-L-ala-L[c0] C8H15N2O3S -1 
cpd00161[c0] L-Threonine[c0] C4H9NO3 0 
cpd11582[c0] ala-L-Thr-L[c0] C7H14N2O4 0 
cpd03761[c0] Precorrin_6A[c0] C44H47N4O16 -7 
cpd00006[c0] NADP[c0] C21H26N7O17P3 -2 
cpd03760[c0] Precorrin_6B[c0] C44H49N4O16 -7 
cpd00005[c0] NADPH[c0] C21H27N7O17P3 -3 
cpd00254[e0] Mg[e0] Mg 2 
cpd00254[c0] Mg[c0] Mg 2 
cpd00036[c0] Succinate[c0] C4H4O4 -2 
cpd02857[c0] DAHP[c0] C7H11O10P -2 
cpd00699[c0] 5-Dehydroquinate[c0] C7H9O6 -1 
cpd00009[c0] Phosphate[c0] HO4P -2 
cpd03519[c0] 
2_5-
Diaminopyrimidine_nucleoside_triphosphate[c0] 
C9H15N5O14P3 -3 
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Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
cpd03518[c0] 
Formamidopyrimidine_nucleoside_triphosphate[
c0] 
C10H15N5O15P3 -3 
cpd00047[c0] Formate[c0] CHO2 -1 
cpd02555[c0] Tetrahydropteroyltri-L-glutamate[c0] C29H33N9O12 -4 
cpd02738[c0] 5-Methyltetrahydropteroyltri-L-glutamate[c0] C30H35N9O12 -4 
cpd00130[c0] L-Malate[c0] C4H4O5 -2 
cpd00032[c0] Oxaloacetate[c0] C4H2O5 -2 
cpd00004[c0] NADH[c0] C21H27N7O14P2 -2 
cpd00003[c0] NAD[c0] C21H26N7O14P2 -1 
cpd00346[c0] L-Aspartate4-semialdehyde[c0] C4H7NO3 0 
cpd00227[c0] L-Homoserine[c0] C4H9NO3 0 
cpd02656[c0] 6-7-Dimethyl-8-1-D-ribityllumazine[c0] C13H18N4O6 0 
cpd02882[c0] 4-1-D-Ribitylamino-5-aminouracil[c0] C9H16N4O6 0 
cpd00220[c0] Riboflavin[c0] C17H20N4O6 0 
cpd02893[c0] 
5'-Phosphoribosyl-4-carboxy-5-
aminoimidazole[c0] 
C9H13N3O9P -1 
cpd00002[c0] ATP[c0] C10H13N5O13P3 -3 
cpd00008[c0] ADP[c0] C10H13N5O10P2 -2 
cpd02140[c0] AIR[c0] C8H14N3O7P 0 
cpd00242[c0] H2CO3[c0] CHO3 -1 
cpd11589[c0] gly-asp-L[c0] C6H9N2O5 -1 
cpd00041[c0] L-Aspartate[c0] C4H6NO4 -1 
cpd00033[c0] Glycine[c0] C2H5NO2 0 
cpd00840[c0] L-beta-Lysine[c0] C6H15N2O2 1 
cpd00039[c0] L-Lysine[c0] C6H15N2O2 1 
cpd14960[c0] Cobalt-precorrin_5B[c0] C43H44CoN4O16 -6 
cpd08371[c0] Cobalt-precorrin_5[c0] C45H47CoN4O16 -5 
cpd00071[c0] Acetaldehyde[c0] C2H4O 0 
cpd00123[c0] 3-Methyl-2-oxobutanoate[c0] C5H7O3 -1 
cpd01646[c0] 2-Isopropylmalate[c0] C7H10O5 -2 
cpd00239[c0] H2S[c0] H2S 0 
cpd15693[c0] Dianteisopentadecanoylphosphatidylserine[c0] C36H68NO10P -2 
cpd00054[c0] L-Serine[c0] C3H7NO3 0 
cpd00046[c0] CMP[c0] C9H13N3O8P -1 
cpd15687[c0] CDP-1_2-dianteisopentadecanoylglycerol[c0] C42H75N3O15P2 -2 
cpd00557[c0] Siroheme[c0] C42H36FeN4O16 -8 
cpd03426[c0] Sirohydrochlorin[c0] C42H38N4O16 -8 
cpd10515[c0] Fe2[c0] Fe 2 
cpd00061[c0] Phosphoenolpyruvate[c0] C3H3O6P -2 
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Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
cpd00482[c0] 2-Phospho-D-glycerate[c0] C3H5O7P -2 
cpd15682[c0] 
1_2-diisohexadecanoyl-sn-glycerol_3-
phosphate[c0] 
C35H68O8P -1 
cpd15688[c0] CDP-1_2-diisohexadecanoylglycerol[c0] C44H79N3O15P2 -2 
cpd00012[c0] PPi[c0] H2O7P2 -2 
cpd00052[c0] CTP[c0] C9H13N3O14P3 -3 
cpd15421[c0] CDP-1_2-dioctadecanoylglycerol[c0] C48H87N3O15P2 -2 
cpd15526[c0] 
1_2-dioctadecanoyl-sn-glycerol_3-
phosphate[c0] 
C39H76O8P -1 
cpd02069[c0] 3-Phosphonooxypyruvate[c0] C3H3O7P -2 
cpd00169[c0] 3-Phosphoglycerate[c0] C3H5O7P -2 
cpd00038[c0] GTP[c0] C10H13N5O14P3 -3 
cpd00009[e0] Phosphate[e0] HO4P -2 
cpd02333[c0] Quinolinate[c0] C7H3NO4 -2 
cpd03470[c0] Iminoaspartate[c0] C4H3NO4 -2 
cpd00095[c0] Glycerone-phosphate[c0] C3H6O6P -1 
cpd08366[c0] 2R-Phosphosulfolactate[c0] C3H4O9PS -3 
cpd02826[c0] 5'-Phosphoribosylformylglycinamidine[c0] C8H16N3O8P 0 
cpd00072[c0] D-fructose-6-phosphate[c0] C6H12O9P -1 
cpd00079[c0] D-glucose-6-phosphate[c0] C6H12O9P -1 
cpd00118[c0] Putrescine[c0] C4H14N2 2 
cpd00147[c0] 5-Methylthioadenosine[c0] C11H15N5O3S 0 
cpd00264[c0] Spermidine[c0] C7H22N3 3 
cpd00837[c0] S-Adenosylmethioninamine[c0] C14H24N6O3S 2 
cpd00013[c0] NH3[c0] NH4 1 
cpd00023[c0] L-Glutamate[c0] C5H8NO4 -1 
cpd00053[c0] L-Glutamine[c0] C5H10N2O3 0 
cpd00238[c0] Sedoheptulose7-phosphate[c0] C7H14O10P -1 
cpd00102[c0] Glyceraldehyde3-phosphate[c0] C3H6O6P -1 
cpd00198[c0] D-Xylulose5-phosphate[c0] C5H10O8P -1 
cpd00101[c0] ribose-5-phosphate[c0] C5H10O8P -1 
cpd00115[c0] dATP[c0] C10H13N5O12P3 -3 
cpd00246[c0] Inosine[c0] C10H12N4O5 0 
cpd00114[c0] IMP[c0] C10H12N4O8P -1 
cpd00084[c0] L-Cysteine[c0] C3H7NO2S 0 
cpd15603[c0] Gly-Cys[c0] C5H10N2O3S 0 
cpd00358[c0] dUTP[c0] C9H12N2O14P3 -3 
cpd00978[c0] dUDP[c0] C9H12N2O11P2 -2 
cpd15555[c0] phosphatidylserine_dihexadecanoyl[c0] C38H72NO10P -2 
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Metabolite ID Metabolite Name Formula Charge 
cpd15419[c0] CDP-1_2-dihexadecanoylglycerol[c0] C44H79N3O15P2 -2 
cpd00357[c0] TTP[c0] C10H14N2O14P3 -3 
cpd00297[c0] dTDP[c0] C10H14N2O11P2 -2 
cpd00655[c0] Dephospho-CoA[c0] C21H33N7O13P2S -2 
cpd00343[c0] N-Carbamoyl-L-aspartate[c0] C5H6N2O5 -2 
cpd00146[c0] Carbamoylphosphate[c0] CH3NO5P -1 
cpd00200[c0] 4MOP[c0] C6H9O3 -1 
cpd00024[c0] 2-Oxoglutarate[c0] C5H4O5 -2 
cpd00107[c0] L-Leucine[c0] C6H13NO2 0 
cpd01777[c0] Phosphoribosyl-AMP[c0] C15H21N5O14P2 -2 
cpd01775[c0] Phosphoribosyl-ATP[c0] C15H21N5O20P4 -4 
cpd00834[c0] Phosphopantetheine[c0] C11H22N2O7PS -1 
cpd02666[c0] R-4'-Phosphopantothenoyl-L-cysteine[c0] C12H21N2O9PS -2 
cpd02979[c0] phosphoribosylformiminoaicar-phosphate[c0] C15H23N5O15P2 -2 
cpd02991[c0] 
phosphoribulosylformimino-AICAR-
phosphate[c0] 
C15H23N5O15P2 -2 
cpd00290[c0] D-fructose-1_6-bisphosphate[c0] C6H12O12P2 -2 
cpd00918[c0] 2-Acetamido-5-oxopentanoate[c0] C7H10NO4 -1 
cpd00342[c0] N-Acetylornithine[c0] C7H14N2O3 0 
cpd11586[c0] ala-L-glu-L[c0] C8H13N2O5 -1 
cpd00067[e0] H[e0] H 1 
cpd00205[e0] K[e0] K 1 
cpd00205[c0] K[c0] K 1 
cpd00018[c0] AMP[c0] C10H13N5O7P -1 
cpd03078[c0] Selenophosphate[c0] HO3PSe -2 
cpd01078[c0] Selenide[c0] H2Se 0 
cpd00091[c0] UMP[c0] C9H12N2O9P -1 
cpd00810[c0] Orotidylic_acid[c0] C10H11N2O11P -2 
cpd00019[c0] S-Adenosyl-homocysteine[c0] C14H20N6O5S 0 
cpd01620[c0] Precorrin_2[c0] C42H40N4O16 -8 
cpd00017[c0] S-Adenosyl-L-methionine[c0] C15H23N6O5S 1 
cpd03420[c0] Precorrin_3A[c0] C43H44N4O16 -6 
cpd14961[c0] Cobalt-precorrin_7[c0] C45H50CoN4O16 -6 
cpd08375[c0] Cobalt-precorrin_8[c0] C45H53CoN4O14 -5 
cpd00092[c0] Uracil[c0] C4H4N2O2 0 
cpd00307[c0] Cytosine[c0] C4H5N3O 0 
cpd15747[c0] 
Myristoyllipoteichoic_acid_n=24__linked__unsu
bstituted[c0] 
C115H224O135P24 -24 
cpd00014[c0] UDP[c0] C9H12N2O12P2 -2 
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Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
cpd15765[c0] 
Myristoyllipoteichoic_acid_n=24__linked__N-
acetyl-D-glucosamine[c0] 
C307H536N24O255P24 -24 
cpd00037[c0] UDP-N-acetylglucosamine[c0] C17H25N3O17P2 -2 
cpd11436[c0] fa3[c0] C15H29O2 -1 
cpd11437[c0] fa3coa[c0] C36H61N7O17P3S -3 
cpd01997[c0] Dimethylbenzimidazole[c0] C9H10N2 0 
cpd00218[c0] Niacin[c0] C6H4NO2 -1 
cpd00873[c0] Nicotinate_ribonucleotide[c0] C11H13NO9P -1 
cpd02904[c0] alpha-Ribazole_5'-phosphate[c0] C14H18N2O7P -1 
cpd03496[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-alanyl-D-glutaminyl-meso-
2_6-diaminopimeloyl-D-alanyl-D-alanine[c0] 
C95H154N9O27P2 -3 
cpd03495[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-ala-D-glu-meso-2-6-
diaminopimeloyl-D-ala-D-ala[c0] 
C95H152N8O28P2 -4 
cpd11621[c0] Oxidizedferredoxin[c0] Fe2R4S6 6 
cpd11620[c0] Reducedferredoxin[c0] Fe2R4S6 4 
cpd08369[c0] Cobalt-precorrin_3[c0] C43H42CoN4O16 -6 
cpd08368[c0] Cobalt-precorrin_2[c0] C42H40CoN4O16 -6 
cpd17041[c0] Protein_biosynthesis[c0] 
 
0 
cpd03492[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-alanyl-D-isoglutaminyl-L-
lysyl-D-alanyl-D-alanine[c0] 
C94H155N9O25P2 -2 
cpd03491[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-alanyl-gamma-D-glutamyl-
L-lysyl-D-alanyl-D-alanine[c0] 
C94H153N8O26P2 -3 
cpd02210[c0] Indoleglycerol_phosphate[c0] C11H13NO6P -1 
cpd00359[c0] indol[c0] C8H7N 0 
cpd02720[c0] 5-Amino-6-5-phosphoribitylaminouracil[c0] C9H16N4O9P -1 
cpd00931[c0] 5-Amino-6-5-phosphoribosylaminouracil[c0] C9H14N4O9P -1 
cpd15768[c0] 
Anteisoheptadecanoyllipoteichoic_acid_n=24__l
inked__N-acetyl-D-glucosamine[c0] 
C313H548N24O255P24 -24 
cpd15750[c0] 
Anteisoheptadecanoyllipoteichoic_acid_n=24__l
inked__unsubstituted[c0] 
C121H236O135P24 -24 
cpd00113[c0] Isopentenyldiphosphate[c0] C5H10O7P2 -2 
cpd00289[c0] Geranylgeranyl_diphosphate[c0] C20H34O7P2 -2 
cpd00350[c0] Farnesyldiphosphate[c0] C15H26O7P2 -2 
cpd02498[c0] 2_3-Dihydroxy-isovalerate[c0] C5H9O4 -1 
cpd00809[c0] O-Phospho-L-homoserine[c0] C4H9NO6P -1 
cpd00361[c0] ACTN[c0] C4H8O2 0 
cpd00668[c0] ALCTT[c0] C5H7O4 -1 
cpd00062[c0] UTP[c0] C9H12N2O15P3 -3 
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cpd00288[c0] D-Glucosamine_phosphate[c0] C6H14NO8P 0 
cpd02775[c0] 
4-Amino-5-phosphomethyl-2-
methylpyrimidine[c0] 
C6H9N3O4P -1 
cpd00939[c0] Toxopyrimidine[c0] C6H9N3O 0 
cpd00868[c0] p-hydroxyphenylpyruvate[c0] C9H7O4 -1 
cpd00069[c0] L-Tyrosine[c0] C9H11NO3 0 
cpd00209[c0] Nitrate[c0] NO3 -1 
cpd00209[e0] Nitrate[e0] NO3 -1 
cpd03421[c0] Cobyrinate[c0] C45H53CoN4O14 -5 
cpd17042[c0] DNA_replication[c0] 
 
0 
cpd00149[c0] Co2[c0] Co 2 
cpd00504[c0] LL-2_6-Diaminopimelate[c0] C7H14N2O4 0 
cpd00516[c0] meso-2_6-Diaminopimelate[c0] C7H14N2O4 0 
cpd00132[c0] L-Asparagine[c0] C4H8N2O3 0 
cpd11581[c0] gly-asn-L[c0] C6H11N3O4 0 
cpd02978[c0] 7_8-Dihydroneopterin_3'-triphosphate[c0] C9H13N5O13P3 -3 
cpd00177[c0] dADP[c0] C10H13N5O9P2 -2 
cpd02737[c0] 5-Methyl-H4MPT[c0] C31H44N6O16P -3 
cpd02438[c0] Methyl_CoM[c0] C3H7O3S2 -1 
cpd00895[c0] H4MPT[c0] C30H42N6O16P -3 
cpd02246[c0] CoM[c0] C2H5O3S2 -1 
cpd00117[c0] D-Alanine[c0] C3H7NO2 0 
cpd00128[c0] Adenine[c0] C5H5N5 0 
cpd02574[c0] methylthioribose-1-phosphate[c0] C6H12O7PS -1 
cpd15684[c0] CDP-1_2-dianteisoheptadecanoylglycerol[c0] C46H83N3O15P2 -2 
cpd15678[c0] 
1_2-dianteisoheptadecanoyl-sn-glycerol_3-
phosphate[c0] 
C37H72O8P -1 
cpd02201[c0] 4-phosphopantothenate[c0] C9H16NO8P -2 
cpd00508[c0] 3MOP[c0] C6H9O3 -1 
cpd02535[c0] 2_3-Dihydroxy-3-methylvalerate[c0] C6H11O4 -1 
cpd00930[c0] imidazole_acetol-phosphate[c0] C6H8N2O5P -1 
cpd00807[c0] L-histidinol-phosphate[c0] C6H12N3O4P 0 
cpd00015[c0] FAD[c0] C27H31N9O15P2 -2 
cpd00982[c0] FADH2[c0] C27H33N9O15P2 -2 
cpd08372[c0] Cobalt-precorrin_6[c0] C44H46CoN4O16 -6 
cpd00956[c0] 
1-2-carboxyphenylamino-1-deoxyribulose_5-
phosphate[c0] 
C12H14NO9P -2 
cpd00286[c0] Undecaprenylphosphate[c0] C55H90O4P -1 
cpd00086[c0] Propionyl-CoA[c0] C24H37N7O17P3S -3 
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cpd00141[c0] Propionate[c0] C3H5O2 -1 
cpd00236[c0] D-Erythrose4-phosphate[c0] C4H8O7P -1 
cpd03706[c0] UppppU[c0] C18H22N4O23P4 -4 
cpd00274[c0] Citrulline[c0] C6H13N3O3 0 
cpd00171[c0] D-Ribulose5-phosphate[c0] C5H10O8P -1 
cpd15422[c0] CDP-1_2-ditetradec-7-enoylglycerol[c0] C40H67N3O15P2 -2 
cpd15523[c0] 
1_2-ditetradec-7-enoyl-sn-glycerol_3-
phosphate[c0] 
C31H56O8P -1 
cpd00096[c0] CDP[c0] C9H13N3O11P2 -2 
cpd01716[c0] 3-Dehydroshikimate[c0] C7H7O5 -1 
cpd08211[c0] 
trans_trans_cis-
Geranylgeranyl_diphosphate[c0] 
C20H34O7P2 -2 
cpd02605[c0] 2-isopropyl-3-oxosuccinate[c0] C7H8O5 -2 
cpd02693[c0] 3-Isopropylmalate[c0] C7H10O5 -2 
cpd03608[c0] 4-Hydroxy-L-threonine[c0] C4H9NO4 0 
cpd03607[c0] 4-Phosphonooxy-threonine[c0] C4H9NO7P -1 
cpd00299[c0] dUMP[c0] C9H12N2O8P -1 
cpd00338[c0] 5-Aminolevulinate[c0] C5H9NO3 0 
cpd00689[c0] Porphobilinogen[c0] C10H13N2O4 -1 
cpd03835[c0] Precorrin_8[c0] C45H53N4O14 -7 
cpd00065[c0] L-Tryptophan[c0] C11H12N2O2 0 
cpd00644[c0] PAN[c0] C9H16NO5 -1 
cpd15554[c0] phosphatidylserine_ditetradec-7-enoyl[c0] C34H60NO10P -2 
cpd00863[c0] beta-D-Glucose_6-phosphate[c0] C6H12O9P -1 
cpd10162[c0] R-3-Hydroxy-3-methyl-2-oxopentanoate[c0] C6H9O4 -1 
cpd00533[c0] dCDP[c0] C9H13N3O10P2 -2 
cpd00356[c0] dCTP[c0] C9H13N3O13P3 -3 
cpd15604[c0] Gly-Leu[c0] C8H16N2O3 0 
cpd02884[c0] FAICAR[c0] C10H14N4O9P -1 
cpd00175[c0] UDP-N-acetyl-D-galactosamine[c0] C17H25N3O17P2 -2 
cpd02569[c0] 2-Oxo-3-hydroxyisovalerate[c0] C5H7O4 -1 
cpd00206[c0] dCMP[c0] C9H13N3O7P -1 
cpd03834[c0] Precorrin_4[c0] C44H45N4O17 -7 
cpd03839[c0] Precorrin_5[c0] C45H47N4O17 -7 
cpd00219[c0] Prephenate[c0] C10H8O6 -2 
cpd00616[c0] Pretyrosine[c0] C10H12NO5 -1 
cpd15524[c0] 
1_2-dihexadecanoyl-sn-glycerol_3-
phosphate[c0] 
C35H68O8P -1 
cpd15420[c0] CDP-1_2-dioctadec-11-enoylglycerol[c0] C48H83N3O15P2 -2 
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cpd15527[c0] 
1_2-dioctadec-11-enoyl-sn-glycerol_3-
phosphate[c0] 
C39H72O8P -1 
cpd00016[c0] Pyridoxal_phosphate[c0] C8H9NO6P -1 
cpd00971[c0] Na[c0] Na 1 
cpd00971[e0] Na[e0] Na 1 
cpd00129[c0] L-Proline[c0] C5H8NO2 -1 
cpd00129[e0] L-Proline[e0] C5H8NO2 -1 
cpd15557[c0] phosphatidylserine_dioctadecanoyl[c0] C42H80NO10P -2 
cpd00203[c0] 1_3-Bisphospho-D-glycerate[c0] C3H6O10P2 -2 
cpd00812[c0] 5-phosphomevalonate[c0] C6H11O7P -2 
cpd00332[c0] Mevalonic_acid[c0] C6H11O4 -1 
cpd00143[c0] Phenylpyruvate[c0] C9H7O3 -1 
cpd03560[c0] Propionyladenylate[c0] C13H17N5O8P -1 
cpd00793[c0] Thiamine_phosphate[c0] C12H17N4O4PS 0 
cpd02894[c0] 
4-Amino-2-methyl-5-
diphosphomethylpyrimidine[c0] 
C6H9N3O7P2 -2 
cpd02654[c0] 4-Methyl-5-2-phosphoethyl-thiazole[c0] C6H9NO4PS -1 
cpd00782[c0] Pimeloyl-CoA[c0] C28H42N7O19P3S -4 
cpd01727[c0] Pimelate[c0] C7H10O4 -2 
cpd11585[c0] L-alanylglycine[c0] C5H10N2O3 0 
cpd15754[c0] 
Isohexadecanoyllipoteichoic_acid_n=24__linked
__unsubstituted[c0] 
C119H232O135P24 -24 
cpd15772[c0] 
Isohexadecanoyllipoteichoic_acid_n=24__linked
__N-acetyl-D-glucosamine[c0] 
C311H544N24O255P24 -24 
cpd00103[c0] PRPP[c0] C5H10O14P3 -3 
cpd15748[c0] 
Stearoyllipoteichoic_acid_n=24__linked__unsub
stituted[c0] 
C123H240O135P24 -24 
cpd15766[c0] 
Stearoyllipoteichoic_acid_n=24__linked__N-
acetyl-D-glucosamine[c0] 
C315H552N24O255P24 -24 
cpd11593[c0] ala-L-asp-L[c0] C7H11N2O5 -1 
cpd11440[c0] fa6[c0] C16H31O2 -1 
cpd11441[c0] fa6coa[c0] C37H63N7O17P3S -3 
cpd03666[c0] 
2_5-Diamino-6-5'-triphosphoryl-3'_4'-trihydroxy-
2'-oxopentyl-_amino-4-oxopyrimidine[c0] 
C9H15N5O14P3 -3 
cpd00448[c0] D-Glyceraldehyde[c0] C3H6O3 0 
cpd00100[c0] Glycerol[c0] C3H8O3 0 
cpd00638[c0] Deamido-NAD[c0] C21H24N6O15P2 -2 
cpd02851[c0] AICAR[c0] C9H14N4O8P -1 
cpd02921[c0] SAICAR[c0] C13H16N4O12P -3 
cpd00142[c0] Acetoacetate[c0] C4H5O3 -1 
cpd00279[c0] Acetoacetyl-CoA[c0] C25H37N7O18P3S -3 
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cpd00020[c0] Pyruvate[c0] C3H3O3 -1 
cpd00093[c0] Anthranilate[c0] C7H6NO2 -1 
cpd00216[c0] Chorismate[c0] C10H8O6 -2 
cpd01017[c0] Cys-Gly[c0] C5H10N2O3S 0 
cpd00213[c0] Lipoamide[c0] C8H15NOS2 0 
cpd00449[c0] Dihydrolipoamide[c0] C8H17NOS2 0 
cpd15692[c0] Diisopentadecanoylphosphatidylserine[c0] C36H68NO10P -2 
cpd15686[c0] CDP-1_2-diisopentadecanoylglycerol[c0] C42H75N3O15P2 -2 
cpd00859[c0] Pseudouridine_5'-phosphate[c0] C9H12N2O9P -1 
cpd11580[c0] Gly-Gln[c0] C7H13N3O4 0 
cpd00025[c0] H2O2[c0] H2O2 0 
cpd00932[c0] 5-O-1-Carboxyvinyl-3-phosphoshikimate[c0] C10H10O10P -3 
cpd03049[c0] 2-Hydroxyethyl-ThPP[c0] C14H21N4O8P2S -1 
cpd00498[c0] 2-Aceto-2-hydroxybutanoate[c0] C6H9O4 -1 
cpd00056[c0] TPP[c0] C12H17N4O7P2S -1 
cpd00094[c0] 2-Oxobutyrate[c0] C4H5O3 -1 
cpd00282[c0] S-Dihydroorotate[c0] C5H5N2O4 -1 
cpd00247[c0] Orotate[c0] C5H3N2O4 -1 
cpd15685[c0] CDP-1_2-diisotetradecanoylglycerol[c0] C40H71N3O15P2 -2 
cpd15679[c0] 
1_2-diisotetradecanoyl-sn-glycerol_3-
phosphate[c0] 
C31H60O8P -1 
cpd02817[c0] HTP[c0] C11H20NO7PS -2 
cpd02935[c0] CoM-S-S-CoB[c0] C13H23NO10PS3 -3 
cpd00735[c0] Formylmethanofuran[c0] C35H39N4O16 -5 
cpd00643[c0] Methanofuran[c0] C34H40N4O15 -4 
cpd00774[c0] UroporphyrinogenIII[c0] C40H36N4O16 -8 
cpd00957[c0] 
2_5-Diamino-6-5'-phosphoribosylamino-4-
pyrimidineone[c0] 
C9H15N5O8P -1 
cpd00210[c0] Taurine[c0] C2H7NO3S 0 
cpd00210[e0] Taurine[e0] C2H7NO3S 0 
cpd02791[c0] methylthioribulose-1-phosphate[c0] C6H12O7PS -1 
cpd17043[c0] RNA_transcription[c0] 
 
0 
cpd00666[c0] Tartrate[c0] C4H4O6 -2 
cpd02345[c0] L-Glutamate1-semialdehyde[c0] C5H9NO3 0 
cpd00528[c0] N2[c0] N2 0 
cpd11640[c0] H2[c0] H2 0 
cpd00792[c0] Reduced_coenzyme_F420[c0] C29H34N5O18P -4 
cpd00649[c0] Coenzyme_F420[c0] C29H32N5O18P -4 
cpd00136[c0] 4-Hydroxybenzoate[c0] C7H5O3 -1 
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cpd02678[c0] N-Formyl-GAR[c0] C8H14N2O9P -1 
cpd00492[c0] N-Acetyl-D-mannosamine[c0] C8H15NO6 0 
cpd11432[c0] fa11coa[c0] C38H65N7O17P3S -3 
cpd11431[c0] fa11[c0] C17H33O2 -1 
cpd00053[e0] L-Glutamine[e0] C5H10N2O3 0 
cpd00298[c0] dTMP[c0] C10H14N2O8P -1 
cpd02030[c0] 3-phosphoshikimate[c0] C7H9O8P -2 
cpd00322[c0] L-Isoleucine[c0] C6H13NO2 0 
cpd15553[c0] phosphatidylserine_ditetradecanoyl[c0] C34H64NO10P -2 
cpd15423[c0] CDP-1_2-ditetradecanoylglycerol[c0] C40H71N3O15P2 -2 
cpd00540[c0] BET[c0] C5H11NO2 0 
cpd00540[e0] BET[e0] C5H11NO2 0 
cpd00251[c0] ADPribose[c0] C15H21N5O14P2 -2 
cpd00068[c0] ITP[c0] C10H12N4O14P3 -3 
cpd00090[c0] IDP[c0] C10H12N4O11P2 -2 
cpd00151[c0] Thymine[c0] C5H6N2O2 0 
cpd01587[c0] 5-Methylcytosine[c0] C5H7N3O 0 
cpd15690[c0] Dianteisoheptadecanoylphosphatidylserine[c0] C40H76NO10P -2 
cpd00066[c0] L-Phenylalanine[c0] C9H11NO2 0 
cpd15605[c0] Gly-Phe[c0] C11H14N2O3 0 
cpd00226[c0] HYXN[c0] C5H4N4O 0 
cpd00226[e0] HYXN[e0] C5H4N4O 0 
cpd01710[c0] 2-Isopropylmaleate[c0] C7H8O4 -2 
cpd00202[c0] DMAPP[c0] C5H10O7P2 -2 
cpd03091[c0] 5'-Deoxyadenosine[c0] C10H13N5O3 0 
cpd01311[c0] Dethiobiotin[c0] C10H17N2O3 -1 
cpd00104[c0] BIOT[c0] C10H15N2O3S -1 
cpd00074[c0] S[c0] S 0 
cpd02375[c0] Adenylosuccinate[c0] C14H15N5O11P -3 
cpd00241[c0] dGTP[c0] C10H13N5O13P3 -3 
cpd01324[c0] L-Histidinal[c0] C6H10N3O 1 
cpd00119[c0] L-Histidine[c0] C6H9N3O2 0 
cpd01080[c0] ocdca[c0] C18H35O2 -1 
cpd00327[c0] strcoa[c0] C39H67N7O17P3S -3 
cpd15522[c0] 
1_2-ditetradecanoyl-sn-glycerol_3-
phosphate[c0] 
C31H60O8P -1 
cpd10515[e0] Fe2[e0] Fe 2 
cpd00641[c0] L-Histidinol[c0] C6H12N3O 1 
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cpd08928[c0] L-Threonine_phosphate[c0] C4H9NO6P -1 
cpd02547[c0] R-1-Aminopropan-2-yl_phosphate[c0] C3H10NO4P 0 
cpd03914[c0] Cob(II)yrinate_diamide[c0] C45H57CoN6O12 -3 
cpd11584[c0] Ala-His[c0] C9H14N4O3 0 
cpd11430[c0] fa1[c0] C14H27O2 -1 
cpd11435[c0] fa1coa[c0] C35H59N7O17P3S -3 
cpd08373[c0] Cobalt-precorrin_6B[c0] C44H48CoN4O16 -6 
cpd00099[c0] Cl-[c0] Cl -1 
cpd00099[e0] Cl-[e0] Cl -1 
cpd00047[e0] Formate[e0] CHO2 -1 
cpd11592[c0] gly-glu-L[c0] C7H11N2O5 -1 
cpd08370[c0] Cobalt-precorrin_4[c0] C44H44CoN4O16 -6 
cpd01982[c0] 5-Phosphoribosylamine[c0] C5H12NO7P 0 
cpd00755[c0] Hydroxymethylbilane[c0] C40H38N4O17 -8 
cpd02843[c0] D-erythro-imidazol-glycerol-phosphate[c0] C6H10N2O6P -1 
cpd00497[c0] XMP[c0] C10H12N4O9P -1 
cpd11587[c0] Ala-Gln[c0] C8H15N3O4 0 
cpd11225[c0] 3-4-dihydroxy-2-butanone4-phosphate[c0] C4H8O6P -1 
cpd02679[c0] 5_10-Methylenetetrahydromethanopterin[c0] C31H42N6O16P -3 
cpd00800[c0] 8-Amino-7-oxononanoate[c0] C9H17NO3 0 
cpd00355[c0] Nicotinamide_ribonucleotide[c0] C11H15N2O8P 0 
cpd15683[c0] CDP-1_2-diisoheptadecanoylglycerol[c0] C46H83N3O15P2 -2 
cpd15689[c0] Diisoheptadecanoylphosphatidylserine[c0] C40H76NO10P -2 
cpd11438[c0] fa4[c0] C15H29O2 -1 
cpd11439[c0] fa4coa[c0] C36H61N7O17P3S -3 
cpd15680[c0] 
1_2-diisopentadecanoyl-sn-glycerol_3-
phosphate[c0] 
C33H64O8P -1 
cpd00078[c0] Succinyl-CoA[c0] C25H36N7O19P3S -4 
cpd15746[c0] 
Palmitoyllipoteichoic_acid_n=24__linked__unsu
bstituted[c0] 
C119H232O135P24 -24 
cpd15764[c0] 
Palmitoyllipoteichoic_acid_n=24__linked__N-
acetyl-D-glucosamine[c0] 
C311H544N24O255P24 -24 
cpd00477[c0] N-Acetyl-L-glutamate[c0] C7H9NO5 -2 
cpd00026[c0] UDP-glucose[c0] C15H22N2O17P2 -2 
cpd00144[c0] UDPglucuronate[c0] C15H19N2O18P2 -3 
cpd02394[c0] GAR[c0] C7H15N2O8P 0 
cpd00383[c0] Shikimate[c0] C7H9O5 -1 
cpd00363[c0] Ethanol[c0] C2H6O 0 
cpd11912[c0] tRNA-Glu[c0] C10H12N5O3R 0 
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cpd12227[c0] L-Glutamyl-tRNA-Glu[c0] C15H19N6O6R 0 
cpd01024[c0] Methane[c0] CH4 0 
cpd15751[c0] 
Isotetradecanoyllipoteichoic_acid_n=24__linked
__unsubstituted[c0] 
C115H224O135P24 -24 
cpd15769[c0] 
Isotetradecanoyllipoteichoic_acid_n=24__linked
__N-acetyl-D-glucosamine[c0] 
C307H536N24O255P24 -24 
cpd02642[c0] N-5-phosphoribosyl-anthranilate[c0] C12H14NO9P -2 
cpd11434[c0] fa12coa[c0] C38H65N7O17P3S -3 
cpd11433[c0] fa12[c0] C17H33O2 -1 
cpd01695[c0] Myristoyl-CoA[c0] C35H59N7O17P3S -3 
cpd03847[c0] Myristic_acid[c0] C14H27O2 -1 
cpd00307[e0] Cytosine[e0] C4H5N3O 0 
cpd02552[c0] n-acetylglutamyl-phosphate[c0] C7H10NO8P -2 
cpd15417[c0] CDP-1_2-didodecanoylglycerol[c0] C36H63N3O15P2 -2 
cpd15552[c0] phosphatidylserine_didodecanoyl[c0] C30H56NO10P -2 
cpd00822[c0] O-Succinyl-L-homoserine[c0] C8H12NO6 -1 
cpd03833[c0] Precorrin_3B[c0] C43H44N4O17 -6 
cpd08210[c0] ADC[c0] C10H10NO5 -1 
cpd15606[c0] Gly-Tyr[c0] C11H14N2O4 0 
cpd00334[c0] L-Lactaldehyde[c0] C3H6O2 0 
cpd00806[c0] L-Fuculose1-phosphate[c0] C6H12O8P -1 
cpd00156[c0] L-Valine[c0] C5H11NO2 0 
cpd00134[c0] Palmitoyl-CoA[c0] C37H63N7O17P3S -3 
cpd00214[c0] Palmitate[c0] C16H31O2 -1 
cpd15767[c0] 
Isoheptadecanoyllipoteichoic_acid_n=24__linke
d__N-acetyl-D-glucosamine[c0] 
C313H548N24O255P24 -24 
cpd15749[c0] 
Isoheptadecanoyllipoteichoic_acid_n=24__linke
d__unsubstituted[c0] 
C121H236O135P24 -24 
cpd00031[c0] GDP[c0] C10H13N5O11P2 -2 
cpd00861[c0] UDP-N-acetyl-D-mannosamine[c0] C17H25N3O17P2 -2 
cpd00446[c0] cAMP[c0] C10H11N5O6P -1 
cpd00182[c0] Adenosine[c0] C10H13N5O4 0 
cpd00292[c0] HMG-CoA[c0] C27H40N7O20P3S -4 
cpd01977[c0] 4-Phospho-L-aspartate[c0] C4H7NO7P -1 
cpd00283[c0] Geranyldiphosphate[c0] C10H18O7P2 -2 
cpd03487[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-alanyl-D-glutamyl-L-lysyl-
D-alanyl-D-alanine[c0] 
C94H153N8O26P2 -3 
cpd03488[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-N-
acetylglucosamine-L-alanyl-D-glutaminyl-L-
lysyl-D-alanyl-D-alanine[c0] 
C94H155N9O25P2 -2 
 
 
194 
 
Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
cpd00089[c0] Glucose-1-phosphate[c0] C6H12O9P -1 
cpd15302[c0] glycogenn-1[c0] C24H42O21 0 
cpd00155[c0] Glycogen[c0] C30H52O26 0 
cpd03913[c0] Hydrogenobyrinate_diamide[c0] C45H58N6O12 -4 
cpd03832[c0] Hydrogenobyrinate[c0] C45H54N4O14 -6 
cpd00764[c0] 7-8-Diaminononanoate[c0] C9H21N2O2 1 
cpd11588[c0] gly-pro-L[c0] C7H12N2O3 0 
cpd02655[c0] 5_10-Methenyltetrahydromethanopterin[c0] C31H41N6O16P -2 
cpd00936[c0] 5-Formyl-H4MPT[c0] C31H42N6O17P -3 
cpd11583[c0] Ala-Leu[c0] C9H18N2O3 0 
cpd15521[c0] 1_2-didodecanoyl-sn-glycerol_3-phosphate[c0] C27H52O8P -1 
cpd00043[c0] UDP-galactose[c0] C15H22N2O17P2 -2 
cpd00092[e0] Uracil[e0] C4H4N2O2 0 
cpd15691[c0] Diisotetradecanoylphosphatidylserine[c0] C34H64NO10P -2 
cpd15269[c0] octadecenoate[c0] C18H33O2 -1 
cpd15274[c0] Octadecenoyl-CoA[c0] C39H65N7O17P3S -3 
cpd11591[c0] Gly-Met[c0] C7H14N2O3S 0 
cpd15753[c0] 
Anteisopentadecanoyllipoteichoic_acid_n=24__l
inked__unsubstituted[c0] 
C117H228O135P24 -24 
cpd15771[c0] 
Anteisopentadecanoyllipoteichoic_acid_n=24__l
inked__N-acetyl-D-glucosamine[c0] 
C309H540N24O255P24 -24 
cpd01914[c0] L-Methionine_S-oxide[c0] C5H11NO3S 0 
cpd15558[c0] phosphatidylserine_dioctadec-11-enoyl[c0] C42H76NO10P -2 
cpd02701[c0] S-Adenosyl-4-methylthio-2-oxobutanoate[c0] C15H19N5O6S 0 
cpd00149[e0] Co2[e0] Co 2 
cpd15556[c0] phosphatidylserine_dihexadec-9-enoyl[c0] C38H68NO10P -2 
cpd15418[c0] CDP-1_2-dihexadec-9-enoylglycerol[c0] C44H75N3O15P2 -2 
cpd00521[c0] dTDP-4-oxo-6-deoxy-D-glucose[c0] C16H22N2O15P2 -2 
cpd02616[c0] dTDP-4-amino-4_6-dideoxy-D-glucose[c0] C16H26N3O14P2 -1 
cpd12005[c0] Lipoylprotein[c0] CHRS2 0 
cpd12225[c0] Dihydrolipolprotein[c0] CH3RS2 0 
cpd15681[c0] 
1_2-dianteisopentadecanoyl-sn-glycerol_3-
phosphate[c0] 
C33H64O8P -1 
cpd15694[c0] Diisohexadecanoylphosphatidylserine[c0] C38H72NO10P -2 
cpd00064[c0] Ornithine[c0] C5H13N2O2 1 
cpd15525[c0] 
1_2-dihexadec-9-enoyl-sn-glycerol_3-
phosphate[c0] 
C35H64O8P -1 
cpd00946[c0] 
Undecaprenyl_diphospho_N-acetyl-
glucosamine[c0] 
C63H103NO12P2 -2 
cpd00126[c0] GMP[c0] C10H13N5O8P -1 
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cpd00311[c0] Guanosine[c0] C10H13N5O5 0 
cpd00485[c0] D-Mannose1-phosphate[c0] C6H12O9P -1 
cpd00235[c0] D-mannose-6-phosphate[c0] C6H12O9P -1 
cpd00305[c0] Thiamin[c0] C12H17N4OS 1 
cpd00305[e0] Thiamin[e0] C12H17N4OS 1 
cpd00295[c0] dGDP[c0] C10H13N5O10P2 -2 
cpd00073[c0] Urea[c0] CH4N2O 0 
cpd00073[e0] Urea[e0] CH4N2O 0 
cpd15238[c0] Hexadecenoyl-CoA[c0] C37H61N7O17P3S -3 
cpd15237[c0] hexadecenoate[c0] C16H29O2 -1 
cpd00830[c0] 4-Hydroxy-2-oxoglutarate[c0] C5H4O6 -2 
cpd01974[c0] 4-Hydroxy-L-glutamate[c0] C5H8NO5 -1 
cpd00712[c0] 2-Dehydropantoate[c0] C6H9O4 -1 
cpd00408[c0] Pantoate[c0] C6H11O4 -1 
cpd02636[c0] 4-Methyl-5-2-hydroxyethyl-thiazole[c0] C6H9NOS 0 
cpd00367[c0] Cytidine[c0] C9H13N3O5 0 
cpd00738[c0] phosphoserine[c0] C3H7NO6P -1 
cpd15770[c0] 
Isopentadecanoyllipoteichoic_acid_n=24__linke
d__N-acetyl-D-glucosamine[c0] 
C309H540N24O255P24 -24 
cpd15752[c0] 
Isopentadecanoyllipoteichoic_acid_n=24__linke
d__unsubstituted[c0] 
C117H228O135P24 -24 
cpd15677[c0] 
1_2-diisoheptadecanoyl-sn-glycerol_3-
phosphate[c0] 
C37H72O8P -1 
cpd00152[c0] Agmatine[c0] C5H16N4 2 
cpd10516[c0] fe3[c0] Fe 3 
cpd10516[e0] fe3[e0] Fe 3 
cpd00001[e0] H2O[e0] H2O 0 
cpd00011[e0] CO2[e0] CO2 0 
cpd02465[c0] tetrahydrodipicolinate[c0] C7H7NO4 -2 
cpd02211[c0] L-2-Amino-acetoacetate[c0] C4H7NO3 0 
cpd00058[c0] Cu2[c0] Cu 2 
cpd00042[c0] GSH[c0] C10H16N3O6S -1 
cpd12370[c0] apo-ACP[c0] HOR 0 
cpd11416[c0] Biomass[c0] 
 
0 
cpd00063[c0] Ca2[c0] Ca 2 
cpd03422[c0] Cobinamide[c0] C48H73CoN11O8 3 
cpd00166[c0] Calomide[c0] C72H101CoN18O17P 1 
cpd11493[c0] ACP[c0] C11H21N2O7PRS -1 
cpd03443[c0] 3-Octaprenyl-4-hydroxybenzoate[c0] C47H69O3 -1 
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cpd03444[c0] 2-Octaprenylphenol[c0] C46H70O 0 
cpd11524[c0] 5-methyl-hexanoyl-ACP[c0] C18H33N2O8PRS -1 
cpd01772[c0] Succinylbenzoate[c0] C11H8O5 -2 
cpd03451[c0] SHCHC[c0] C11H10O6 -2 
cpd00421[c0] Triphosphate[c0] HO10P3 -4 
cpd11492[c0] Malonyl-acyl-carrierprotein-[c0] C14H22N2O10PRS -2 
cpd11525[c0] 7-methyl-3-oxo-octanoyl-ACP[c0] C20H35N2O9PRS -1 
cpd00034[e0] Zn2[e0] Zn 2 
cpd11496[c0] 4-methyl-3-oxo-hexanoyl-ACP[c0] C18H31N2O9PRS -1 
cpd11495[c0] 2-methylbutyryl-ACP[c0] C16H29N2O8PRS -1 
cpd02083[c0] CoproporphyrinogenIII[c0] C36H40N4O8 -4 
cpd00817[c0] D-Arabinose5-phosphate[c0] C5H10O8P -1 
cpd11515[c0] 12-methyl-tetra-decanoyl-ACP[c0] C26H49N2O8PRS -1 
cpd01741[e0] ddca[e0] C12H23O2 -1 
cpd11488[c0] Acetoacetyl-ACP[c0] C15H25N2O9PRS -1 
cpd15268[c0] Octadecanoyl-ACP[c0] C29H55N2O8PRS -1 
cpd01270[c0] FMNH2[c0] C17H22N4O9P -1 
cpd04122[c0] Aminoacetaldehyde[c0] C2H6NO 1 
cpd00050[c0] FMN[c0] C17H20N4O9P -1 
cpd00027[c0] D-Glucose[c0] C6H12O6 0 
cpd11532[c0] 9-methyl-decanoyl-ACP[c0] C22H41N2O8PRS -1 
cpd00080[c0] Glycerol-3-phosphate[c0] C3H8O6P -1 
cpd11533[c0] 11-methyl-3-oxo-dodecanoyl-ACP[c0] C24H43N2O9PRS -1 
cpd03918[c0] Adenosyl_cobinamide[c0] C58H85CoN16O11 2 
cpd00355[e0] Nicotinamide_ribonucleotide[e0] C11H15N2O8P 0 
cpd00626[c0] dTDPglucose[c0] C16H24N2O16P2 -2 
cpd02120[c0] Dihydrodipicolinate[c0] C7H5NO4 -2 
cpd03448[c0] 
2-Octaprenyl-3-methyl-6-methoxy-1_4-
benzoquinone[c0] 
C48H72O3 0 
cpd11516[c0] 14-methyl-3-oxo-hexa-decanoyl-ACP[c0] C28H51N2O9PRS -1 
cpd11507[c0] 8-methyl-decanoyl-ACP[c0] C22H41N2O8PRS -1 
cpd11508[c0] 10-methyl-3-oxo-dodecanoyl-ACP[c0] C24H43N2O9PRS -1 
cpd11504[c0] 8-methyl-3-oxo-decanoyl-ACP[c0] C22H39N2O9PRS -1 
cpd03447[c0] 2-Octaprenyl-6-methoxy-1_4-benzoquinone[c0] C47H70O3 0 
cpd00058[e0] Cu2[e0] Cu 2 
cpd00906[c0] all-trans-Hexaprenyl_diphosphate[c0] C30H50O7P2 -2 
cpd11540[c0] 13-methyl-tetra-decanoyl-ACP[c0] C26H49N2O8PRS -1 
cpd00760[c0] 2-Methylbutyryl-CoA[c0] C26H41N7O17P3S -3 
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cpd11499[c0] 4-methyl-hexanoyl-ACP[c0] C18H33N2O8PRS -1 
cpd03919[c0] Adenosyl_cobinamide_phosphate[c0] C58H84CoN16O14P 0 
cpd03917[c0] Adenosylcobyric_acid[c0] C55H77CoN15O11 1 
cpd02039[c0] 1-Aminopropan-2-ol[c0] C3H10NO 1 
cpd02590[c0] all-trans-Heptaprenyl_diphosphate[c0] C35H58O7P2 -2 
cpd02557[c0] Farnesylfarnesylgeraniol[c0] C40H66O7P2 -2 
cpd11484[c0] HMA[c0] C25H47N2O9PRS -1 
cpd11529[c0] 9-methyl-3-oxo-decanoyl-ACP[c0] C22H39N2O9PRS -1 
cpd00558[e0] Spermine[e0] C10H30N4 4 
cpd15479[c0] glucosyl-inner_core_oligosaccharide_lipid_A[c0] C151H265N2O79P4 -7 
cpd00030[e0] Mn2[e0] Mn 2 
cpd02685[c0] N-acetyl-LL-2_6-diaminopimelate[c0] C9H15N2O5 -1 
cpd03916[c0] Adenosyl_cobyrinate_diamide[c0] C55H69CoN11O15 -3 
cpd03915[c0] Cob(I)yrinate_diamide[c0] C45H57CoN6O12 -4 
cpd00063[e0] Ca2[e0] Ca 2 
cpd03920[c0] Adenosylcobinamide-GDP[c0] C68H96CoN21O21P2 0 
cpd11503[c0] 6-methyl-octanoyl-ACP[c0] C20H37N2O8PRS -1 
cpd11536[c0] 11-methyl-dodecanoyl-ACP[c0] C24H45N2O8PRS -1 
cpd00655[e0] Dephospho-CoA[e0] C21H33N7O13P2S -2 
cpd03289[c0] L-2-Acetamido-6-oxopimelate[c0] C9H11NO6 -2 
cpd08316[c0] 
D-Glycero-D-manno-heptose1-7-
bisphosphate[c0] 
C7H14O13P2 -2 
cpd15489[c0] inner_core_oligosaccharide_lipid_A[c0] C145H255N2O74P4 -7 
cpd04920[c0] D-Glycero-D-manno-heptose1-phosphate[c0] C7H14O10P -1 
cpd11521[c0] 5-methyl-3-oxo-hexanoyl-ACP[c0] C18H31N2O9PRS -1 
cpd11520[c0] isovaleryl-ACP[c0] C16H29N2O8PRS -1 
cpd02021[c0] Succinylbenzoyl-CoA[c0] C32H40N7O20P3S -4 
cpd11511[c0] 10-methyl-dodecanoyl-ACP[c0] C24H45N2O8PRS -1 
cpd00045[c0] Adenosine_3-5-bisphosphate[c0] C10H13N5O10P2 -2 
cpd02886[c0] 
UDP-3-O-beta-hydroxymyristoyl-N-
acetylglucosamine[c0] 
C31H51N3O19P2 -2 
cpd03423[c0] alpha-Ribazole[c0] C14H18N2O4 0 
cpd11537[c0] 13-methyl-3-oxo-tetra-decanoyl-ACP[c0] C26H47N2O9PRS -1 
cpd15269[e0] octadecenoate[e0] C18H33O2 -1 
cpd11541[c0] 15-methyl-3-oxo-hexa-decanoyl-ACP[c0] C28H51N2O9PRS -1 
cpd11528[c0] 7-methyl-octanoyl-ACP[c0] C20H37N2O8PRS -1 
cpd03494[c0] 
Undecaprenyl-diphospho-N-acetylmuramoyl-L-
alanyl-D-glutamyl-meso-2-6-diaminopimeloyl-D-
alanyl-D-alanine[c0] 
C87H139N7O23P2 -4 
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cpd15358[c0] 2-octadecanoyl-sn-glycerol_3-phosphate[c0] C21H42O7P -1 
cpd02295[c0] 1-4-Dihydroxy-2-naphthoate[c0] C11H7O4 -1 
cpd11512[c0] 12-methyl-3-oxo-tetra-decanoyl-ACP[c0] C26H47N2O9PRS -1 
cpd00111[c0] Oxidized_glutathione[c0] C20H30N6O12S2 -2 
cpd03422[e0] Cobinamide[e0] C48H73CoN11O8 3 
cpd02968[c0] 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-
carboxy-L-lysyl-D-alanyl-_D-alanine[c0] 
C41H61N9O28P2 -4 
cpd00658[c0] Isochorismate[c0] C10H8O6 -2 
cpd01080[e0] ocdca[e0] C18H35O2 -1 
cpd00111[e0] Oxidized_glutathione[e0] C20H30N6O12S2 -2 
cpd11500[c0] 6-methyl-3-oxo-octanoyl-ACP[c0] C20H35N2O9PRS -1 
cpd03847[e0] Myristic_acid[e0] C14H27O2 -1 
cpd00869[c0] 4-methylthio_2-oxobutyrate[c0] C5H7O3S -1 
cpd11295[c0] 2_3-diketo5-methylthio-1-phosphopentane[c0] C6H10O6PS -1 
cpd11217[c0] 1_4-Dihydroxy-2-naphthoyl-CoA[c0] C32H39N7O19P3S -3 
cpd00070[c0] Malonyl-CoA[c0] C24H34N7O19P3S -4 
cpd00085[c0] beta-Alanine[c0] C3H7NO2 0 
cpd00506[c0] gamma-Glutamylcysteine[c0] C8H13N2O5S -1 
cpd00013[e0] NH3[e0] NH4 1 
cpd02591[c0] pendp[c0] C25H42O7P2 -2 
cpd16335[c0] 
2-Succinyl-5-enolpyruvyl-6-hydroxy-3-
cyclohexene-1-carboxylate[c0] 
C14H13O9 -3 
cpd00460[c0] sulfoacetaldehyde[c0] C2H3O4S -1 
cpd03285[c0] 3-sulfopyruvate[c0] C3H2O6S -2 
cpd08367[c0] (2R)-3-sulfolactate[c0] C3H4O6S -2 
cpd00607[c0] Citramalate[c0] C5H6O5 -2 
cpd01502[c0] Citraconate[c0] C5H4O4 -2 
cpd03593[c0] D-erythro-3-methylmalate[c0] C5H6O5 0 
cpd00029[e0] Acetate[e0] C2H3O2 -1 
cpd00278[c0] Indole-3-pyruvate[c0] C11H8NO3 -1 
cpd11175[c0] S-2-(indol-3-yl)acetyl-CoA[c0] C31H40N8O17P3S -3 
cpd00035[e0] L-Alanine[e0] C3H7NO2 0 
cpd00117[e0] D-Alanine[e0] C3H7NO2 0 
cpd00528[e0] N2[e0] N2 0 
cpd00239[e0] H2S[e0] H2S 0 
cpd15886[c0] trans-homoaconitate[c0] C7H5O6 -3 
cpd15833[c0] S-homocitrate[c0] C7H7O7 -3 
cpd02483[c0] cis-Homoaconitate[c0] C7H5O6 -3 
cpd15888[c0] threo-isohomocitrate[c0] C7H7O7 -3 
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cpd15901[c0] 2-oxohexanedioic_acid[c0] C6H6O5 -2 
cpd15831[c0] (R)-(homo)2citrate[c0] C8H9O7 -3 
cpd15882[c0] cis-(homo)2aconitate[c0] C8H7O6 -3 
cpd15908[c0] (-)threo-iso(homo)2citrate[c0] C8H9O7 -3 
cpd15900[c0] 2-oxoheptanedioic_acid[c0] C7H8O5 -2 
cpd15832[c0] (R)-(homo)3citrate[c0] C9H11O7 -3 
cpd15883[c0] cis-(homo)3aconitate[c0] C9H9O6 -3 
cpd15909[c0] (-)threo-iso(homo)3citrate[c0] C9H11O7 -3 
cpd16398[c0] 2-Oxosuberate[c0] C8H10O5 -2 
cpd15829[c0] 7-oxoheptanoic_acid[c0] C7H11O3 -1 
cpd15827[c0] 7-mercaptoheptanoic_acid[c0] C7H13O2S -1 
cpd15828[c0] 7-mercaptoheptanoylthreonine[c0] C11H20NO4S -1 
cpd15850[c0] 7,8-dihydronepterin_2_3-cyclicphosphate[c0] C9H11N5O6P -1 
cpd03521[c0] Dihydroneopterin_phosphate[c0] C9H13N5O7P -1 
cpd02961[c0] Dihydroneopterin[c0] C9H13N5O4 0 
cpd00954[c0] 6-hydroxymethyl_dihydropterin[c0] C7H9N5O2 0 
cpd00229[c0] Glycolaldehyde[c0] C2H4O2 0 
cpd02920[c0] 
2-Amino-4-hydroxy-6-hydroxymethyl-7-8-
dihydropteridinediphosphate[c0] 
C7H9N5O8P2 -2 
cpd00443[c0] ABEE[c0] C7H6NO2 -1 
cpd15830[c0] 
4-(B-D-ribofuranosyl)aminobenzene_5-
phosphate[c0] 
C11H14NO7P -2 
cpd15851[c0] 
7,8-dihydropterin-6-ylmethyl-4-(B-D-
ribofuranosyl)_aminobenzene_5-phosphate[c0] 
C18H21N6O8P -2 
cpd02041[c0] (S)-2-Hydroxyglutarate[c0] C5H6O5 -2 
cpd15853[c0] 6-deoxy-5-ketofructose-1-phosphate[c0] C6H9O8P -2 
2ATDLH6U[c0] 
2-amino-2,3,7-trideoxy-D-lyxo-hept-6-
ulosonate[c0] 
C7H11NO5 -2 
cpd17158[c0] Hydroxypyruvaldehyde_phosphate[c0] C3H5O6P 0 
2A3DHQ[c0] 4-Amino-3-Dehydroquinate[c0] C7H10O5N -1 
4A3DHS[c0] 4-Amino-3-Dehydroshikimate[c0] C7H8O4N -1 
4ASKM[c0] 4-Aminoshikimate[c0] C7H10O4N -1 
4A3H15D1C[c0
] 
4-amino-3-hydroxycyclohexa-1,5-diene-1-
carboxylate[c0] 
C7H8O3N -1 
cpd00139[c0] Glycolate[c0] C2H3O3 -1 
cpd00040[c0] Glyoxalate[c0] C2HO3 -1 
cpd00374[c0] Tyramine[c0] C8H12NO 1 
GGT[c0] gamma-Glutamyl-tyramine[c0] C13H18N2O4 0 
4HM2FCP[c0] 
4-(hydroxymethyl)-2-furancarboxaldehyde-
phosphate[c0] 
C6H6O6P -1 
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5AM3FMP[c0] 
5-(aminomethyl)-3-furanmethanol-
phosphate[c0] 
C6H10O5NP 0 
5AM3FMPP[c0] 
5-(aminomethyl)-3-furanmethanol-
pyrophosphate[c0] 
C6H10O8NP2 -1 
AEPM2FMA[c0
] 
4((4-(2-aminoethyl)phenoxy)methyl)-2-
furanmethanamine[c0] 
C19H26O5N3 1 
cpd00244[c0] Ni2[c0] Ni 2 
cpd15873[c0] Pyrrochorphinate[c0] C42H42N6NiO14 -6 
cpd15874[c0] Dihydrocorphinate[c0] C42H45N6NiO14 -5 
cpd15875[c0] Tetrahydrocorphinate[c0] C42H47N6NiO14 -5 
cpd15905[c0] 15_17-seco-F430-17-acid[c0] C42H47N6NiO14 -5 
cpd03425[c0] Factor_430[c0] C42H46N6O13Ni -4 
cpd00244[e0] Ni2[e0] Ni 2 
cpd00180[c0] Oxalate[c0] C2O4 -2 
cpd15839[c0] 7,8-didemethyl-8-hydroxy-5-deazariboflavin[c0] C16H17N3O7 0 
cpd00159[c0] L-Lactate[c0] C3H5O3 -1 
cpd15809[c0] 2-phospho-L-lactate[c0] C3H4O6P -3 
cpd15889[c0] lactyl-(2)-diphospho-(5)-guanosine[c0] C13H16N5O13P2 -3 
cpd15864[c0] Coenzyme_F420-0[c0] C19H20N3O12P -2 
cpd15865[c0] Coenzyme_F420-1[c0] C24H26N4O15P -3 
cpd15868[c0] Coenzyme_F420-3[c0] C34H38N6O21P -5 
cpd00204[c0] CO[c0] CO 1 
cpd00204[e0] CO[e0] CO 1 
cpd00131[e0] Molybdenum[e0] Mo 0 
cpd00131[c0] Molybdenum[c0] Mo 0 
cpd03523[c0] 7,8-Dihydromethanopterin[c0] C30H40N6O16P -3 
cpd03732[c0] UDP-N-acetyl-D-mannosaminouronate[c0] C17H22N3O18P2 -3 
cpd02782[c0] UDP-N-acetyl-D-glucosaminouronate[c0] C17H22N3O18P2 -3 
U2A2D3OG[c0] 
UDP-2-acetamido-2-deoxy-3-oxo-
glucuronate[c0] 
C17H20N3O18P2 -2 
U2A3A23DDG[
c0] 
UDP-2-acetamido-3-amino-2,3-dideoxy-
glucuronate[c0] 
C17H23N4O17P2 -2 
U23DA23DDG[
c0] 
UDP-2,3-diacetamido-2,3-dideoxy-
glucuronate[c0] 
C19H25N4O18P2 -2 
U23DA23DDM[
c0] 
UDP-2,3-diacetamido-2,3-dideoxy-
mannuronate[c0] 
C19H25N4O18P2 -2 
U3A23DAM[c0] UDP-3-acetamido-2,3-diaminomannuronate[c0] 
 
0 
N2A24D5MH4
U15P[c0] 
NDP-2-acetamino-2,4-dideoxy-5-O-methyl-
hexos-5-ulo-1,5-pyranose[c0]  
0 
N2A24D5MAE
H5U15P[c0] 
NDP-(5S)-2-acetamido-2,4-dideoxy-5-O-methyl-
alpha-L-erythro-hexos-5-ulo-1,5-pyranose[c0]  
0 
LIP4SUG[c0] Lipid_tetrasaccharide[c0] 
 
0 
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Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
LIP4SUGT[c0] Lipid_tetrasaccharide_Thr[c0] 
 
0 
LIP1SUG[c0] Lipid_monosaccharide[c0] 
 
0 
LIP2SUG[c0] Lipid_disaccharide[c0] 
 
0 
LIP3SUG[c0] Lipid_trisaccharide[c0] 
 
0 
LIP4SUGT[e0] Lipid_tetrasaccharide_Thr[e0] 
 
0 
FLGN[e0] Flagellin[e0] 
 
0 
ARCN[e0] Archaellin[e0] 
 
0 
MEMLIP[c0] Membrane_lipid[c0] 
 
0 
cpd00703[c0] Indoleacetate[c0] C10H8NO2 -1 
cpd00703[e0] Indoleacetate[e0] C10H8NO2 -1 
cpd00489[e0] 4-Hydroxyphenylacetate[e0] C8H7O3 -1 
cpd00489[c0] 4-Hydroxyphenylacetate[c0] C8H7O3 -1 
cpd00430[e0] PACT[e0] C8H8O2 0 
cpd00430[c0] PACT[c0] C8H8O2 0 
cpd03165[c0] 4-Hydroxyphenylacetyl-CoA[c0] C29H39N7O18P3S -3 
cpd00452[c0] Phenylacetyl-CoA[c0] C29H39N7O17P3S -3 
cpd00802[c0] D-fructose-1-phosphate[c0] C3H4O2 0 
cpd00428[c0] 2-Oxopropanal[c0] C3H4O2 0 
cpd00055[c0] Formaldehyde[c0] CH2O 0 
cpd15573[c0] tRNA(SeCys)[c0] C10H12N5O3R 0 
cpd15565[c0] L-Seryl-tRNA(Sec)[c0] C18H28NO18P2R3 -2 
cpd16442[c0] O-Phosphoseryl-tRNA(Sec)[c0] C12H15N3O5S 0 
cpd15563[c0] L-Selenocysteinyl-tRNA(Sec)[c0] C18H30NO17P2R3Se 0 
cpd16579[c0] Selenoprotein[c0] C5H12O 0 
cpd03387[c0] Selenite[c0] H2O3Se 2 
cpd03396[c0] Selenate[c0] H2O4Se 4 
cpd03396[e0] Selenate[e0] H2O4Se 4 
cpd00207[c0] Guanine[c0] C5H5N5O 0 
cpd17039[c0] Isopentenylphosphate[c0] C5H9O4P -2 
cpd02797[c0] 
sn-3-O-(Geranylgeranyl)glycerol_1-
phosphate[c0] 
C23H40O6P -1 
cpd02824[c0] 
2,3-Bis-O-(geranylgeranyl)glycerol_1-
phosphate[c0] 
C43H72O6P -1 
cpd18042[c0] CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol[c0] C52H83N3O13P2 -2 
ARCHLS[c0] Archaetidylserine[c0] C46H77NO8P -1 
SATARCHL[c0] Saturated_CDP-archaeol[c0] C52H99N3O13P2 -2 
SATARCHLS[c
0] 
Saturated_Archaetidylserine[c0] C46H93NO8P -1 
cpd11640[e0] H2[e0] H2 0 
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Table B.2 (cont.) 
Metabolite ID Metabolite Name Formula Charge 
cpd01024[e0] Methane[e0] CH4 0 
SATARCHLS[c
0] 
Saturated_Archaetidylserine[c0] C46H93NO8P -1 
cpd11640[e0] H2[e0] H2 0 
cpd01024[e0] Methane[e0] CH4 0 
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Table B.3: McNA Chemostat Medium.  This is the recipe for the medium used in chemostat experiments described 
in Chapter 3 Methods and simulated by the “maxGrowthOnH2” script (see Table B.4). Importantly, this recipe is for 
liquid media only and does not contain gases; these are listed in Chapter 3 methods.  
Compound Amount 
(g) 
Amount 
(mL) 
Final Concentration 
(mM) 
H2O - 8289 - 
KCl 3.02 - 4.5 
NaHCO3 45 - 59.5 
NaCl 198 - 376.5 
NaC2H3O2∙3H2O 12.6 - 10 
FeSO4 Solution - 45 - 
Resazurin Solution - 9 - 
Trace Minerals Solution - 9 - 
Vitamin Solution - 90 - 
Cysteine HCl 4.5 - 2.85 
Divalent Cation Solution - 500 - 
NH4Cl Solution - 18 - 
K2HPO4 Solution - 90 - 
    
FeSO4 Solution (per 100 mL of 10 mM HCl)    
FeSO4∙7H2O 0.19 - 0.034 
    
Resazurin Solution (per L H2O)    
Resazurin 1 - 0.004 
    
1000X Trace Mineral Solution (per 100 mL H2O)    
Na3Citrate∙2H2O 2.1 - 0.081 
MnSO4∙H2O 0.5 - 0.030 
CoCl2∙6H2O 0.1 - 0.004 
ZnSO4∙7H2O 0.1 - 0.003 
CuSO4∙5H2O 0.01 - 4.00E-04 
AlK(SO4)2 0.01 - 3.87E-04 
H3BO4 0.01 - 0.001 
Na2MoO4∙2H2O 0.1 - 0.002 
NiCl2∙6H2O 0.025 - 0.001 
Na2SeO3 0.2 - 0.012 
VCl3 0.01 - 6.36E-04 
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Table B.3 (cont.) 
Compound Amount 
(g) 
Amount 
(mL) 
Final Concentration 
(mM) 
Na2WO4∙2H2O 0.0033 - 1.00E-04 
    
100X Vitamin Solution (per L H2O)    
Biotin 0.002 - 8.19E-05 
Folic Acid 0.002 - 4.53E-05 
Pyridoxine HCl 0.01 - 4.86E-04 
Thiamine HCl 0.005 - 1.48E-04 
Riboflavin 0.005 - 1.33E-04 
Nicotinic Acid 0.005 - 4.06E-04 
DL-Calcium Pantothenate 0.005 - 1.05E-04 
Vitamin B12 0.0001 - 7.38E-07 
p-Aminobenzoic Acid 0.005 - 3.65E-04 
Lipoic Acid 0.005 - 2.42E-04 
    
5 M NH4Cl Solution (per L H2O)    
NH4Cl 267.5 - 10 
    
80 mM K2HPO4 Solution (per L H2O)    
K2HPO4 14 - 0.8 
    
Divalent Cation Solution (per 500 mL H2O)    
CaCl2∙2H2O 1.26 - 8.6 
MgCl2∙6H2O 24.75 - 121.7 
MgSO4∙7H2O 31.05 - 126.0 
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Table B.4: iMR540 in silico Medium.  This is the medium for the “maxGrowthOnH2.m” script, which simulates 
growth of M. maripaludis on H2+CO2 with acetate supplementation. It contains some, but not all, of the trace 
minerals in McNA chemostat medium (see Table B.3). Adding these compounds as possible in silico medium 
components would not affect simulations because the model does not require these compounds to simulate 
growth, thus they are not included here.  
Compound ID Compound Name Reaction ID 
cpd00001 H2O EX_cpd00001[e0] 
cpd00009 Phosphate EX_cpd00009[e0] 
cpd00011 CO2 EX_cpd00011[e0] 
cpd00013 NH3 EX_cpd00013[e0] 
cpd00029 Acetate EX_cpd00029[e0] 
cpd00030 Mn2+ EX_cpd00030[e0] 
cpd00034 Zn2+ EX_cpd00034[e0] 
cpd00058 Cu2+ EX_cpd00058[e0] 
cpd00063 Ca2+ EX_cpd00063[e0] 
cpd00099 Cl- EX_cpd00099[e0] 
cpd00131 Molybdenum EX_cpd00131[e0] 
cpd00149 Co2+ EX_cpd00149[e0] 
cpd00205 K+ EX_cpd00205[e0] 
cpd00239 H2S EX_cpd00239[e0] 
cpd00244 Ni2+ EX_cpd00244[e0] 
cpd00254 Mg EX_cpd00254[e0] 
cpd00305 Thiamin EX_cpd00305[e0] 
cpd00355 Nicotinamide ribonucleotide EX_cpd00355[e0] 
cpd03396 Selenate EX_cpd03396[e0] 
cpd10515 Fe2+ EX_cpd10515[e0] 
cpd10516 Fe3 EX_cpd10516[e0] 
cpd11640 H2 EX_cpd11640[e0] 
cpd15269 Octadecenoate EX_cpd15269[e0] 
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Supplementary Information B.1: Comparison with Genome-Scale Essentiality Indices. The following short analysis 
compares gene knockout predictions from iMR540 against essentiality index predictions, another model that 
attempts to evaluate essential genes. 
A previous group performed a genome-scale analysis gene function of Methanococcus 
maripaludis via a saturated mutagenesis technique on rich and minimal media [163]. Although 
this dataset does not contain the same quality of knockout data as actual knockout experiments, it 
provides a valuable “first pass” test set for gene essentiality of our model. For minimal medium 
in particular, their data included 2 whole genome libraries of mapped insertions, each of which 
contained growth data for 7 (T1) and 14 generations (T2). Reasoning that essential genes would 
likely be conserved across mutants, they correlated number of insertions at a particular gene 
location with gene essentiality by calculating an “essentiality index” (EI) for each location. 
Based upon a set of “known essential” genes, they set a cutoff of EI ≤ 3 for essential genes, 
effectively creating predictions of gene essentiality for all genes.  
Considering the 4 sets of library:generation combinations—Lib.1:T1, Lib.1:T2, Lib.2:T1, 
Lib.2:T2—each gene  could be predicted to be essential in 0-4 cases. Rather than globally 
classify gene essentiality based on all 4 cases, we created 4 separate sets of essential genes by 
setting different essentiality thresholds. For example, in “4 instances”, only genes that were 
predicted as essential in all 4 libraries were treated as essential genes and all other genes were 
considered non-essential; in “1 instance”, all genes that were predicted as essential in at least 1 
library were treated as essential genes. The iMR540 reconstruction shared 538 genes with this 
dataset, thus we were able to compare gene essentiality predictions across nearly the entire 
model.  
As shown by Figure B.1, different thresholds had a great effect on the EI predictions; a lower 
threshold necessarily caused an increase in negative (no-growth) outcomes and a decrease in 
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positive (yes-growth) outcomes. Our model experienced no change in its gene essentiality 
predictions in relation to threshold, hence a decrease in threshold resulted in improved 
performance on negative predictions and decreased performance on positive predictions.  The 
threshold’s effect on overall performance, displayed in Figure B.2, shows that our model’s 
predictive accuracy in the four cases ranged from 61.3-65.2% and was maximized in the “3 
instances” dataset, whereas MCC ranged from 0.283-0.326 and was highest for “2 instances”. 
This small discrepancy reflects the difference in how these metrics are calculated, with MCC 
putting greater emphasis on our model’s improved ability to predict true negative outcomes.  
Overall, this analysis revealed a slight positive correlation between EI predictions and gene 
essentiality predictions from out model. It is important to keep in mind that EI, like our 
reconstruction, is a model of gene essentiality and should not be confused for actual knockout 
data. Through different methods, both models provide hypotheses for gene functions outside 
known metabolism and could fuel future investigations to directly measure gene essentiality. 
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Figure B.1: Comparison of model predictions with genome-scale essentiality indices (EI) on minimal media across 
4 libraries. Instances indicate the threshold of libraries for qualifying a gene as lethal. Positive results indicate 
predicted non-lethal genes, negative results indicate predicted lethal-genes. TP: true positive, model and EI both 
predict non-lethality; TN: true negative, model and EI both predict lethality; FP: false positive, model predicts non-
lethality, EI predicts lethality; FN: false negative, model predicts lethality, EI predicts non-lethality.  
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Figure B.2: A comparison of model predictions with genome-scale essentiality indices (EI) on minimal media 
across 4 libraries. We used Matthews Correlation Coefficient (MCC; left y-axis) and predictive accuracy (ACC; right 
y-axis) to compare our model’s predictions against the EI predictions. Instances indicate the threshold of libraries 
for qualifying a gene as lethal.  
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Figure B.3: Determination of the relationship between cell density and optical density (OD660). Linear regression 
was set to intersect (0,0), as cell density must necessarily be 0 when OD660 = 0. For specific methodology on how 
these points were gathered, see Chapter 3 Methods.  
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Figure B.4: Illustration of the process used to determine ATP maintenance values (see Chapter 3 Methods). Using 
all 9 measured samples, GAM (slope) and NGAM (y-intercept) were determined as 168.4 and 5.12 (mmol per 
grams [cell mass] per hour), respectively.  
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Supplementary File B.1: Example scripts for simulating iMR540. Reproduced here are the following scripts: 
“optimizeThermoModel” code that adds overall free energy estimation to an FBA solution; “maxGrowthOnH2” 
code that simulates maximum growth on H2+CO2 and prints out relevant fluxes; “simulateKOPanel” code that 
creates the knockout validation panel shown in Chapter 3. A full set of scripts for working with iMR540 can be 
found on GitHub (https://github.com/marichards/methanococcus) 
function [solution,gibbs_flux,model] = 
optimizeThermoModel(model,substrateRxns,concentrations,T,water_rxn,constraint_flag) 
 
%% 
% Version 4: 06/23/2015 
% 
% Accepts a model and necessary parameters for estimating thermodynamics of 
% the overall system. Adds a new metabolite "dG" to the system that measures 
% the free energy contribution for each exchange metabolite and a new 
% reaction "GIBBS_kJ/GDW" that sums overall free energy for the system 
% 
% INPUT: 
% model: a COBRA Toolbox model structure with a freeEnergy field 
% substrateRxns: a set of exchange reactions for metabolites with specified 
% concentrations 
% concentrations: a set of concentrations corresponding to the specified 
% substrateRxns (in mM) 
% T: temperature (in Kelvin) for simulating growth 
% water_rxn: identity of the water exchange reaction in the model. Water is 
% treated separately from the aqueous metabolites and must be specified 
% here. 
% 
% OUTPUT: 
% solution: an FBA flux distribution that optimizes the supplied model 
% gibbs_flux: an estimation of free energy produced by the model in the 
% specified flux distribution (in kJ/gDCW/h) 
% model: the supplied model with the addition of an overall reaction, 
% GIBBS_kJ/GDW, that sums free energy for exchange reactions flowing in and 
% out of the model 
% 
% Matthew Richards, 10/06/2015 
 
% dG values are at pH=7.0 and ionic strength of 0.1 M 
 
% Don't constrain solutions to be negative if there's no flag 
if nargin < 6 
    constraint_flag = false; 
end 
 
% Catch concentrations that are 0 
if any(~concentrations) 
    solution = optimizeCbModel(model,[],'one'); 
    gibbs_flux = inf;   
 
 
213 
 
Supplementary File B.1 (cont.) 
 
else 
     
    % Give an error for things not the same size 
    if length(substrateRxns) ~= length(concentrations) 
        error('substrateRxns and concentrations must be of equal length') 
    end 
     
    % Gas constant specification 
    R = 8.314e-6; %kJ/mmol*K 
 
    % Add the new reaction first, which adds the metabolite 
    model = addReaction(model,'GIBBS_kJ/GDW','dG <=> ');  
    % Give it no free energy of its own 
    [~,gibbs_idx] = intersect(model.rxns,'GIBBS_kJ/GDW'); 
    model.freeEnergy(gibbs_idx) = 0; 
    % Find index of dG 
    [~,met_idx] = intersect(model.mets,'dG'); 
 
    % Alter the free energy values for things with substrate reactions in 
    % the free energy vector itself 
    % First grab the index of the exchange reactions in the model 
    [rxns,rxn_idx] = intersect(model.rxns,substrateRxns,'stable'); 
    % Make a dictionary 
    dict = containers.Map(rxns,rxn_idx);       
    % For those indices, change the free energy numbers using concentration 
    % Loop: put in the correct free energy term for each: 
    % Basis: dG = dG_0 + RTln(C) 
    for i = 1:length(substrateRxns) 
       % Change the dG weight for the exchange reaction (Conc in mM) 
       model.freeEnergy(dict(substrateRxns{i})) = model.freeEnergy(dict(substrateRxns{i}))... 
           +R*T*log(concentrations(i));     
    end 
     
    % Add free energy values to S matrix for every one at once 
    model.S(met_idx,:) = model.freeEnergy; 
     
    % Go back and fix the Gibbs reaction to take in dG 
    model.S(met_idx,gibbs_idx) = -1; 
 
    % New Part (4/30/2013) 
    % Add water contribution, which isn't reflected elsewhere 
    [~,rxn_idx] = intersect(model.rxns,water_rxn); 
    model.S(met_idx,rxn_idx) = model.freeEnergy(rxn_idx); 
 
    % Let the free energy be as low as it desires 
    model = changeRxnBounds(model,'GIBBS_kJ/GDW',-inf,'l'); 
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Supplementary File B.1 (cont.) 
   
    % If there's a constraint flag, then make free energy have to be 
    % negative 
    if constraint_flag 
        model = changeRxnBounds(model,'GIBBS_kJ/GDW',0,'u'); 
    end 
 
    % Simulate the model with minimization of overall flux 
    solution = optimizeCbModel(model,[],'one'); 
 
    % Find the gibbs flux 
    if isempty(solution.x) 
        % If no solution, return that 
        fprintf('\nNO THERMODYNAMICALLY FEASIBLE SOLUTION\n') 
        gibbs_flux = []; 
    else 
        [~,idx] = intersect(model.rxns,'GIBBS_kJ/GDW'); 
        gibbs_flux = solution.x(idx); 
    end 
end 
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Supplementary File B.1 (cont.) 
 
function [solution,gibbs_flux,model] = 
maxGrowthOnH2(model,substrate_rxns,concentrations,print_flag) 
 
% Simulate M. maripaludis growth on CO2 and H2 media, with ammonia as the 
% nitrogen source. Print out the growth rate and relevant fluxes, return 
% the full solution, the predicted free energy generation, and the modified 
% model with the overall Gibbs free energy reaction added to the S matrix 
% 
% INPUT 
% model: the M. maripaludis model, a COBRA Toolbox model structure 
%  
% OPTIONAL INPUT 
% substrate_rxns: a list of exchange reactions in the M. maripaludis model 
% for which a known concentration will be supplied. If supplied, it must be 
% accompanied by a corresponding "concentrations" array. (Default = 
% {'EX_cpd00011[e]','EX_cpd11640[e0]','EX_cpd01024[e0]'}) 
% concentrations: a list of effective concentrations in mM corresponding to 
% the exchange reactions listed in "substrate_rxns". (Default = [1 1 1]) 
% 
% OUTPUT 
% solution: a flux distribution solution from running FBA on the M. 
% maripaludis model that maximizes biomass yield 
% gibbs_flux: model prediction of overall free energy generation, based on 
% the model exchange fluxes in the solution 
% model: the M. maripaludis model, with an additional reaction 
% (GIBBS_kJ/GDW) that predicts overall free energy generation 
%  
% Matthew Richards, 09/24/2015 
 
% Check if print_flag is supplied 
if nargin < 4 
    % Set default to true 
    print_flag = true; 
end 
 
% Ensure that H2 is the electron source 
model = switchToH2(model); 
 
% Make sure that ammonia is the nitrogen source 
model = switchToNH3(model); 
 
% Specify substrate reactions and concentrations as 1 mM if not given 
if nargin<2 
     
    substrate_rxns = {'EX_cpd00011[e0]','EX_cpd11640[e0]','EX_cpd01024[e0]'}; 
    concentrations = [1 1 1]; 
 
 
216 
 
Supplementary File B.1 (cont.) 
 
    warning_flag = 1; 
end 
%Solve by maximizing biomass 
[solution,gibbs_flux,model] = optimizeThermoModel(model,substrate_rxns... 
    ,concentrations,310,'EX_cpd00001[e0]'); 
 
% Check for print flag  
if print_flag 
 
    %Pull out the overall reaction CO2 + 4H2 --> CH4 + 2H2O 
    %Find the reaction indices 
    [~,h2_idx]  = intersect(model.rxns,'EX_cpd11640[e0]'); 
    [~,co2_idx] = intersect(model.rxns,'EX_cpd00011[e0]'); 
    [~,ch4_idx] = intersect(model.rxns,'EX_cpd01024[e0]'); 
    [~,h2o_idx] = intersect(model.rxns,'EX_cpd00001[e0]'); 
    [~,form_idx] = intersect(model.rxns,'EX_cpd00047[e0]'); 
    [~,nh3_idx] = intersect(model.rxns,'EX_cpd00013[e0]'); 
    [~,po4_idx] = intersect(model.rxns,'EX_cpd00009[e0]'); 
    [~,ac_idx] = intersect(model.rxns,'EX_cpd00029[e0]'); 
 
    %Print the biomass flux 
    fprintf('\n\nBiomass flux: %f\n\n',solution.f); 
    %Print the reaction fluxes 
    fprintf('Formate flux: %f\n',solution.x(form_idx)) 
    fprintf('CO2 flux: %f\n',solution.x(co2_idx)) 
    fprintf('H2 flux: %f\n',solution.x(h2_idx)) 
    fprintf('H2O flux: %f\n',solution.x(h2o_idx)) 
    fprintf('CH4 flux: %f\n',solution.x(ch4_idx)) 
    fprintf('NH3 flux: %f\n',solution.x(nh3_idx)) 
    fprintf('PO4 flux: %f\n',solution.x(po4_idx)) 
    fprintf('Acetate flux: %f\n',solution.x(ac_idx)) 
 
    %Print the per-CO2 actual reaction 
    fprintf('\nOverall reaction:\nCO2 + 4 H2 --> 2 H2O + CH4\n') 
    fprintf('\nModel overall reaction (per mole CH4)\n') 
    fprintf('%0.2f CO2 + %0.2f H2 --> %0.2f H2O + CH4\n\n',-
solution.x(co2_idx)/solution.x(ch4_idx),... 
        -solution.x(h2_idx)/solution.x(ch4_idx),solution.x(h2o_idx)/solution.x(ch4_idx)) 
 
    %Print the yield coefficient (grams biomass per mole CH4 produced) 
    fprintf('Measured Yield Coefficient: 4.11 +/- 0.83 gDCW/mol CH4\n') 
    fprintf('Predicted Yield Coefficient: %0.2f gDCW/mol 
CH4\n\n',solution.f*1000/solution.x(ch4_idx)/log(2)) 
 
    %Find the ATP reaction index 
    [~,atp_idx] = intersect(model.rxns,'ATPS'); 
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    %Print the ATP yield coefficient (ATP per CH4) 
    fprintf('Expected ATP/CH4 Yield: 0.5\n') 
    fprintf('Predicted ATP/CH4 Yield: %0.3f\n\n', solution.x(atp_idx)/solution.x(ch4_idx)) 
end 
 
 
%Add a warning for simulations with no concentrations given 
if warning_flag 
    warning('All external metabolite concentrations set to 1 mM'); 
end 
 
% Print out the gibbs free energy prediction 
if print_flag 
     
    fprintf('Predicted Free Energy Generation: %f kJ/gDCW\n\n',gibbs_flux) 
 
end 
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function simulateKOPanel(model) 
 
% For the M. maripaludis S2 model, simulate the model for known gene KO 
% experiments to get predictions and compare predictions to reality. Do all 
% possible KOs for all 4 conditions, not just the replicates of experiments 
% 
% INPUT 
% model: the M. maripaludis model, a COBRA Toolbox model structure 
% 
% Matthew Richards, 09/24/2015 
 
 
% Alteration on 05/26/2015: Add MCC and accuracy calculations 
% Create TP/TN/FP/FN metrics to fill up on appropriate things 
tp = 0; tn = 0; fp = 0; fn = 0; 
 
% Set GAPOR off to begin with 
model = changeRxnBounds(model,'rxn07191[c0]',0,'b'); 
% Make sure model is set to H2 
model = switchToH2(model); 
% Set methane and EhA/Ehb Bounds on model 
model = setMethaneSecretion(model,50); 
 
% H2-CO2 simulations 
fprintf('================================\nGrowth on H2 + 
CO2\n================================'); 
 
% First simulate Wild-type growth 
solution = optimizeCbModel(model,[],'one'); 
fprintf('\nWild-Type Growth: %0.2f\n\n',solution.f); 
wt_growth = solution.f; 
 
% Simulate Hmd KO (mmp0127) 
ko_model = deleteModelGenes(model,'mmp0127',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Hmd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
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% Simulate Mtd KO (mmp0372) 
ko_model = deleteModelGenes(model,'mmp0372',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Mtd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FrcA KO (mmp0820) 
ko_model = deleteModelGenes(model,'mmp0820',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FruA KO (mmp1382) 
ko_model = deleteModelGenes(model,'mmp1382',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FrcA-FruA double KO (mmp0820 and mmp1382) 
ko_model = deleteModelGenes(model,{'mmp0820','mmp1382'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
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% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  VhuAU-VhcA triple KO (mmp1694, mmp1693, mmp0823) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1694','mmp1693','mmp0823'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-VhuAU-VhcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  HdrB2 KO (mmp1053) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1053'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-HdrB2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1 KO (mmp1298) 
ko_model = deleteModelGenes(model,{'mmp1298'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2 KO (mmp0138) 
ko_model = deleteModelGenes(model,{'mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1-FdhA2 double KO (mmp1298 and mmp0138) 
ko_model = deleteModelGenes(model,{'mmp1298','mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2B2 KO (mmp0138 and mmp0139) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp0138','mmp0139'},0); 
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solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2B2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate EhbF KO (mmp1628) 
ko_model = deleteModelGenes(model,'mmp1628',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-EhbF Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 3H2ase KOs of frcAGB,fruAGB,hmd 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, and mmp0127) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp0818','mmp0817','mmp1382','mmp1384','mmp1385','mmp0127'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-3H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 5H2ase KOs of frcA,fruA,hmd,vhuAU,vhcA 
% (mmp0820, mmp1382,mmp0127,mmp1694,mmp1693,mmp0823) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-5H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
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else 
    % Then add to False Negative 
    tn = tn+1; 
end 
 
% Simulate 6H2ase KOs of frcA,fruA,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
else 
    % Then add to False Negative 
    tn = tn+1; 
end 
 
% Simulate 6H2ase-cdh KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN, and cdh WITH CO supp 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, 
mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp0983-0995) 
ko_model = deleteModelGenes(ko_model,... 
    {'mmp0983','mmp0984','mmp0985'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase-cdh Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Turn on GAPOR 
model = changeRxnBounds(model,'rxn07191[c0]',-1000,'l'); 
model = changeRxnBounds(model,'rxn07191[c0]',1000,'u'); 
 
% Simulate 6H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase_supp Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 7H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN,ehaNO 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp1461,mmp1462) 
ko_model = deleteModelGenes(model,... 
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{'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153','mmp1461','m
mp1462'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-7H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% Formate simulations 
fprintf('\n================================\nGrowth on 
Formate\n================================'); 
model = switchToFormate(model); 
 
% Set GAPOR off to begin with 
model = changeRxnBounds(model,'rxn07191[c0]',0,'b'); 
 
% First simulate Wild-type growth 
solution = optimizeCbModel(model,[],'one'); 
fprintf('\nWild-Type Growth: %0.2f\n\n',solution.f); 
wt_growth = solution.f; 
 
% Simulate Hmd KO (mmp0127) 
ko_model = deleteModelGenes(model,'mmp0127',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Hmd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate Mtd KO (mmp0372) 
ko_model = deleteModelGenes(model,'mmp0372',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Mtd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
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    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FrcA KO (mmp0820) 
ko_model = deleteModelGenes(model,'mmp0820',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FruA KO (mmp1382) 
ko_model = deleteModelGenes(model,'mmp1382',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate FrcA-FruA double KO (mmp0820 and mmp1382) 
ko_model = deleteModelGenes(model,{'mmp0820','mmp1382'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
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% Simulate  VhuAU-VhcA triple KO (mmp1694, mmp1693, mmp0823) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1694','mmp1693','mmp0823'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-VhuAU-VhcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  HdrB2 KO (mmp1053) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1053'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-HdrB2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  FdhA1 KO (mmp1298) 
ko_model = deleteModelGenes(model,{'mmp1298'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  FdhA2 KO (mmp0138) 
ko_model = deleteModelGenes(model,{'mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
 
226 
 
 
Supplementary File B.1 (cont.) 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate  FdhA1-FdhA2 double KO (mmp1298 and mmp0138) 
ko_model = deleteModelGenes(model,{'mmp1298','mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
else 
    % Then add to False Negative 
    tn = tn+1; 
end 
 
% Simulate  FdhA2B2 KO (mmp0138 and mmp0139) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp0138','mmp0139'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2B2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate EhbF KO (mmp1628) 
ko_model = deleteModelGenes(model,'mmp1628',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-EhbF Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 3H2ase KOs of frcAGB,fruAGB,hmd 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, and mmp0127) 
ko_model = deleteModelGenes(model,... 
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    {'mmp0680','mmp0820','mmp0818','mmp0817','mmp1382','mmp1384','mmp1385','mmp0127'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-3H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 5H2ase KOs of frcA,fruA,hmd,vhuAU,vhcA 
% (mmp0820, mmp1382,mmp0127,mmp1694,mmp1693,mmp0823) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-5H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
else 
    % Then add to True Negative 
    tn = tn+1; 
end 
 
% Simulate 6H2ase KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
else 
    % Then add to True Negative 
    tn = tn+1; 
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end 
 
% Simulate 6H2ase-cdh KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN, and cdh WITH CO supp 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, 
mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp0983-0995) 
ko_model = deleteModelGenes(ko_model,... 
    {'mmp0983','mmp0984','mmp0985'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase-cdh Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Turn on GAPOR 
model = changeRxnBounds(model,'rxn07191[c0]',-1000,'l'); 
model = changeRxnBounds(model,'rxn07191[c0]',1000,'u'); 
 
% Simulate 6H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase_supp Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 7H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN,ehaNO 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp1461,mmp1462) 
ko_model = deleteModelGenes(model,... 
    
{'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153','mmp1461','m
mp1462'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-7H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
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    % Then add to False Negative 
    fn = fn+1; 
end 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% Formate plus H2 simulations 
fprintf('\n================================\nGrowth on Formate + 
H2\n================================'); 
model = changeRxnBounds(model,'EX_cpd11640[e0]',-1000,'l'); 
 
% Set GAPOR off to begin with 
model = changeRxnBounds(model,'rxn07191[c0]',0,'b'); 
 
% First simulate Wild-type growth 
solution = optimizeCbModel(model,[],'one'); 
fprintf('\nWild-Type Growth: %0.2f\n\n',solution.f); 
wt_growth = solution.f; 
 
% Simulate Hmd KO (mmp0127) 
ko_model = deleteModelGenes(model,'mmp0127',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Hmd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate Mtd KO (mmp0372) 
ko_model = deleteModelGenes(model,'mmp0372',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Mtd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FrcA KO (mmp0820) 
ko_model = deleteModelGenes(model,'mmp0820',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FruA KO (mmp1382) 
ko_model = deleteModelGenes(model,'mmp1382',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FrcA-FruA double KO (mmp0820 and mmp1382) 
ko_model = deleteModelGenes(model,{'mmp0820','mmp1382'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  VhuAU-VhcA triple KO (mmp1694, mmp1693, mmp0823) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1694','mmp1693','mmp0823'},0); 
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solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-VhuAU-VhcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  HdrB2 KO (mmp1053) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1053'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-HdrB2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1 KO (mmp1298) 
ko_model = deleteModelGenes(model,{'mmp1298'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2 KO (mmp0138) 
ko_model = deleteModelGenes(model,{'mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1-FdhA2 double KO (mmp1298 and mmp0138) 
ko_model = deleteModelGenes(model,{'mmp1298','mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2B2 KO (mmp0138 and mmp0139) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp0138','mmp0139'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2B2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate EhbF KO (mmp1628) 
ko_model = deleteModelGenes(model,'mmp1628',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-EhbF Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 3H2ase KOs of frcAGB,fruAGB,hmd 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, and mmp0127) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp0818','mmp0817','mmp1382','mmp1384','mmp1385','mmp0127'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-3H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 5H2ase KOs of frcA,fruA,hmd,vhuAU,vhcA 
% (mmp0820, mmp1382,mmp0127,mmp1694,mmp1693,mmp0823) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823'}... 
    ,0); 
 
 
231 
 
Supplementary File B.1 (cont.) 
 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-5H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 6H2ase KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 6H2ase-cdh KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN, and cdh WITH CO supp 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, 
mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp0983-0995) 
ko_model = deleteModelGenes(ko_model,... 
    {'mmp0983','mmp0984','mmp0985'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase-cdh Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Turn on GAPOR 
model = changeRxnBounds(model,'rxn07191[c0]',-1000,'l'); 
model = changeRxnBounds(model,'rxn07191[c0]',1000,'u'); 
 
% Simulate 6H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
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solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase_supp Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 7H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN,ehaNO 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp1461,mmp1462) 
ko_model = deleteModelGenes(model,... 
    
{'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153','mmp1461','m
mp1462'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-7H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% Formate plus CO simulations 
fprintf('\n================================\nGrowth on Formate + 
CO\n================================'); 
model = changeRxnBounds(model,'EX_cpd11640[e0]',0,'l'); 
model = changeRxnBounds(model,'EX_cpd00204[e0]',-1000,'l'); 
 
% Set GAPOR off to begin with 
model = changeRxnBounds(model,'rxn07191[c0]',0,'b'); 
 
% First simulate Wild-type growth 
solution = optimizeCbModel(model,[],'one'); 
fprintf('\nWild-Type Growth: %0.2f\n\n',solution.f); 
wt_growth = solution.f; 
 
% Simulate Hmd KO (mmp0127) 
ko_model = deleteModelGenes(model,'mmp0127',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Hmd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate Mtd KO (mmp0372) 
ko_model = deleteModelGenes(model,'mmp0372',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-Mtd Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FrcA KO (mmp0820) 
ko_model = deleteModelGenes(model,'mmp0820',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FruA KO (mmp1382) 
ko_model = deleteModelGenes(model,'mmp1382',0); 
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solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate FrcA-FruA double KO (mmp0820 and mmp1382) 
ko_model = deleteModelGenes(model,{'mmp0820','mmp1382'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FrcA-FruA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  VhuAU-VhcA triple KO (mmp1694, mmp1693, mmp0823) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1694','mmp1693','mmp0823'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-VhuAU-VhcA Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  HdrB2 KO (mmp1053) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp1053'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-HdrB2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1 KO (mmp1298) 
ko_model = deleteModelGenes(model,{'mmp1298'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2 KO (mmp0138) 
ko_model = deleteModelGenes(model,{'mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA1-FdhA2 double KO (mmp1298 and mmp0138) 
ko_model = deleteModelGenes(model,{'mmp1298','mmp0138'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA1-FdhA2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate  FdhA2B2 KO (mmp0138 and mmp0139) 
ko_model = deleteModelGenes(model,{'mmp0680','mmp0138','mmp0139'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-FdhA2B2 Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate EhbF KO (mmp1628) 
ko_model = deleteModelGenes(model,'mmp1628',0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-EhbF Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 3H2ase KOs of frcAGB,fruAGB,hmd 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, and mmp0127) 
ko_model = deleteModelGenes(model,... 
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    {'mmp0680','mmp0820','mmp0818','mmp0817','mmp1382','mmp1384','mmp1385','mmp0127'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-3H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 5H2ase KOs of frcA,fruA,hmd,vhuAU,vhcA 
% (mmp0820, mmp1382,mmp0127,mmp1694,mmp1693,mmp0823) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-5H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 6H2ase KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (non-lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to True Positive 
    tp = tp+1; 
else 
    % Then add to False Negative 
    fn = fn+1; 
end 
 
% Simulate 6H2ase-cdh KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN, and cdh WITH CO supp 
% (mmp0820, mmp0818, mmp817, mmp1382, mmp1384, mmp1385, 
mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp0983-0995) 
ko_model = deleteModelGenes(ko_model,... 
    {'mmp0983','mmp0984','mmp0985'},0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase-cdh Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Compare to experimental result (lethal) 
if solution.f/wt_growth >= 0.1 
    % Then add to False Positive 
    fp = fp+1; 
else 
    % Then add to True Negative 
    tn = tn+1; 
end 
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% Turn on GAPOR 
model = changeRxnBounds(model,'rxn07191[c0]',-1000,'l'); 
model = changeRxnBounds(model,'rxn07191[c0]',1000,'u'); 
 
% Simulate 6H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153) 
ko_model = deleteModelGenes(model,... 
    {'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-6H2ase_supp Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Simulate 7H2ase_supp KOs of frcAGB,fruAGB,hmd,vhuAU,vhcA,ehbN,ehaNO 
% (mmp0820, mmp1382, mmp0127,mmp1694,mmp1693,mmp0823,mmp1153,mmp1461,mmp1462) 
ko_model = deleteModelGenes(model,... 
    
{'mmp0680','mmp0820','mmp1382','mmp0127','mmp1694','mmp1693','mmp0823','mmp1153','mmp1461','m
mp1462'}... 
    ,0); 
solution = optimizeCbModel(ko_model,[],'one'); 
fprintf('-7H2ase Growth Ratio: %0.2f\n',solution.f/wt_growth); 
 
% Addition on 5/26/2015: Add MCC and accuracy calculation 
total = tp+tn+fp+fn; 
% First calculate total accuracy 
fprintf('\nGene Knockout Accuracy: %0.1f%%(%d/%d)\n',100*(tp+tn)/total,(tp+tn),total); 
 
% Next, calculate MCC 
mcc = (tp*tn-fp*fn)/sqrt((tp+fp)*(tp+fn)*(tn+fp)*(tn+fn)); 
fprintf('Matthews Correlation Coefficient: %0.2f\n',mcc) 
